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Abstract 
The human cytomegalovirus (HCMV) is the main agent of congenital infection worldwide. Although 
primary infections or reactivations do not represent a threat to most individuals, they impose a life-
threating event to a developing foetus or immunocompromised individuals. Although we have learnt 
much about sites of viral replication and cells involved in the end-stage disease, the specific pathway 
and essential cell types that the virus must go through to later establish a successful infection and 
latency is still not clear. HCMV encodes four GPCR homologues (vGPCR): US27, US28, UL33 and 
UL78. vGPCR have been implicated in viral pathogenesis due to their ability to activate signalling 
pathways and, thus, alter physiological processes to favour infection. US28 and UL33 have been 
shown to activate several kinases and transcriptional factors. A key component of both US28 and 
UL33 sequence is the DRY (Asp/Arg/Tyr) motif, a region directly involved with G protein binding. 
Because Gα protein content is cell type-dependent, signalling activation by vGPCR can differ from 
cell to cell. Furthermore, these receptors share the particular characteristic of being constitutively 
activated. Because HCMV studies are restricted to in vitro infections, murine cytomegalovirus 
(MCMV) has been used as a good model for HCMV infection. MCMV encodes M33, a homolog of 
UL33 that activates signalling pathways similarly to US28. It has been shown that M33 is essential 
for salivary gland tropism (SG) in mice, but where the defect occurs is still unknown. This thesis aims 
to determine the contribution of HCMV and MCMV vGPCR in virus modification of, or 
dissemination in, cell types/tissues that are implicated in the pathway to disease: (i) effects of 
expression in trophoblasts (HTR-8) and human umbilical vein endothelial cells (HUVEC) on 
downstream signalling (HCMV); (ii) dissemination from a peripheral infection via blood and 
lymphatics (MCMV); and (iii) identification of contribution of particular cell types in M33-dependent 
dissemination using Cre-loxP tagging of M33.  
Functional studies demonstrated migration induction of HTR-8 following transfection by either US28 
or UL33. In order to investigate potential mechanisms, signalling pathways were probed via detection 
of activated kinases and the secretion of matrix metalloproteinases (MMP) and chemokines (CK) via 
luminex assays.  Although differences in the level of kinases could not be measured by western blot, 
induction of MMP and CK were detected by Luminex assays, with contrasting results for US28 and 
UL33 in transfected cells (HTR-8 and HUVEC). An HCMV recombinant disrupted for US28 
signalling (DQY) was generated and compared with wild type HCMV and a US28 null mutant for 
induction of MMP and CK in virus-infected cells. US28-dependent effects were identified for 
infected human foreskin fibroblasts, but results for HUVEC were equivocal.   
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To determine potential bottlenecks to viral dissemination that may require M33 function(s), mice 
were infected with M33 knockout (M33) viruses by different routes: intranasal, -mimicking the 
most natural route, footpad - a more compartmentalized route, and intraperitoneal, the most direct 
route to major organs. To help track viral dissemination, a luciferase tagged M33 was generated and 
infection was compared to control virus (M78luc). M33 intranasal infection did not result in 
attenuation for colonisation of the nose, draining (superficial cervical) lymph nodes (dLN) or the 
lungs. Via footpad route, M33 colonised the footpad and dLN to levels equivalent to control virus, 
but was significantly attenuated in spread to the spleen and, subsequently, the salivary glands.  
Following intraperitoneal infection, the virus is readily delivered to major organs due to direct access 
to the bloodstream, there was no difference in the colonisation of primary organs (spleen, liver) 
between M33 and control MCMV, but M33 was still unable to colonise the SG. Taken together, 
these studies demonstrate that M33 is not required for the early stages of host colonisation to primary 
organs via the local lymphatics, but is essential for subsequent salivary gland tropism and/or infection.   
To assess contribution of specific cell types to dissemination of virus to SG, MCMV expressing M33 
under the control of loxP sites for either expression (“switching on”; M33ON) or deletion (“switching 
off”; M33OFF) were used to infect transgenic mice expressing Cre-recombinase. Following 
intranasal infection, M33ON and M33OFF viruses showed evidence of the contribution of switching 
to establishing or ameliorating SG dissemination, respectively.  The switching efficiency was more 
apparent in CD11c-Cre+ than LysM-Cre+ mice, suggesting that passage via myeloid CD11c+ cells 
may be important for M33-dependent MCMV tropism through this route. In intraperitoneal infection 
of transgenic mice, the “switching on” of M33 was evident in a proportion of infected mice that 
showed replication in the salivary glands. Infection could be detected in the SG of all transgenic mice 
inoculated with M33OFF virus. However, effect upon “switching off” was apparent in LysM-Cre+ 
mice, which presented a moderate reduction in infection of the SG. These findings suggest that, 
intraperitoneally, neither CD11c-Cre+ nor LysM-Cre+ cells are essential to SG dissemination, 
although they can contribute to SG colonization.  
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Chapter 1 - Introduction 
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1.1 Significance 
Human cytomegalovirus (HCMV) typically establishes an asymptomatic and persistent infection in 
the general population, but may cause a life-threatening infection to immunocompromised individuals 
or, via placental infection and transplacental spread, serious congenital disease. Cytomegaloviruses 
encode G protein-coupled receptor homologues (vGPCR), which are most closely related to 
chemokine receptors: while HCMV encodes four vGPCR (UL33, UL78, US27 and US28), the mouse 
cytomegalovirus (MCMV) encodes two (M33 and M78). Host chemokine receptors activate 
signalling pathways, mediated via G proteins or other moieties, and hence induce cell migration to 
sites of inflammation or specific tissue sites (‘homing’). Likewise, vGPCR can also alter cellular 
signalling pathways, greatly impacting viral pathogenesis: MCMV infection has been shown to be 
attenuated when M33 is deleted or its G protein-coupled signalling is ablated; and HCMV US28 and 
UL33 have been shown to partially complement M33 in vivo, indicating functional conservation. 
Studies of signalling by the CMV GPCR have often utilised model, readily transfected/infected cell 
types, which may reduce their relevance to viral pathogenesis.  This project sought to investigate 
functional effects of HCMV vGPCR in human cell types, including trophoblasts, of relevance to 
placental infection, and to delineate cell types important for the in vivo phenotypes attributable to 
M33 of MCMV. 
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1.2 Aims 
Characterize alterations in cellular processes and pathogenesis induced by G-protein coupled 
receptors (GPCR) homologues encoded by the human cytomegalovirus (HCMV) and the close related 
murine cytomegalovirus (MCMV), respectively 
1.2.1. Specific aims 
a) Characterise differences in cellular processes induced by the HCMV GPCR homologues US28 and 
UL33 in human cell types.  
b) Determine effects of US28 or UL33 mutation (affecting signalling) upon virus replication and 
cellular processes. 
c) Characterise effects of viral GPCR mutations upon infection and replication in specific cell types 
in vivo, using recombinant mouse CMV (MCMV) with mutations of M33. 
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1.3 Literature Review 
1.3.1 Herpesvirales Order 
The word “herpes” originates from the Greek word “herpein”, which means “creeping” or “crawling”. 
This is actually the description of the clinical signs produced by the infection of only some 
herpesviruses, particularly those that can replicate in epithelial cells (Franco & Roehe, 2007). Due to 
a close evolutionary process, typically, herpesviruses are very species-specific, but some can have a 
narrow range of hosts. In both cases, however, the virus has adapted to better survive within its natural 
host, developing mechanisms to overcome, or at least match, the host’s defences resulting in 
persistence long-term (presumably lifelong), with periodic shedding and transmission to new hosts. 
These adaptations probably contribute to severe disease being an infrequent event during 
herpesviruses infections, except for abnormal circumstances, like individuals with incomplete or 
compromised immune systems or when a virus ‘jumps species’ to infect an ‘accidental’ host (Pellett 
& Roizman, 2015, Franco & Roehe, 2007; Pellett et al., 2007). The members of the Herpesvirales 
order, however, are very heterogeneous regarding their clinical signs and cell tropism. Herpesviruses 
are among the biggest and more complex viruses found on Earth (Davison et al., 2002). These viruses 
are greatly disseminated, having a large range of host animal species – from homoeothermic to 
heterothermic; from vertebrates to invertebrates – and it is believed that many herpesviruses have not 
yet been made known (Pellett & Roizman, 2015; Pellett et al., 2007).  
The herpesviruses constitute a unique order in the viral taxonomy consisting of three families: 
Alloherpesviridae (fish and amphibian viruses), Herpesviridae (mammalian, avian and reptile 
viruses) and Malacoherpesviridae (mollusc virus); three subfamilies (all belonging to Herpesviridae 
family); 19 genera and 102 species (Davison et al., 2009; Savin et al., 2010) (ICTV, 2014). However, 
the most unique attribute of this order is the very distinguishable virion morphology that arranges 
these viruses together, rather than genetic identity. This is an extraordinary fact, since phylogenetic 
relationships generally take precedence for taxonomical organization following the advance of 
molecular technologies; nevertheless, for herpesviruses, this is still a secondary factor. In fact, these 
three families share a narrow genetic similarity (Hanson et al., 2011; McGeoch et al., 2006; Wu et 
al., 2009) (Pellett & Roizman, 2015). Only two genes have been described to display homology at 
the amino acid level among the families, namely DNA polymerase and the putative ATPase subunit 
of terminase. These genes encode, respectively, proteins responsible for replication and packaging of 
viral DNA into the capsid (Davison, 2010; 2011) (Pellett et al., 2011). 
Of all biological characteristics of the herpesviruses, the most striking, indeed the defining feature, is 
the virion morphology because, as aforementioned (Pellett & Roizman, 2015) (Davison et al., 2005; 
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Hanson et al., 2011). A herpesvirus is defined by its molecular structure: a spherical-shaped particle 
composed of a linear double-stranded DNA core coated by an icosahedral protein capsid, which is 
immersed in the tegument, an amorphous matrix composed mainly by proteins, which in turn is 
covered by a lipid envelope (Pellett & Roizman, 2015) (Davison, 2007). The viral genome is 
packaged in a highly compact state. The single copy of DNA occupies the entire interior of the capsid 
and it varies in size according to each viral species, ranging approximately from 108 (Ateline 
herpesvirus 3 and Bovine herpesvirus 4) to 295 kbp (Cyprinid herpesvirus 3). The capsid consists of 
162 protein subunits, denominated capsomers, that form a 20 triangular-face structure (ergo, 
icosahedral shape) with 125-130 nm of diameter; it is termed nucleocapsid since it encapsulates the 
viral genome. The matrix that surrounds the nucleocapsid appears to lack a defined organization, 
presenting symmetry to the capsid only where there is proximity with its structure. It can be comprised 
of more than 30 viral proteins, in addition to viral mRNA, host proteins and a few other host 
molecules. The tegument is a significant component of the virion, since it not only represents about 
40% of the protein viral mass, but it has been suggested to play an important role during the initial 
stages of infection, when the viral genome has not been yet released, and stabilizing the virion 
framework. Lastly, the envelope is the outmost layer of the viral particle. It consists of a bilaminar 
lipid membrane studded with glycosylated proteins, which are principally related to viral adsorption 
and entry into the host cell; however, they can also be involved in producing specific cellular 
responses in the host cell that may be of benefit to the viral infection. Most of these glycoproteins are 
poorly conserved across the order; in fact, the compositions of both tegument and envelope diverge 
extensively among the herpesviruses. Additionally, the envelope is comprised of host cell membrane 
lipids and may also contain some host proteins. A herpesvirus particle has a diameter of 
approximately 200 nm, although it may differ according to the species (Pellett & Roizman, 2015; 
Pellett et al., 2011) (Davison, 2007; 2010; Liu & Zhou, 2007; McGeoch et al., 2006). 
A second distinct trait common to herpesviruses is their particular life cycle. It can be divided in two 
phases: a productive infection, during which the virus replicates and may produce symptoms in the 
host, and a latent infection, which is characterized by a “dormant” state with low viral gene 
expression, no replication of infectious virions and maintenance of the genome as an episomal 
molecule (i.e. a circular shaped DNA) (Pellett & Roizman, 2015; Pellett et al., 2011). Herpesviruses 
have different replication strategies; however, a productive infection usually culminates with the 
death of the infected cell and the release of the viral progeny. For this reason, this phase of infection 
is also termed lytic infection. During infection, both DNA replication and particle assembly initially 
happen in the cell nuclei, with acquisition of mature tegument and envelope occurring in several 
extra-nuclear compartments. The establishment of a latent infection is a remarkable herpesvirus 
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attribute, as it allows the setting of a lifelong persistent infection. This ability is crucial to viral 
persistence, since it enables not only the virus survival but also new cycles of dissemination: in the 
presence of the right stimuli, viruses can reactivate, starting a new cycle of lytic infection and 
shedding. Unfortunately, a complete understanding of what influences latency maintenance and viral 
reactivation has not yet been achieved and, due to the diversity of the order, what is known for one 
virus is rarely applicable for another (Pellett & Roizman, 2015; Davison et al, 2002; Pellett et al., 
2011). For example, one of the triggers for reactivation of Malacoherpesviruses and 
Alloherpesviruses seems to be changes in the environment’s temperature; on the other hand, for some 
members of the Herpesviridae family two common scenarios associated with reactivation are stress 
and low immunity (Burge et al., 2006; Eide et al., 2011; Jones, 2003; Nicoll et al., 2012). Probably, 
the diversity of molecular systems points to changes in the strategy along evolution (Davison et al., 
2002). Nevertheless, even though mechanisms vary among viruses, it is believed that a key element 
distinguishing between productive and latent infection resides in the expression of the immediate-
early viral genes, which are responsible for regulating viral and host gene expression (Pellett & 
Roizman, 2015; Pellett et al., 2011). 
1.3.2. Herpesviridae Family 
The Hepesviridae family is the most populated in the order, comprising 88 viral species (ICTV). The 
family shares 44 homologous genes, which are considered core genes and constitute the fundamental 
systems for replication (viral entry, DNA synthesis, DNA packaging, viral particle assembly and 
structural components). Although the arrangement of individual genes or gene families may differ 
among the subfamilies, these genes maintain a central position in the viral genome (ergo, core genes). 
Nevertheless, due to evolutionary divergences, even core genes that preserve sequence homology 
may exhibit dissimilar functions among the families, explaining, at least partially, the diversity of the 
main biological mechanisms and infection outcomes that different herpesviruses can produce within 
the same host.  The family also shares other genes, coding tegument, surface and control proteins, 
which are not considered core genes, because they were evolutionally acquired more recently. These 
(non-core) genes are generally localized in the extremities of the genome. They are responsible for 
accessory functions (like host-pathogen interaction, cell tropism, latency, control of life cycle, 
immune evasion) that assist the viral adjustment to the host environment and they often exert a 
function that is herpesvirus species or type-specific. The viral GPCR homologues are an example of 
accessory genes which are characteristic of the beta- and gammaherpesviruses, to be discussed later. 
(Davison, 2002; 2010; Davison et al., 2002; Mocarski Jr, 2007).  
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Herpesvirus genes are categorized according to their temporal expression in the infected cell: 
immediate-early (IE), early (E) and late (L) genes. The expression occurs in a regulatory cascade 
manner. The IE genes are the first to be expressed in the host cell and do not require any de novo viral 
DNA or protein synthesis, being instead reliant upon the host transcriptional machinery. After the 
viral genome is delivered into the nucleus, certain tegument proteins promote transcription of the IE 
genes. However, tegument proteins are not essential for IE gene expression, which enables latent 
virus to reactivate in the absence of tegument proteins and also enables purified viral DNA to be 
infectious upon transfection of cells.  The IE genes encode proteins that regulate cellular and viral 
gene expression, including essential factors for transactivation of early genes. Early genes encode 
proteins related with viral DNA synthesis and, therefore, their expression is also independent of viral 
DNA replication. Both IE and E promoters contain binding sites for transcription factors, such as 
CREB and NFκ-B. Late genes are responsible for the synthesis of the virion structural proteins and 
their expression is regulated by the E genes. Based on expression requirements, L genes can be 
subdivided in partial-late, those where expression is amplified by viral DNA synthesis, and true-late 
genes, for which viral DNA synthesis is a prerequisite for expression (Pellett & Roizman, 2015; 
ICTV, 2011) (Seitz et al., 2010; Sinclair & Sissons, 2006). 
According to shared biological features of its members and phylogenetic similarity, this family is 
divided in three subfamilies: Alphaherpesvirinae, Betaherpesvirinae and Gammaherpesvirinae. The 
alphaherpesviruses have a short replication cycle, with fast dissemination in cell culture, culminating 
with the lysis of the host cell. Many of the alphaherpesviruses have sensory ganglia as a major (but 
not necessarily sole) site of latency. Alphaherpesviruses that infect humans are the Human 
herpesvirus 1 (HHV-1, also known as Herpes simplex 1, HSV-1), Human herpesvirus 2 (HHV-2 or 
Herpes simplex 2, HSV-2) and Human herpesvirus 3 (HHV-3, also named as Varicella-zoster virus, 
VZV). The betaherpesviruses are known for having a narrower host range. Their life-cycle is long 
and in vitro replication develops at slower pace. Latent infections can be established in a variety of 
tissues. Betaherpesviruses that have a human host are Human herpesvirus 5 (HHV-5, also designated 
as Human cytomegalovirus, HCMV), Human herpesvirus 6 (HHV-6) and Human herpesvirus 7 
(HHV-7). In contrast to alpha and betaherpesviruses, gammaherpesviruses often establish latency 
upon cell infection instead of entering a lytic replication cycle. These viruses, in general, have a major 
tropism for T or B lymphocyte cells and establish latency in lymphoid cells. The human viruses of 
this subfamily are Human herpesvirus 4 (HHV-4 or Epsten-barr virus, EBV) and Human herpesvirus 
8 (HHV-8, formerly known as Kaposi’s sarcoma-associated herpesvirus, KSHV) (Pellett & Roizman, 
2015; ICTV, 2011).  
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In immunocompetent individuals, frequently, virus from the Betaherpesvirinae subfamily manifest 
themselves as a subclinical disease, i.e., without or with mild symptoms (ICTV, 2011). During in 
vitro infection, virus spread through the culture is often highly cell-associated (Seitz et al., 2010). 
During lytic infection, viruses alter cell-cycle progression, inhibiting both cellular division and cell 
apoptosis. Even though none of the members of the Betaherpesvirinae subfamily has been 
definitively associated with tumorigenesis, association between viral DNA/antigen and certain 
tumours has been described and some proteins have been found to contribute to the progression of 
certain cancers (Khan et al., 2014; Soroceanu et al., 2011). Also, in chronic infections, 
betaherpesviruses’ ability to modulate the host’s cell cycle may play a part in particular disorders 
(McCormick & Mocarski Jr, 2007). The Betaherpesvirinae subfamily is composed of four genera: 
Cytomegalovirus, Muromegalovirus, Proboscivirus and Roseolovirus.  
1.3.3. Cytomegalovirus (CMV) 
Cytomegaloviruses infect a variety of mammals and comprise not only the Cytomegalovirus genera, 
but also the Muromegalovirus genera and a few viruses that have not been yet assigned to any genera. 
As the name indicates, these viruses promote cell swelling (cytomegalo is derived from the Greek 
words “kytos”, cell, and “megas”, large) (ICTV, 2011). Besides the enlargement of the infected cell, 
these viruses also are known for being readily isolated from explanted salivary glands (Davison & 
Bhella, 2007). Gene duplication is also a common phenomenon among these viruses, demonstrated 
by the presence of clusters of related genes (Davison, 2002).  
Human CMV (HCMV) is considered the prototype virus among CMVs – it also is considered the 
model of the subfamily – and it is the most extensively studied virus within this group. However, 
research of other CMV species is crucial, since CMV viruses are highly species-specific. Even though 
non-human based models are not completely representative of the infection development in humans, 
they are imperative for studying viral pathogenesis. Thus, they have been to research many viral 
biologic mechanisms, as well as to try to better comprehend pathogenesis, immune response and host-
virus interactions. Murine models have also been largely employed to investigate diseases caused by 
HCMV: hepatitis and myocarditis, using MCMV; vascular disorders, employing a RCMV model; 
congenital infection, exploiting the cross-placental ability of GPCMV. Among the non-primate 
CMVs, the most thoroughly studied virus is the MCMV (Davison & Bhella, 2007, Redwood et al, 
2008). 
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1.3.4. Human cytomegalovirus (HCMV) 
Descriptions of HCMV pathology have been reported since at least 1881. The term “cytomegalia” 
has been first used in 1921 by Goodpasture and Talbot to describe the cell lesions provoked by the 
virus – although only five years later the causative agent would be confirmed as a virus. At that time, 
the virus was frequently found in salivary gland and visceral organs of infants. In 1950, it was 
suggested by Smith and Vellios that intrauterine infection could occur and lead to miscarriage or 
stillbirth. However, it was only in the mid-fifties that the HCMV isolation was achieved, due to the 
use of a new technique at the time: cell culture, which Smith used to replicate the mouse CMV using 
explants of mouse embryonic tissues. Applying the same principle, between 1954 and 1956, three 
distinct researchers – Smith, Rowe and Weller – isolated HCMV from different samples: salivary 
gland, adenoid tissue (clinical isolated also known as AD169) and liver (Davis strain), respectively 
(Griffiths, 2006; Riley, 1997) (Mocarski et al., 2015). In 1960, Weller proposed that the virus, 
previously only described as “salivary gland viruses”, be called after its cytopathologic effect 
(Mocarski et al., 2015; Griffiths, 2006).   
Cells infected by the HCMV have distinct morphologic alterations: the virus induces an abnormal 
growth in the cell and generates marked and typical intracellular inclusions in both cytoplasm and 
nucleus, leading to the emergence of multinucleated giant cells (cytomegalia) (Syggelou et al., 2010) 
(ICTV, 2011). The morphology of the HCMV viral particle follows the architecture of a typical 
herpesvirus virion, adjusting, however, to the HCMV particularities. The nucleocapsid lodges a 235 
kbp genome in 130-nm diameter (approx. 55% larger genome within a 17% larger volume 
nucleocapsid compared with HSV-1). In order to accomplish that, the viral DNA is in a highly 
compacted state, with only 26 Å of distance between helices, and fills the whole capsid. During 
replication, HCMV produces three types of capsid, reflecting the steps of viral particle assembly: 
empty capsids that accumulate in the cell due to inappropriate DNA packaging (type A); premature 
capsids that include only viral assembly proteins (type B), that probably originate non-infectious 
enveloped viruses; and DNA containing complete mature capsids (type C). Another structure 
abundantly formed during HCMV infection are the dense bodies, aggregations of tegument proteins 
with cytoplasmic-derived envelopes (Mocarski et al., 2015).   
Among the human herpesviruses, HCMV has the largest DNA. The GC content of HCMV genome 
is quite elevated, exhibiting a 57% average (Renzette et al., 2011). The genome also contains a larger 
number of sequence repeats, when compared to other herpesviruses. The HCMV genome, after serial 
passages in vitro, is known to suffer a process of deletion, originating defective viruses with genomes 
as small as 150 kps – curiously the DNA average size of other herpesviruses (Mocarski et al., 2015). 
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A good example would be the high-passage strains AD169 and Towne. Many experiments with 
HCMV are conducted using these strains, which have notably lost large sequences, 15 and 13 kb, 
respectively, of the UL/inverted b region of the genome. This region contains genes encoding the 
CXCL viral chemokine, tumour necrosis factor receptor homolog, natural killer cell evasion proteins 
and latency-related proteins, among others, explaining why AD169 and Towne have diminished 
virulence (Stanton et al., 2010). In fact, the size of HCMV genome is mainly due to the vast presence 
of accessory (family) genes – only 40 genes of the HCMV genome are considered core genes. Human 
CMV actually lost a few core genes during evolution, e.g. the thymidine kinase gene – part of DNA 
synthesis coding genes. This is an important feature, since many antiviral drugs target the product of 
this gene. On the other hand, many genes that manipulate the host immune system have arisen over 
the time within the HCMV genome, like ULL111A, an interleukin-10 coding gene, or US28, a 
chemokine receptor coding gene (Davison et al., 2002; Syggelou et al., 2010). Interestingly, many 
genes of different viral isolates may have a low level of similarity. Some of these are believed to be 
secreted or expressed at the cellular membrane and, thus, may be subject to a greater evolutional 
pressure by the immune system (Davison & Bhella, 2007). 
Regardless of broad in vivo tissue tropism, in vitro effective replication of HCMV is better achieved 
in human fibroblast culture (Mocarski et al., 2015). Epithelial and endothelial cell cultures are also 
quite permissive for viral infection. The virus can also replicate in some glioblastomas cell lines and 
smooth muscle cells, although with diminished productiveness (Landolfo et al., 2003). The 
expression profile of HCMV genes may differ, however, according with the cell-type infected. 
Different cell-types execute specialized functions and, thus, they express different genes that 
modulate their environment. In vitro, viral titers, CPE, replication kinetics, viral DNA yields, level 
of gene expression, viral molecular trafficking, translational and posttranslational processes differ 
considerably according to the cell type infected, demonstrating the major influence of cellular 
environment upon viral replication (Towler et al., 2012). 
In fibroblast cell culture, HCMV replication happens with a slow progress. After 5 hour of infection, 
cell rounding and intracellular inclusions become apparent. Sixteen hours after infection, DNA 
synthesis initiates. Since HCMV does not encode genes for nucleotide synthesis, it relies on host 
dNTPs and, therefore, HCMV infection also promotes host transcriptional and translational processes 
in the infected cell. DNA is then packaged into the capsid and the nucleocapsid exits the nucleus 
(Landolfo et al., 2003). One day post infection, the nucleus is positioned in the centre of the cell and 
it has a very well delimited nucleolus. The cell accumulates eosinophilic inclusions around the 
nucleus (Mocarski et al., 2015). To exit the nucleus, the virus crosses the nuclear membrane, going 
through a process of envelopment and de-envelopment. The HCMV particle leaves the nucleus 
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having already acquired a layer of (immature) tegument proteins. In the cytoplasm, it is not known 
how the particle is guided to the secondary site of envelopment that, for HCMV, occurs at the 
endoplasmic reticulum-Golgi intermediate compartment. There, the immature virion assembles with 
the outer tegument proteins and acquires the final envelope and associated glycoproteins, possibly in 
an endosome. Then, the mature virion is transported in a vesicle to the plasma membrane and, by 
membrane fusion, it exits the cell (Mettenleiter et al., 2006; 2009). At the third day post-infection, 
the characteristic cytopathic effect (CPE) is prominent. Cells have enlarged by the emergence of 2 
types of inclusion: a basophilic nuclear inclusion, result of cumulated capsids (giving the so called 
“owl's eye” aspect); and a big, well delineated, eosinophilic perinuclear inclusion, formed by capsids, 
dense bodies and the Golgi organelle. Not until the fourth day of infection can virions, which have 
been accumulating in the cytoplasm, be detected at elevated levels in the cell culture media (Mocarski 
et al., 2015). Nevertheless, an important portion of viral particles remain cell associated even at later 
stages of infection (Landolfo et al., 2003). Human CMV strains may, however, present divergent 
CPE from the one described above: while Davis strain displays a CPE characterized by rounded cells 
with the nucleus resembling the shape of a kidney, AD169 retains the cell fusiform shape and exhibits 
less prominent inclusions. Many clinical isolates have a cell-to-cell spread on cell culture and produce 
either a minor CPE, with few infection foci and very low viral titers, or Davis strain-like CPE 
(Mocarski et al., 2015).  
1.3.4.1. Human CMV infection 
Human CMV is a common cause of infection worldwide. It is the main causative agent of congenital 
infection in humans across the globe (Bale, 2012). The virus has also gained clinical importance in 
the past decades, due to its impact in the growing population of hosts with impaired immune 
responses: transplant patients, individuals with acquired immune deficient syndrome (AIDS) and 
even elderly population (Pawelec & Derhovanessian, 2011).  
HCMV infection has an incubation period that can vary from 1 to 2 months, during which viruses can 
be circulating in the blood, mainly as a cell-associated viraemia. In a naturally acquired infection, 
many cell types are permissive for replication: epithelial cells, among those the ductal cells of the 
salivary glands, renal epithelial cells and glandular cells of the reproductive tract, are particularly 
infected; endothelial cells; parenchyma cells; and mononuclear cells are the main targets (Seitz et al., 
2010). Following primary infection, the immune system fails to clear the virus, and a lifelong 
infection is set. Latency is established in hematopoietic progenitor cells (CD34+ and CD33+) in the 
bone marrow, where little viral gene transcription can be detected, mostly of presumed latency 
maintenance products. It has been estimated that the peripheral blood of a seropositive HCMV healthy 
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individual has 0.2% of leukocytes latently infected with HCMV. Reactivation episodes follow 
differentiation of the myeloid cells into macrophages and dendritic cells. Both of these cell types are 
permissive for viral productive infection, and expression of IE lytic genes can be detected in 
circulating cells. The immune system is responsible for restraining any viral reactivation attempts and 
serious symptoms are only observed in individuals with compromised immunity (Poole et al., 2015; 
Reeves & Sinclair, 2013; Towler et al., 2012).   
Unlike most herpesviruses, primary HCMV infection in healthy individuals is frequently silent 
(Syggelou et al., 2010). Less frequently, it induces minor symptoms similar to those of influenza or 
mononucleosis, such as fever, lymphocytosis, pharyngitis, lymphadenopathy, hepatosplenomegaly, 
minor increase in transaminase levels. On the other hand, productive viral infection, either primary 
or reactivation, can result in severe disease or even death in individuals of risk groups. The wide 
spectrum of cell types – and, thus, tissues and organs – that HCMV can infect plays a crucial part in 
the viral pathogenesis and it is the reason why the virus can promote a variety of symptoms. The 
major risk groups for HCMV disease are anyone with an impaired immune system: either acquired 
(e.g. AIDS patients) or genetic immunodeficiency; subjects with a low count of T lymphocytes 
induced by drugs or therapy (cancer treatment, transplanted patients); developing foetuses and 
premature neonates (Sacher et al., 2012; Seitz et al., 2010; Towler et al., 2012).  
1.3.4.2. Prevalence 
The virus is considered a ubiquitous human pathogen with a prevalence profile that increases with 
the ageing of population. The annual incidence of HCMV in central European countries ranges 
between 0.8 to 1.2% (Seitz et al., 2010). Congenital infection caused by HCMV afflicts 0.25 to 2% 
of neonates. In Australia, the rate of congenital infection is about 0.3%, which translates as over 400 
neonates born, every year, with congenital malformation due to HCMV (Munro et al., 2005; Naing 
et al., 2016).  
It is now clear that the epidemiology of HCMV may vary considerably between developed compared 
with developing countries, or between different socio-economic groups within a country. Though a 
major part of the population eventually becomes infected, the prevalence in developed countries is 
lower, when compared to undeveloped countries: in America, Western Europe and Australia the 
HCMV prevalence is between 40 and 70%, whereas in many Asian and African countries, the 
prevalence may go as high as 100% (Manicklal et al., 2013; Mocarski et al., 2015). In Australia, 38% 
of (healthy) infants between 1 and 2 years old are seropositive. By early twenties, about 50% of the 
population have contracted HCMV. At the late thirties, there is another peak of seroconversion in the 
population, with about 70% of the population being infected. By the late fifties, prevalence reaches 
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80% (Seale et al., 2006). This age-stratified prevalence is a characteristic of HCMV prevalence in 
developed countries. Modes of transmission are presumed to vary according to age group: first 
exposure may be congenital or via breast-milk; between 2-3 years old, by contact with saliva/urine 
of an infected person or contaminated objects; then between the teenage years and adulthood, as a 
result of sexual contact (Cannon, 2009; Cannon et al., 2010; Kurath et al., 2010). This age 
stratification contrasts with the situation in developing countries, such as India, where CMV is often 
acquired during early infancy and seroprevalence of young adult women may approach 100% 
(Kothari et al., 2002; Manicklal et al., 2013).   
Viral dissemination may be reducing in developed countries, due to increased hygiene habits 
(Mocarski et al., 2015; Seitz et al., 2010). However, high socioeconomic status is not a 
straightforward association to lower HCMV prevalence, as demographic markers can also influence 
seroprevalence. Worldwide, prevalence among reproductive age women varies from 45 to 100%: 
seroprevalence is higher in South America, Africa and Asia, but is also high (over 70%) in some 
countries in Europe (in Sweden and Italy, for example) and the Middle East (like Turkey and Israel) 
(Cannon et al., 2010). In Australia, the prevalence among women in reproductive age is 58% (Seale 
et al., 2006). Other factors may influence prevalence as well. In the U.S., HCMV prevalence was 
found to be 20-30% higher in non-white population and 10-30% higher among individuals with lower 
socioeconomic status. It is likely that these differences in prevalence are related with behaviour and 
environmental factors that can lead to exposure to HCMV transmission sources: breastfeeding 
frequency and duration; childcare attendance; sexual activity and practices; number of children per 
family (Cannon et al., 2010).  
1.3.4.3. Congenital infection 
The decrease in prevalence seen in developed countries carries a very dangerous downside: a big 
fraction of adults has become susceptible to primary infection and, thus, the risk of congenital HCMV 
transmission and related disorders has increased (Mocarski et al., 2015). It has been calculated that 
annually, in the U.S., over 500 thousand women at reproductive age will contract HCMV infection 
for the first time (Cannon et al., 2011). In Australia, primary infection rate of pregnant women is 
estimated at 1.2% (Munro et al., 2005). Mothers seropositive at conception should not be overlooked, 
however, as a significant contribution to the burden of congenital HCMV. Immunity against HCMV 
does not prevent reactivation episodes or infection with other viral strains, which may happen in 10% 
of pregnancies of HCMV carriers. Despite maternal immunity, re-infections or reactivations can still 
be fatal to the unborn. A higher number of congenital infections is associated with recurrent infection 
of seropositive mothers. However, manifestations and sequelae are more severe in congenital 
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infections caused by maternal primary infection than recurrent episode of infection (Hyde et al., 2010; 
Rahav et al., 2007; Syggelou et al., 2010). Nevertheless, the viral vertical transmission rate diverges 
greatly between the two groups, as the presence of antibodies can also represent a reducer factor of 
intrauterine transmission chances: while only in 0.2 to 1.8% of foetuses become infected with HCMV 
in seropositive mothers, the transmission rate of virus from mothers with primary infection during 
pregnancy is about 30 to 40% (Boppana et al., 2001; Kenneson & Cannon, 2007; Manicklal et al., 
2013; Syggelou et al., 2010; Zalel et al., 2008) (CDC, 2016). There is one study, however, suggesting 
that although differences in vertical transmission rate exist and are high, they are not as high as it has 
been indicated, and both groups share similar rates of congenital infection (Rahav et al., 2007).  
Congenital infection arises from HCMV placenta-crossing during a productive infection in 
pregnancy, which can happen with a seronegative woman – an individual that has never been in 
contact with the agent – or with a seropositive one. The latter can undergo through two different 
situations: reactivation of a latent infection or infection with another HCMV strain (Boppana et al., 
2001; Hyde et al., 2010; McDonagh et al., 2004; Wang et al., 2011). Maternal infected leukocytes 
allow viral access to permissive placental cells and amniotic fluid, which provide access to the foetus 
(Griffiths & Walter, 2005; Syggelou et al., 2010). Congenital infection can lead to severe permanent 
disabilities and to death. Consequences of infection are fatal in 10% of the cases, half of these deaths 
occurs during the perinatal period (Bale, 2012; Seitz et al., 2010; Zalel et al., 2008). In Australia, 
HCMV-related reported deaths correspond to 0.2 per 100,000 births. Even though it seems a small 
rate, HCMV is an important contributor to childhood mortality, representing 0.2% of deaths in 
neonates under 1 month old and accounting for 45% of deaths caused by congenital viral infections 
in the past 13 years (Smithers-Sheedy et al., 2015). Infection of neonates, on the other hand, occurs 
via contact of the newborn with infected maternal genital secretion or with infected breast milk. It 
usually affects 2 to 3% of newborns and it is frequently mistaken for sepsis, but infection of full-term 
newborns does not cause deafness or central nervous system (CNS) disorders. HCMV can only 
promote more severe consequences in very premature newborns. In both disorders, virus can be found 
in the urine and antibody response can only be detected after three weeks of life in perinatal infection. 
Thus, the diagnosis window of congenital infection is during the first three weeks of the neonate’s 
life (Damato & Winnen, 2002; Griffiths & Walter, 2005; Stern-Ginossar et al., 2012). 
Intrauterine HCMV infection is the main cause of deficiencies and developmental disabilities in 
neonates. During infection of the foetus, the main targets of virus replication are the eye, cochlea and 
brain. Severity of manifestation and outcome of congenital infection are related with the stage of 
development of the foetal tissues at the time of viral replication. Some of the most common conditions 
induced by congenital infection are hearing impairment, ophthalmologic disorders, microcephaly and 
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other anatomical brain abnormalities and abnormal cognitive abilities (mental retardation) (Hyde et 
al., 2010; Pass et al., 2006; Seitz et al., 2010). The majority of the intrauterine infected newborns 
present no signs at birth. However, during the first years of life, 10% of these subclinical infected 
neonates will manifest symptoms, including deafness, cerebral palsy, cognition disabilities, seizures 
or mental retardation. Later onset sequelae seem to be related with viral load (Amir et al., 2016; 
Forner et al., 2015; Rahav et al., 2007). 10 to 15% of neonates born with symptoms may develop 
other sequelae. Cytomegalic inclusion disease affects 10% of newborns with congenital infection. 
Clinical manifestations of cytomegalic inclusion disease at birth (microcephaly, hepatosplenomegaly, 
thrombocytopenic purpure, hearing loss, intracranial calcifications) are indicative of poor prognosis, 
culminating in death of 20 to 30% of neonates manifesting the disease (Damato & Winnen, 2002; 
Griffiths & Walter, 2005). 
Pathogenesis of HCMV intrauterine infection is also caused by placenta infection. It has been shown 
that viruses are found in the placenta of HCMV congenital infections (Benard et al., 2014; Sinzger et 
al., 1993). In early pregnancy miscarriages, HCMV can also be detected in placentas of uninfected 
foetuses (Hayes & Gibas, 1972), demonstrating that infection of the placenta precedes foetal 
infection. Furthermore, infection of villous trophoblasts was shown to release less than one percent 
of progeny into the stroma, where HCMV would gain access to the foetus (Hemmings & Guilbert, 
2002), which may suggest that foetal infection may also depend on other cell types, such as leukocytes 
or endothelial cells. In utero infected placentas, IE1/2 protein was detected in clusters of 
cytotrophoblasts, in syncytiotrophoblasts, in cytotrophoblast stem cells and in various cell types in 
the villous cores, including fibroblasts, endothelial cells and macrophages (Fisher et al., 2000). High 
loads of viral DNA in the placental villi or decidua have been associated with a higher incidence of 
miscarriages (Yan et al., 2015). Placenta infection has also been associated with development of 
intrauterine growth restriction. HCMV is able to infect trophoblasts, arrest their differentiation and 
interfere with cell proliferation (Pereira et al., 2014; Tabata et al., 2015). It has been suggested that 
expression of IE genes in infected cells results in a TNF--induced apoptosis of neighbouring 
trophoblasts (Chan et al., 2002). Taken together, this could explain the placenta damage and impaired 
development detected in infections. Moreover, it has also been reported that HCMV infection of 
trophoblasts can alter signalling pathways, such as Wnt/, expression of adhesion molecules, 
secretion of cytokines and cellular function, such as migration and invasion (Angelova et al., 2012; 
Hamilton et al., 2012; Schleiss et al., 2007; van Zuylen et al., 2016; Warner et al., 2012), causing 
further dysregulation of placenta functions. These changes are linked with higher risks of severe 
disease in the foetuses and poor pregnancy outcome during the first trimester (Enders et al., 2011; 
Pass et al., 2006).  
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1.3.4.4. HCMV infection of immunocompromised individuals 
HCMV is a major cause of morbidity in immunocompromised patients (Ross et al., 2011). 
Immunocompromised individuals are more likely to acquire primary infection or to develop 
reactivation episodes than healthy individuals. In these situations, acute fulminant infections can 
easily occur. These infections are hard to treat, regardless of antiviral therapy, threatening the life of 
the host. In most of the patients with Acquired Immune Deficiency Syndrome (AIDS), HCMV 
disease is more related to HCMV reactivation triggered by HIV-induced immunosuppression rather 
than experiencing a primary infection. Severity of symptoms is associated with the degree of 
immunodeficiency. The most common outcome is progressive retinitis that can lead to blindness. 
Other more infrequent HCMV-induced disorders include gastroenteritis, colitis, pneumonia, 
meningoencephalitis and polyradiculoneuropathy (Seitz et al., 2010) (Mocarski et al., 2015).  
Chemo- and radiotherapy, despite the intermittent induction of immune imbalance, do not usually 
lead to HCMV disease in patients. However, it can occur in transplanted subjects due to prolonged 
immune suppression. A previously acquired infection can be reactivated by a range of stimuli: other 
concomitant infections, cytokine production, graft-versus-host disease. The organ transplanted also 
influences the development of HCMV disease and, in cases of a HCMV infected donor, the disease 
usually affects the graft. The pathogenesis of HCMV in transplant patients is related to the immune 
regulatory ability of the virus and outcomes vary from organ rejection, superinfections by other 
microorganisms to post-transplantation lymphoproliferative disorders (Seitz et al., 2010) (Mocarski 
et al., 2015).  
1.3.4.5. Transmission 
HCMV is not a very contagious agent and contraction of the virus requires usually direct and extended 
contact with fluids or tissue containing HCMV. Virus has been isolated from various body fluids – 
including saliva, blood, breast milk, urine, faeces, cervical secretions and semen – and, thereby, they 
are sources of infection. Infection occurs by viral entry through the mucous membrane and through 
the bloodstream, which allows numerous manners of contraction (Damato & Winnen, 2002; Seitz et 
al., 2010). Transmission may also be related to cultural factors (Cannon et al., 2010). In a study by 
Staras et al. (2008) with 6 and 10 years old subjects from the U.S., the stronger association found 
between serostatus and subjects was serostatus of the mother and siblings. Human CMV-positivity in 
children was associated 2 to 4 times more with serostatus of family members then other childhood 
variables. This same study also found a small association between child care attendance and 
seroprevalence. To adults, caring for young children represent a high risk to contract infection. A 
study in Australia showed a remarkable increase in seropositivity between two age groups of women: 
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while 56% of 30 to 34 year old women were seropositive, 79% of 35 to 39 year old women were 
seropositive. Most likely, this rise in HCMV prevalence among parents of young children is via 
infection by their own children (Seale et al., 2006). Exposure to HCMV is increased by crowded 
living conditions, early sexual activity and greater numbers of sexual partners (Damato & Winnen, 
2002).  
It is believed that children represent the main source of HCMV infection, because the period of virus 
shedding is longer after primary infection and infants are more likely to be going through a first 
infection episode. The principal sites of viral shedding may differ between adults and children. In 
children, virus is more commonly found in urine, although the virus is also frequent in saliva. Thus, 
transmission between infants occurs mainly by contact with hands and toys contaminated with 
infected saliva or urine. All congenitally infected children shed virus at birth. Shedding may decline 
during the first 5 years of life, however, studies indicate that 80% of congenitally infected infants 
keep shedding virus after that period. This percentage is significantly smaller for other infected 
children, whose shedding is present in about 23% and 12% of individuals, depending on day care 
attendance or not, respectively. On the other hand, in adults viral shedding varies, depending on risk 
group. In adults without risk factors, shedding is more frequently detected in genital secretions – 
however saliva is frequently not examined. Adults exposed to risk factors (like raising an infant) are 
more likely to excrete virus through the urine. Adults in a risk group have 22% of chance to be 
shedding virus – which is 15% higher than shedding in adults without risk factors. Generally, blood 
plays only a small part in HCMV transmission (Cannon et al., 2011) 
Annual rates of first HCMV infection (i.e. seroconversion) differ among populations, according to 
environment and to risk behaviours. The risk of seroconversion among pregnant women is 2.3% and 
it has been associated with HCMV positive husband, having younger children at home or being Asian. 
Mothers can contract infection from caring of their older children; however, only 20 to 24% of 
parents, whose children are shedding virus, become infected (Cannon et al., 2010; CDC, 2016). 
Families with a CMV-positive member have a 10% rate of viral contraction. The average of 
seroconversion rates in healthcare population, especially in paediatric establishments, is also very 
low, only 2.3% (Hyde et al., 2010).  
1.3.5. Murid cytomegalovirus 1 (MCMV) infection 
The murid cytomegalovirus 1 is one of the best studied cytomegaloviruses, as it has been utilised as 
an animal model for HCMV infection due to the strict host specificities of these viruses. MCMV has 
been used to investigate several aspects of infection, especially viral-host interactions (cell tropism, 
early and latent infection, viral dissemination) and immunological responses (host response, virus 
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manipulation of host’s mechanism, viral immune evasion. MCMV serves as good model for HCMV 
infection, because both viruses share many aspects of their pathogeneses and gene functionality, 
including several immune evasion mechanisms, such as inhibition of MHC-I presentation, chemokine 
and chemokine receptor homologs and evasion of NK cell recognition (Jackson et al., 2011b; 
Rawlinson et al., 1996; Scalzo et al., 2006). Although the murine model replicates acute, latent and 
chronic infection, it only partially emulates congenital infection due to its lack of or low transplacental 
transmission (Hamano et al., 1998; Tsutsui, 1995). Alternative methods have been developed to study 
congenital infection using the mouse model (both central nervous system and sensorineural hearing 
loss disorders), achieving comparable results by infecting directly the foetus or the placenta or by 
inoculating the newborn (Baskar et al., 1983; Bradford et al., 2015; Cekinovic et al., 2014; Ikuta et 
al., 2015; Juanjuan et al., 2011).  
Traditionally, MCMV infection is preformed intravenously (iv) or intraperitoneally (ip) (Hsu et al., 
2009). These experimental infections have provided many insights into viral dissemination. After iv 
or ip inoculation, most of the viruses readily reach the bloodstream, gaining access to the liver and 
the spleen as early as 6 hours post-infection, where it infects specific cell types (initially marginal 
zone cells in the spleen and hepatocytes in the liver). At day two, other cell types have been infected 
in the spleen, including diverse leukocyte populations (Hsu et al., 2009). Viral dissemination to 
secondary sites occurs by infected peripheral blood mononuclear cells. At day 3, virus can be detected 
at the salivary glands and, at seven days, viral replication can be detected in most visceral organs. 
The infection is cleared in most organs seven to ten days post-inoculation, due to an intense 
immunological response, both innate and adaptive (with a heavy participation of macrophages, NK 
cells and CD8+ T lymphocytes). However, virus replication in the salivary glands can still be detected 
for over a month post-infection (Hamano et al., 1998; Mitrović et al., 2012; Stoddart et al., 1994). 
MCMV establish latency in several organs, including salivary glands, lungs, spleen and myeloid 
progenitors (Alexandre et al., 2014; Balthesen et al., 1993; Koffron et al., 1998; Pollock et al., 1997).  
In the past few years, however, different routes of infection have been tested to either simulate a more 
natural route of contraction or to study dissemination in a more contained context (Farrell et al., 2015; 
Ni et al., 2013; Oduro et al., 2015; Tan et al., 2014). These alternative inoculation routes provide a 
better understanding of physiological and/or immunological obstacles faced by the virus during 
infection. 
1.3.6. Cytomegalovirus chemokine and chemokine receptor homologues  
In a healthy individual, despite control of the infection by the host, the virus is able to establish a 
latent infection, guaranteeing survival of both parties (Griffin et al., 2010). The ability of CMVs to 
19 
 
establish latency and maintain persistent infection with periodic reactivation and shedding is aided 
by their ability to misguide the immune system. In order to survive, the CMVs have developed many 
strategies of immune evasion, i.e., means to circumvent elimination by the host defences. The HCMV 
expresses a vast pool of genes that target immune system threats, interfering with the host’s response 
(Jackson et al., 2011a). Some viral products may allow immune evasion by altering or misleading 
pathways of viral recognition and clearance, while others take advantage of particular immune 
reactions, promoting them, to improve viral replication (Miller-Kittrell & Sparer, 2009). In order to 
accomplish this, CMVs have hijacked many host genes during evolution. These host homologues 
mimic immune effectors or regulators, impairing viral elimination or enhancing efficiency of 
infection (Vink et al., 1999).  Examples of such hijacked immunosubversive genes include those 
related to chemokines and their receptors. 
1.3.6.1. Viral Chemokine Homologues 
Chemokines are attractant cytokines responsible for recruiting and activating leukocytes during an 
inflammatory response and for non-inflammatory ‘homing’ of leukocytes to specific tissue 
compartments. There are four classes of chemokines, based on their molecular structure (conserved 
position of cysteine residues): C, CC, CXC and CX3C (Vink et al., 1999).  UL146 and UL147 are 
the two HCMV CXC chemokine homologs also known as vCXCL-1 and vCXCL-2, respectively. 
vCXCL-1 binds uniquely to human chemokine receptor CXCR-2, attracting neutrophils and 
promoting degranulation and activation of effector functions in these cells. Since CXCR-2 is present 
on mononuclear and progenitor cells, sites of viral dissemination and latency, vCXCL-1 may have an 
important part in viral pathogenesis, altering the behaviour of these cells (Penfold et al., 1999). 
vCXCL-2 sequence variability is limited compared to vCXCL-1, concentrated at the N-terminal 
region, but both genes can be grouped in several genotypes. The vCXCL-2 role in HCMV infection 
has not yet been identified (Arav-Boger et al., 2006; Heo et al., 2008). Furthermore, no clear clinical 
outcome has been associated with any of the vCXCL (-1 or -2) genotypes, although it has been 
suggested that certain genotypes may induce higher viral load and specific sequelae in congenital 
infections (Paradowska et al., 2014). 
Functional characterisation of CMV CC-chemokine homologues occurred first in the rodent CMVs.  
Murid CMV encodes m131 which is expressed as a spliced transcript with m129, the latter providing 
the C-terminus and membrane anchor. The product of m131/129, also known as MCK-2, is a pro-
inflammatory molecule with the ability to recruit myelomonocytic leukocytes to the site of infection. 
In its absence, host infection is attenuated in the salivary gland and it presents a faster clearance 
(Fleming et al., 1999; MacDonald et al., 1999; Noda et al., 2006; Saederup et al., 2001). Rat CMV 
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encodes r129 and r131, but unlike MCMV these genes are not spliced; r131 is a CC chemokine 
homologue and the sequence counterpart of m131, r129 (unlike m129) also has homology to CC 
chemokines.  r129 was shown to induce migration of memory CD4+ cells and to bind with high 
affinity to several rat CC chemokine receptors (Vomaske et al., 2012). r131 was reported to be a 
functional homolog to m129/m131, inducing inflammation and similar pathogenesis (Kaptein et al., 
2004). HCMV also encodes two potential CC chemokines, UL128 (homologous to r129) and UL130 
(homologous to r131 and m131). Expression of UL128 was associated with tropism of leukocytes to 
infection sites (Miller-Kittrell & Sparer, 2009; Mocarski, 2002; Zheng et al., 2012). Besides 
recruitment of monocytes, UL128 has shown to induce proliferation of mononuclear cells and to be 
a pro-inflammatory molecule, increasing levels of cytokines, such as IL-6 and TNF-α (Zheng et al., 
2012).  In addition to chemokine activity, both UL128-UL130 and their mouse counterpart, 
m129/m131, have been shown to also be involved in viral entry, replacing gO in the gH/gL entry 
complex, expanding cellular tropism to non-fibroblast cell types. (Wagner et al., 2013; Zhou et al., 
2015).  
1.3.6.2. Chemokine Receptor Homologues 
Chemokine receptors are G protein-coupled receptors (GPCR), a subgroup of the 7-transmembrane 
receptor family. These receptors respond to chemokine binding, eliciting many cellular responses 
through G protein signalling. GPCRs have an important involvement in cellular physiology, which 
means that disturbances of their usual signals can lead to pathophysiologic scenarios. These receptors 
are activated by a range of external stimuli that guide their fine-tuned G protein-related signalling – 
in the case of chemokine receptors, binding of chemokines elicits their activation. G proteins, in turn, 
can activate a broad range of signalling cascades in the cell via both Gα and Gβγ subunits, which may 
trigger both instantaneous (e.g. calcium flux) and longer term (modulation of gene transcription) 
effects upon the cellular functions. Constitutive activation of these signalling cascades has been 
associated with many pathologies, including proliferative disorders (Vischer et al., 2006b).  
Chemokine receptor homologues are viral GPCR (vGPCR), viral molecules that share most of the 
structural characteristics of a chemokine receptor: (a) an N-glycosylation site and negatively charged 
domains in the extracellular N-terminus; (b) N-terminal region and third extracellular loop linked by 
disulphide bridges; (c) positively charged domains in the third intracellular loop; (d) presence of 
conserved motifs within the transmembrane α-helices; (e) intracellular C-terminus containing many 
serine and threonine residues (Beisser et al., 2008; Vischer et al., 2006a). The human CMV encodes 
four vGPCR: US27, US28, UL33 and UL78. While the first two viral homologues are only conserved 
in the primate CMVs), the latter two are conserved in all betaherpesviruses (e.g. M33 and M78 
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(mouse CMV), R33 and R78 (rat CMV), U12 and U51 (HHV-6/-7), are homologues of UL33 and 
UL78, respectively) (Jensen et al., 2012). Since the UL33 and UL78 genes have been largely 
preserved in the genome of CMVs, it is likely that their products have an important function in the 
viral survival or pathogenesis. vGPCR, like cellular GPCR, can alter important cellular functions and, 
thus, influence viral pathogenesis. They may also affect viral replication, as many transcriptional 
factors, whose expression is induced by vGPCR, can bind to viral IE gene promoters (Beisser et al., 
2008). 
vGPCR signalling can be transduced upon ligand interaction, dimerization with other receptors (both 
viral or host) or constitutive activity (Casarosa et al., 2005; Molleskov-Jensen et al., 2015; Tschische 
et al., 2011; Waldhoer et al., 2002). Remarkably, ligand profile of vGPCR is not necessarily 
consistent with the ligand profile of host receptors, which are quite specific. Indeed, while some 
vGPCR have a wide spectrum of ligands, many vGPCR remain orphans (i.e., without an identified 
ligand), albeit functional, signalling without the necessity of ligand binding (constitutive signalling 
is a common feature of vGPCR). These differences in ligand binding pattern highlight the viral 
subversion of the host chemokine system (Beisser et al., 2008).  
Most studies have demonstrated how vGPCR exert their effects through G protein signalling. Since 
the Gα subunit profile is cell type-dependent, vGPCR can modulate host responses in a cell specific 
manner, altering the cellular environment to favour infection and viral dissemination. Characterizing 
signalling pathways induced by vGPCR and their outcomes in a cell type-specific context can help 
improve our understanding of HCMV pathogenesis (Billstrom et al., 1998; Melnychuk et al., 2004). 
To better understand the role of vGPCR in the HCMV pathogenesis, many studies in vitro with 
HCMV, MCMV and RCMV have been conducted.  In addition to extrapolating findings from tissue 
culture to propose potential contributions to pathogenesis, studies in vivo using MCMV, RCMV and 
recombinant viruses have demonstrated effects upon dissemination and disease. These studies have 
given a partial comprehension of the profound effects that the vGPCR evoke in an infected cell and 
how this may affect virus replication and disease. The attenuation profile of viruses with disrupted 
receptors in vivo supports the potential for antiviral therapies targeting vGPCR. Indeed, cellular 
GPCR have become a common drug target for many diseases by the pharmaceutical industry and 
similar approaches may be adapted to the vGPCR. Drugs directed against the vGPCR have the 
potential to not only impair viral replication – like regular antiviral agents do –, but also to prevent, 
or least restrain, viral reactivation and dissemination (Beisser et al., 2008). Moreover, vGPCR could 
represent a novel target for antiviral therapy, as demonstrated by Spiess et al. (2015). They fused a 
toxin to a synthetic CX3CL1 with high affinity for US28, which induced cell death in cells expressing 
US28, and had better efficacy than Ganciclovir for repression of virus replication in tissue culture.  
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1.3.6.2.1. UL33 family 
UL33 transcription is detectable early during infection, with levels increasing at late times (Bodaghi 
et al., 1998; Davis-Poynter et al., 1997; Vischer et al., 2006b; Welch et al., 1991). Unlike most viral 
genes, many members of the UL33 family are spliced across a short intron, with the majority of the 
coding sequence within the second exon (Davis-Poynter et al., 1997). At steady state, the majority of 
UL33 molecules are localized at intracellular domains. Its mouse counterpart, M33, however, has 
been detected mainly at the outer plasma membrane, like a traditional cellular GPCR, with only a 
small portion of receptors remaining at the cell perinuclear region (Casarosa et al., 2003; Waldhoer 
et al., 2002). The accumulation of receptors in the intracellular compartment is due to constant 
endocytosis, which has been suggested as a mechanism for incorporation of these vGPCR in the 
envelope of the virus particle (Margulies et al., 1996; Waldhoer et al., 2002).  
UL33 still is considered an orphan receptor (McSharry et al., 2012). UL33 family members were 
noted to have a relatively low level conservation to cellular chemokine receptors at the (extracellular) 
N-terminus, which may underlie the apparent lack of ligands (Davis-Poynter et al., 1997). 
Nevertheless, UL33, similar to its murine counterparts M33 and R33, has been shown to signal in a 
constitutive manner, altering transcriptional pathways (Casarosa et al., 2003; Case et al., 2008; 
Gruijthuijsen et al., 2004; Gruijthuijsen et al., 2002; Waldhoer et al., 2002). Upregulation of 
transcription factors vary among the homologues. Constitutive activity of UL33 has been associated 
with enhancement of gene transcription induced by cAMP. Although this also applies for M33, R33 
has been shown to reduce levels of cAMP. UL33 regulates cAMP response element-binding protein 
(CREB) activation by three pathways: Gαs, Gαi/o and Rho/p38 Mitogen-Activated Protein (MAP) 
kinase signalling (via Gβ). M33 constitutive activation of CREB involves only two mechanisms 
(p38 activation and Gαq/11 signalling), still M33 mechanism seems to induce CREB more efficiently 
than UL33. This could be related to the fact that UL33 is able to couple a broader range of Gα proteins, 
which could both up and down regulate CREB expression (Casarosa et al., 2003; Sherrill et al., 2009; 
Waldhoer et al., 2002). R33, on the other hand, inhibits CREB transcription via Gαi/o (both UL33 
and R33 also signal through Gαq/11-phospholipase C-β pathways, but it does not seem to influence 
CREB activation) (Casarosa et al., 2003; Gruijthuijsen et al., 2002). On the other hand, NFκ-B-
mediated transcription has been demonstrated to present the opposite scenario: while it is increased 
by R33, it is not influenced by UL33 (Gruijthuijsen et al., 2002; Waldhoer et al., 2002).  M33 was 
reported to induce NFκ-B-mediated transcription, however this has not been a consistent finding in 
subsequent studies in the Farrell/Davis-Poynter lab. 
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All three receptors were shown not to be essential to viral growth in certain tissues in vitro (Beisser 
et al., 1998; Davis-Poynter et al., 1997; Margulies et al., 1996). In the absence of M33, however, 
viral replication was found attenuated in primary bone marrow macrophages when using low 
multiplicity of infection, suggesting that the receptor may play a role in cell to cell dissemination in 
certain cell types (Farrell et al., 2013). Despite being generally non-essential for replication in vitro, 
R33 and M33 have been identified as determinant elements for viral pathogenesis in vivo. R33 
deletion viruses have shown to promote less mortality than the wild-type virus in rats and to be 
necessary for salivary gland infection (Beisser et al., 1998). M33 is also necessary for salivary gland 
infection (Davis-Poynter et al., 1997). The specific defect caused by the absence of M33 is still not 
known; resolution of this question is complicated by the diverse cell types, anatomical context and 
potential modulation of immune responses that may contribute to the in vivo phenotype. Deletion 
mutants can still reach the salivary glands, but they are unable to efficiently colonize it: in a study 
using severe immunocompromised mice, with impaired cellular immunity, in the absence of M33, 
MCMV was able to infect the salivary glands, but not to efficiently replicate in the organ (Bittencourt 
et al., 2014). Because disruption of M33 signalling prevents MCMV replication in the salivary glands 
in vivo, but it has no effect on replication in vitro, it might indicate that the virus cannot contain the 
immunological response when M33 is not expressed during infection. Further work is required, 
however, to determine the contribution of M33 to different stages of the MCMV life-cycle. 
Using a panel of M33 mutations, the importance of specific regions and motifs for signalling in tissue 
culture and in vivo biological function were determined. Mutations that disrupted trafficking to the 
cell-surface were signalling negative.  Analysis in vivo of mutants that preserved cell-surface 
trafficking highlighted the importance of signalling to biological function.  Single amino acid 
substitutions in either TMII or TMIII that abolished signalling were defective for salivary gland 
replication; mutations where signalling was not reduced replicated normally and a C-tail truncated 
mutant with an intermediate signalling profile was partially attenuated (Case et al, 2008).  Mutagenic 
analysis of UL33 and R33 has also been conducted and highlighted differences in signalling 
associated with structural differences. UL33 conserves a DRY motif between the third α-helix 
(TMIII) and the second intracellular loop, like most GPCRs. In contrast, R33 and M33 have a NRY 
motif. The DRY motif (or NRY for the murine receptors) is responsible for G protein interaction. 
Whilst mutation of the arginine abrogates constitutive G protein-coupled signalling for all three 
receptors, changing the NRY motif of M33 to DRY motif (the UL33 motif) greatly enhanced the 
CREB and NFAT signalling (Case et al., 2008; Gruijthuijsen et al., 2004; Waldhoer et al., 2002). 
Notably, the M33/DRY mutant was not attenuated in vivo. The C-terminal region of the receptor may 
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be responsible for differences in signalling pathways between R33 and UL33: the human CMV 
receptor has a longer C-tail, which seems to be essential for Gαi/o coupling (Casarosa et al., 2003).  
When M33 expression is disrupted, virus recovery may be altered in organs other than the salivary 
glands. Care should be taken with interpretation, however, depending upon the method of disruption. 
The original M33 deletion mutant carried a lacZ expression cassette.  This mutant was found to be 
attenuated for replication in the pancreas and spleen (Cardin, 2009). However, attenuation in the 
pancreas was not observed for either a signalling defective mutant [M33(R131Q)] or a lacZ negative 
deletion mutant (premature stop codon within M33), suggesting that lacZ expression, rather than 
disruption of M33, resulted in defective replication in the pancreas (Farrell et al 2011). For the spleen, 
however, there was a consistent phenotype for M33 disrupted mutants, apparent as early clearance 
compared with wild type. Tissue specific phenotypes attributable to M33 are explored further in this 
thesis, including evaluation of different routes of infection and suppression of innate immunity. 
Disruption of M33 has been found to suppress reactivation (explant culture) from several latency sites 
(salivary glands, lungs and bone marrow) (Cardin et al., 2009; Farrell et al., 2013). There was a 
tendency for disrupted M33 to result in lower levels of viral DNA in tissues at the time of explant, 
suggesting that that M33 plays a role in effectively establishing or maintaining MCMV latency. 
Whether primary infection and the efficiency of seeding to sites of latency, thereby establishing initial 
DNA viral load, is the dominant determinant of reactivation efficiency is not known.  There is 
potential for M33 to play a role during reactivation, where M33-mediated signalling might modulate 
cellular/viral gene transcription; however, there is currently no evidence in support of this hypothesis.  
A similar proposal has been made for US28 to play a role during latency, as discussed further below. 
It is noteworthy that US28 only partially restored salivary gland replication (which may contribute to 
seeding to sites of latency) but fully restored explant reactivation rates, in recombinant MCMV where 
the M33 coding sequence was replaced by US28 (Farrell et al., 2011).  
1.3.6.2.2. UL78 family 
Transcription across UL78 occurs in two different phases during infection. At early times (insensitive 
to blockade of DNA replication), a 1.7kb transcript is detected; at late times a longer transcript (4kb) 
is also detected, which corresponds to a bicistronic message initiated upstream of UL77 and running 
through to the UL78 poly(A) site. Both R78 and M78 present similar kinetics of transcription as UL78 
(Beisser et al., 1999; Michel et al., 2005; Oliveira & Shenk, 2001). Similar to UL33, UL78 family 
members have been found to accumulate predominantly within intracellular compartments 
particularly at the endoplasmic reticulum, Golgi apparatus and endosomes. M78 and UL78 have been 
found to be rapidly endocytosed from the cell surface (Sharp et al., 2009; Wagner et al., 2012).  
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Furthermore, both M78 and UL78 have been found to be associated with purified virions, presumably 
present in the viral envelope (O'Connor & Shenk, 2012; Oliveira & Shenk, 2001). It has been 
suggested that UL78 accumulates at sites of virion assembly and hence is incorporated into the 
envelope, although a recent study using fluorescently tagged UL78 reported that the protein did not 
associate with sites of virus assembly in infected HFF (Niemann et al., 2014). There has been 
conflicting evidence concerning whether UL78 family members modulate CMV replication in tissue 
culture. Both M78 and R78 deletion virus presented growth defects in vitro, which were variable 
between different cell types (Beisser et al., 1999; Oliveira & Shenk, 2001).  Studies of HCMV with 
disrupted UL78 reported contrasting results, highlighting cell-type specific effects.  Whereas UL78 
deletion mutants of AD169 (fibroblast adapted strain) were able to replicate in fibroblast and in ex 
vivo cultures (renal arteries) at wild type levels (Michel et al., 2005), an M78 deficient mutant of 
TB40/E (endothelial cell adapted strain) replicated normally in fibroblasts but was attenuated for 
replication in endothelial cells (5-fold reduced) and more markedly in epithelial cells (100-fold 
reduced) (O'Connor & Shenk, 2012).  The defect was reported as a delay of entry and delivery of 
viral DNA to the nucleus. Lower levels of viral mRNA and proteins were detected. This could be a 
parallel function to M78 ability to mediate IE mRNA accumulation at early stages of infection without 
de novo protein synthesis (Oliveira & Shenk, 2001). Rodent studies have demonstrated that disruption 
of M78 or R78 resulted in reduced pathogenesis and higher survival rates in vivo (Beisser et al., 1999; 
Oliveira & Shenk, 2001). The mechanisms responsible for this phenotype have not been fully 
elucidated, but at least in part result from replication defects in certain cell-types.  Similar to UL33, 
there are no known ligands for UL78 or the rodent CMV counterparts. 
1.3.6.2.3. US28 family 
The US28 family, when compared with the UL33 and UL78 families, are the receptors with greatest 
similarity to host chemokine receptors. It is also found exclusively in primate CMVs, suggesting a 
more recent evolutionary origin than the other CMV vGPCRs.  The presence of tandemly repeated 
genes suggests that the gene family originated from a single host GPCR hijacking episode, followed 
by duplication events. It is comprised by the adjacent US28 and US27 genes in HCMV and 
chimpanzee CMV. Rhesus CMV and African green monkey CMV, instead of encoding the two genes, 
have a cluster containing five/six homologous genes (Alcendor et al., 2009; Penfold et al., 2003). In 
RhCMV, the five genes have diverged considerably from each other and RhUS28.5 is the homologue 
with closest similarity to US28; functionally, it presents a chemokine binding profile similar to that 
of US28 (Beisser et al., 2008; Jensen et al., 2012; Penfold et al., 2003).  
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US27 
Little is still known about US27. It presents a late kinetics of expression. Within the cell, it is found 
at perinuclear compartments, especially at the trans-Golgi network and endosomes, co-localizing in 
vesicles with glycoproteins essential for virion maturation and at the viral envelope. The C-terminal 
domain is required for intracellular localization, probably due to the activity of a di-leucine endocytic 
motif (Fraile-Ramos et al., 2002; Margulies & Gibson, 2007; Niemann et al., 2014; Stapleton et al., 
2012). Despite not being essential to viral replication, US27 is involved in viral dissemination, and, 
in its absence, there is a decrease in the extracellular progeny (O'Connor & Shenk, 2011). US27 is 
still an orphan receptor but recent studies suggest a potential for modulation of cellular signalling.  
US27 expression has been associated with an increase in cell proliferation by up-regulating pro-
survival genes (AP-1 transcription factor of jun and fos, factor Bcl-x and oncostatin M) (Lares et al., 
2013). While both the DRY motif and the C-terminal tail of US27 are responsible for the cell 
proliferation phenotype, other domains are involved in the cell survival property of the receptor (Tu 
& Spencer, 2014).  US27 has also been described to enhance cellular CXCR4 expression and 
signalling, inducing intracellular calcium mobilization and increasing chemotaxis induced by 
CXCL12 (Arnolds et al., 2013). These effects (in HEK293 cells) contrast with those reported for 
UL78, which was found to inhibit CXCR4-mediated responses in monocytes, highlighting cell-type 
specific effects of the vGPCR (Tadagaki et al., 2012). Potentially, GPCR function may be modulated 
by dimerization and several studies have highlighted the potential for heterodimerisation of vGPCR, 
between different vGPCR and between vGPCR and cellular receptors.  UL33 and UL78 have been 
reported to form heterodimers with CCR5 and CXCR4, affecting the function of the human receptors 
(Tadagaki et al., 2012). US27, UL33 and UL78 have each been demonstrated to heteromerise and co-
localise with US28, in the case of UL33 and UL78 being reported to downregulate US28-mediated 
NF-kB activation (Tschische et al., 2011). However, an experiment using infected cells (and not 
transient expression) did not detect co-localization, at least not between US27 with UL78. The same 
study also reported that the cellular localization of the receptors varied according with the cell type 
and infection phase (Niemann et al., 2014). 
US28 
US28 is the best characterized of the CMV vGPCR. It is expressed as an early gene, upon virus entry. 
US28 is present in the viral envelope (Humby & O'Connor, 2015). US28 molecules accumulate at 
intracellular domains, especially at perinuclear regions, in cells expressing the receptor. It was 
demonstrated that US28 undergoes constitutive endocytosis, dependent upon the cytoplasmic C-tail.  
This process was modulated by phosphorylation, but did not require interaction with -arrestins 
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(Droese et al., 2004; Fraile-Ramos et al., 2003; Miller et al., 2003; Mokros et al., 2002; Stropes et 
al., 2009; Waldhoer et al., 2003). Disruption of a di-leucine motif, characteristic of clathrin-mediated 
endocytosis, reduced but did not abolish US28 internalisation (Droese et al., 2004).  Endocytosis was 
not coupled with constitutive signalling, however, since C-tail mutations blocking endocytosis 
resulted in an increase of signalling (Miller et al., 2003; Waldhoer et al., 2003).  
US28 is the only CMV vGPCR with identified ligands. The majority of cellular chemokine receptors 
have a ligand profile restricted to a few chemokines of a particular family. US28 can bind not only to 
a broad spectrum of chemokines, but also to chemokines of different families (CC-chemokine CCL2, 
3, 4, 5, 7, 11, 13, 26 and 28; CX3C-chemokine CX3CL1). Many of these interactions can occur at 
the same time, demonstrating the presence of different binding sites in US28 (Vischer et al., 2006b; 
Vomaske et al., 2009). These interactions can generate divergent cellular responses, reflecting 
US28’s ability to couple with a range of Gα proteins. US28 activation mediated by CCL5 and CCL7 
binding allows coupling of Gαi/0, Gαi12/13 and Gαi16, inducing intracellular calcium influx and the 
ERK2 MAP kinase pathway. When activation is mediated by CX3CL1, the receptor couples with 
Gαq. (Billstrom et al., 1998; Vomaske et al., 2009). Focal adhesion kinase-1 pathway and 
cytoskeleton re-organization are induced in fibroblast by both CCL5 and CX3CL1. Both chemokines 
also induce intracellular calcium mobilization in smooth muscle cells (SMC), but not in gliobastoma 
multiforme cells. In contrast, SMC migration is only induced by CCL5 binding, whereas CX3CL1 
prevents SMC migration. Intriguingly, this situation reverses in macrophages, where CX3CL1 
binding to US28 promotes cell movement and CCL5 inhibits it. These data indicate that US28 
signalling produces particular responses according to both ligand binding and cell type, probably 
reflecting cell type-dependent Gα content (Melnychuk et al., 2004; Miller et al., 2012; Vomaske et 
al., 2009), which certainly demonstrates the viral plasticity during infection.  
The constitutive US28 signalling can stimulate cellular transcription. It has been demonstrated that 
cells expressing US28 constitutively activate CREB via p38 MAP kinase. Also, without requiring a 
ligand, US28 is able to activate NFκ-B, which is mediated by Gβ, and NFAT. US28 also activates 
the phospholipase C (PLC-β) pathway, through Gαq and Gα11, producing a gene-dose-dependent 
increase in phosphatidylinositol turnover, which also can influence cellular gene expression 
(Casarosa et al., 2001; McLean et al., 2004; Miller et al., 2012; Waldhoer et al., 2002). US28 also 
stimulates the PLC-β pathway through a GPCR ligand-dependent manner. The disruption of the DRY 
motif (for a DAY motif) not only ablates PLC-β signalling, but also diminishes CCL5 binding ability 
– however not due to interference with surface expression -, demonstrating the importance of this 
region for both ligand-dependent and independent signalling (Stropes & Miller, 2008). Curiously, the 
signalling profile and desensitization mechanisms of US28 and M33 are closer to each other than 
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M33 and its human homolog UL33 and US28 can also partially rescue M33 phenotype (Farrell et al., 
2013; Sherrill & Miller, 2006; Waldhoer et al., 2002). 
US28 expression may assist in HCMV pathogenesis, influencing viral dissemination, establishment 
of latency and reactivation. In the absence of US28, there is little impact upon replication kinetics in 
fibroblasts, but replication is deficient in epithelial cells in vitro (Miller et al., 2012; Noriega et al., 
2014; Vieira et al., 1998). Epithelial cells rely on cell-to-cell viral dissemination, demonstrating that 
US28 may play a part during the final phase of the replication cycle (Noriega et al., 2014). US28 has 
been detected in the viral envelope. This would potentially allow the virus to activate p38 and 
transcriptional factors immediately after viral entry, increasing transactivation of the IE promoter and 
promoting the takeover of the cell machinery (Fraile-Ramos et al., 2001; Humby & O'Connor, 2015). 
The broad range of US28 ligands may facilitate HCMV migration via chemokine gradients and, thus, 
assist HCMV dissemination. US28 expression can potentially assist leukocytes to travel from the 
bloodstream to solid tissues, by promoting migration of infected cells to new sites of infection (Hjorto 
et al., 2013; Randolph-Habecker et al., 2002).US28 may play an important role in reactivation from 
latency, by facilitating extravasation of infected monocytes to sites of inflammation (Vischer et al., 
2006b), which are a source of a range of cytokines that could lead to differentiation and, consequently, 
viral reactivation (Sinclair & Sissons, 2006). In fact, US28 is important to maintenance of latency. In 
the absence of US28, transcription from the IE promoter can be detected in hematopoietic progenitors 
(CD34+) and subsequent viral lytic replication is detected, implicating US28 as a repressor of virus 
reactivation (Humby & O'Connor, 2015). US28 expression has been detected not only during latency 
in monocytes - Gα16 expressing cells, within which US28 can activate signalling – but it is 
maintained during cell differentiation (Beisser et al., 2001; Billstrom et al., 1998). 
The development or progression of several diseases have been associated with HCMV infection. 
Some of these outcomes may potentially be related, at least partially, to US28 activity. The promotion 
of infected cell motility induced by US28 is consistent with reports of association between CMV and 
atherosclerosis, since signalling could be driving SMC to sites of inflammation (Lunardi et al., 2007; 
Streblow et al., 2001; Streblow et al., 1999; Vomaske et al., 2009). US28 also improves cell-to-cell 
fusion and entry of other viruses, by acting as a co-receptor. This function, however, seems to be cell 
type-dependent, involving other unidentified cellular factors (Ohagen et al., 2000; Pleskoff, 1997). A 
few mechanisms, which could mediate neoplastic progression, were identified as part of the range of 
US28 activities. US28 was shown to induce proliferation in vitro, by keeping cells in the S and G2/M 
phase of cell cycle. Cells expressing US28 up-regulated expression of cyclin D, a check point protein 
that mediates cell entry in the S phase of the cell cycle (Maussang et al., 2006). US28 has also been 
found to induce invasion of glioblastoma cells in vitro, which was enhanced by the presence of CCL5 
29 
 
(a known US28 ligand), and induction of other pro-angiogenic and pro-inflammatory factors, such as 
vascular endothelial growth factor, COX-2 and eNOS (Maussang et al., 2009; Soroceanu et al., 2011). 
US28 has been shown to increase secretion levels of IL-6. Induction of IL-6 has been associated with 
activation NF-B by JAK1-STAT3 signalling pathway. In HCMV positive glioblastoma biopsies, 
US28 was detected mostly in the endothelia, but also in a few tumour cells. The level of US28 
expression was correlated with amount of phosphorylated STAT3, IL-6 expression and patient 
outcome (Slinger et al., 2010). NFAT is one of the transcriptional factors regulating expression of 
many genes, including IL-8, RCAN1 and genes involved in tumorigenesis. NFAT is also one of 
transcriptional factors induced by US28. Its activation has been shown to be mediated by US28 
interaction with sarcoplasmic reticulum calcium ATPase (SARCA). Inhibition of SARCA by US28 
facilitates intracellular calcium accumulation, which is critical to US28-dependent NFAT activation. 
In a mouse xenograft tumour formation model, expression of US28 was sufficient to induce 
tumorigenesis and treatment with an inhibitor of calcineurin, which inhibits NFAT activity, was 
sufficient to reduce tumour volume and to abolish IL-8 and RCAN1 induction (Zhang et al., 2015). 
In contrast, US28 was also found to be able to induce apoptosis in a caspase-dependent manner (Joshi 
et al., 2015; Pleskoff et al., 2005). Thus, it has been suggested that US28 may mediate tumorigenesis 
only when cells already present a transformed or a predisposed phenotype (Maussang et al., 2006).  
Functional complementation between HCMV and MCMV vGPCRs 
Evolutionary considerations suggest that the CMV vGPCR may have functional conservation and 
some evidence for this has been provided via chimeric MCMV recombinants.  When M33 was 
replaced by either UL33 or US28, a functional complementation was observed in vivo, consistent 
with some conservation of function among the receptors (Case et al., 2008; Farrell et al., 2011). With 
the exception of salivary glands, replication titres in different sites of infection were similar when 
comparing MCMV expressing either M33 or US28 (in place of M33) with wild type virus. This 
included the spleen, suggesting that UL33 and US28 were competent for rescue of the ‘early 
clearance’ phenotype observed for M33 null (Farrell et al, 2011).  UL33 and US28 also partially 
rescued replication in salivary glands, although the titres were substantially lower than wild-type.  
With regard to complementation of the latency reactivation phenotype (spleen and lung explant), 
US28 restored to wild type efficiency and UL33 resulted in partial rescue, compared with a signalling 
deficient M33 mutant (Farrell et al, 2011).  In some respects, signalling by US28 is more similar to 
M33 than UL33, which may have influenced the outcomes (Sherrill & Miller, 2006; Waldhoer et al., 
2002). Further studies suggested that the salivary gland and reactivation phenotypes may be mediated 
by different signalling pathways.  Whereas salivary gland replication was predominantly linked with 
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G protein-coupled signalling (of M33 or US28), the reactivation phenotype suggested that other 
signalling pathways (G protein-independent), involving MAP kinases, were playing a role (Farrell et 
al., 2013; Farrell et al., 2011). 
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Chapter 2 - Reagent Generation 
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2.1. Introduction 
To study the function of the vGPCRs, we undertook a series of in vitro and in vivo investigations.  In 
vitro studies were conducted in the context of expression of individual viral GPCRs and of virus 
infection; in vivo studies were in the natural context of MCMV infection of mice. In addition to 
investigating the presence or absence of GPCR expression, we also analysed the effects dependent 
upon GPCR-induced signalling, using signalling mutants. To accomplish these studies, several tools 
were designed. With a view to study cell types that are hard to transfect, we investigated lentivirus 
transduction as an alternative approach for expression of the target genes.  Recombinant MCMV and 
HCMV were also produced, in order to introduce GPCR mutations (null, signalling deficient or Cre-
dependent) and in some cases combine the mutation with a secondary marker (GFP or luciferase). 
Whereas the MCMV recombinants were derived by recombination in cell culture, HCMV 
recombinants were made through bacterial artificial chromosome (BAC) recombineering. Thus, in 
this chapter, we describe the construction (or attempted construction) of plasmid vectors, lentivirus 
and recombinant virus to be used in this study. Standardization of methods, obstacles encountered 
along the way and the use of alternative methods are also commented upon.  
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2.2 Materials & Methods 
2.2.1. Cloning procedures 
All digestions were performed with New England BioLabs (NEB) endonucleases according to 
manufacturer’s instructions and all DNA purifications were carried out as agarose gel extractions 
using High Pure PCR Product Purification Kit (Roche) following manufacturer’s instructions. 
Ligations were performed overnight at 16°C with T4 DNA Ligase (NEB). Plasmids were transformed 
into chemo-competent Escherichia coli DH5α (NEB) by heat shock (42°C) and bacteria were seeded 
on 2xTY agar (a list of bacterial media composition can be found in the Appendix 2.1), supplemented 
with ampicillin (Amp), Kanamycin (Kan) or chloramphenicol (CAM) or a combination of these, as 
necessary, and grown for 24h at 37°C. Blue and white selection was performed by adding X-gal and 
IPTG to the agar. Plasmid DNA extractions were performed following either standard mini-prep 
(alkaline lysis) protocol, when screening, or Plasmid Midi Kit (Qiagen), when preparing DNA stocks 
for transfection. Results of cloning were confirmed with plasmid digestion and sequencing 
(Australian Genome Research Facility Ltd). 
Expression plasmids  
pcDNA3.1 derived expression plasmids for wild type and mutant US28 and UL33 (AD169 strain), 
including epitope-tagged (HA- or FLAG-tags) versions, had been generated in the lab prior to the 
start of this project. Additional plasmids expressing wild type / mutant US28 and UL33 (Merlin 
strain) were generated by PCR using the 1158 Merlin BAC (kindly provided by Prof. Gavin 
Wilkinson, Cardiff University) as template (Stanton et al., 2010).  
Lentivirus constructs. A third generation lentivirus packaging system was utilised (Rubinson et al., 
2003) (plasmids kindly provided by Dr. David Simmons, UQ). The plasmids for lentivirus packaging 
were derived from pLL3.7, with either the HCMV immediate early promoter (IEp) or cellular 
elongation factor 1 alpha promoter (EF1 α) driving expression of either wild type or mutant US28 
derived from the pcDNA3.1 expression plasmids.   
HCMV recombination plasmids.  
To clone target genes with flanking genomic DNA to direct recombination, 1158 Merlin BAC DNA 
was directly digested (with EcoRI and SalI), fragments were gel purified and ligated into prepared 
pUC19 plasmid. Selectable markers for insertion at the target gene locus comprised either a lacZ–
Ampicillin cassette (extracted from either pUC19 or adenovector pAL1151), or a Kanamycin cassette 
(extracted from the pEP-KanS vector, kindly provided by Prof. Klaus Osterrieder, Cornell 
University), generating alternative sets of selective marker cassettes. A list describing the names and 
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the sequences inserted in all plasmids can be found in the Appendix 2.2. Likewise, maps of all parental 
and engineered plasmids can be found in the Appendix 2.3 and 2.4, respectively. 
2.2.2. Polymerase chain reactions (PCR) 
PCR was conducted for different purposes, namely to detect mutations, amplify targets for cloning 
or sequencing, or to genotype mice. Genomic DNA was extracted from mice ears using Wizard 
genomic DNA Purification Kit (Promega), according to manufacturer’s instructions. DNA from 
virus-infected mammalian cells was extracted using High Pure PCR Template Preparation Kit 
(Roche). Plasmid DNA was either extracted using the methods described under cloning procedures, 
or DNA was directly amplified from bacterial colonies lysed by boiling. For general purposes, 
standard reactions were performed using Taq Polymerase (Life Technologies). To amplify sequences 
longer than 4kb or where high fidelity was required, Expand Long Template PCR System (Roche) 
was used. In both cases, reactions were set up following the manufacturer’s instructions. Table 2.1 
presents a list of primers used, with a description of the amplification target. 
2.2.3. Cells  
Human foreskin fibroblasts (HFF), human embryonic kidney cells (HEK293), mouse fibroblasts 
(3T3) and 3T3 expressing cre-recombinase (3T3-Cre) were cultivated in Dulbecco's Modified Eagle's 
medium (DMEM) (Gibco, Life Technologies). HTR-8 were grown in RPMI medium (Gibco). 
Primary mouse embryonic fibroblasts (MEF) and HeLa cells were cultured in Minimum Essential 
Medium (MEM) (Gibco, Life Technologies). All aforementioned cell media were routinely 
supplemented with 10% foetal bovine serum (FBS, HyCLone), 2mM glutamine (Gibco) and 
antibiotics (Penicillin and Streptomycin, Gibco). HUVEC were cultivated with EBM-2 medium 
supplemented with Bullet Kit (Lonza). All cells were maintained in a humid atmosphere with 5% 
CO2 at 37°C.  For preparation of virus stocks and virus plaque assay (HFF for HCMV, MEF or 3T3 
for MCMV), maintenance medium was used (standard medium but with reduced serum (2% FBS)). 
2.2.4. Plasmid Transfections 
Cells were transfected with 500 ng of plasmid DNA (24-well format) using Lipofectamine 2000 (Life 
Technologies), following manufacturer’s instructions. pGFP-N1 plasmid was transfected into cells 
and green fluorescent protein (eGFP) expression was used to evaluated efficiency. In 6-well tray 
format transfections, 1.5 µg of DNA were used. After 6 hrs, wells were washed and cells were 
incubated with fresh medium overnight.  
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2.2.5. Immunofluorescence 
Cells were seeded on 13 mm cover slips, incubated for 16-24 hours and then either infected or 
transfected.  At selected times after treatment (whether transfection or infection), medium was 
aspirated and cells were washed once with HBA (HBSS 0.2% BSA) and once with HBSS. (Between 
each subsequent step, monolayers were washed at least twice with HBA). Cells were then fixed (with 
either HBSS 3% paraformaldehyde or HBSS 80% acetone) for 15 min and permeabilized (HBA 0.2% 
Triton-100). Unspecific antigen blocking and nuclei counterstaining were performed simultaneously 
(HBA 2% goat serum 0.1% Hoechst) at room temperature (r.t.) for 20 min. Cells were incubated with 
primary monoclonal (mouse) or polyclonal (rabbit) antibody for 1h at r.t., which was followed by 
secondary Alexa Fluor-conjugated goat anti-mouse antibody (1:1000) incubation for 1h at r.t. Cells 
were washed three time before slides were mounted with Prolong Gold (ThermoFisher). Fluorescence 
was visualized on a Nikon Eclipse E600 UV microscope, using ProgRes C3 Capture Pro 2.1 recording 
system. Rabbit primary antibodies (Abcam) tested: anti-HA (ab9110). Mouse primary antibodies 
(Abcam) tested: anti-FLAG (ab45766) (1:750), anti-gB (ab6499) (1:20), anti-IE1 72 (E13) (ab65104) 
(1:5000), anti-pp65 (ab49214) (1:20), anti-US28 (ab129972) (1:1000). Alexa Flour secondary 
antibodies: goat anti-mouse (AF488), goat anti-rabbit (AF488) and goat anti-rabbit (AF594). All 
antibodies were diluted as per manufacturer’s instruction. 
2.2.6. Western blot 
Expression of US28 from both pcDNA3.1 and pLL3.7 was tested. Plasmids were transfected in 24-
well plates containing either HEK or HeLa cells. Protein content was extracted from 24h transfected 
cells as follows. Monolayers were washed twice with cold HBSS and incubated on ice for 15 min 
with 50 µl of protein extraction buffer [1x Pierce RIPA buffer, 1x Halt Protease Inhibitor Cocktail 
and 0.5 mM EDTA (ThermoFisher Scientific)]. Lysate was transferred to microcentrifuge tubes, 
sonicated and centrifuged (10 min at 17000 x g at 4ºC). Supernatants were transferred into new tubes 
and stored at -20ºC. After addition of sample mix (1x LDS and 1x Reducing Agent, Life 
Technologies), samples were denatured at 50ºC for 10 min and run on a 4-12% Bis-Tris gel (NuPage, 
Life Technologies), using Bolt Unit and MES SDS running buffer (Life Technologies). Gels were 
blotted onto Nitrocellulose membranes (Life Technologies). Five different solutions were tested as 
blocking and antibody buffers: TBS 5% BSA, TBS 5% SMP, TBST 5% BSA, TBST 5% SMP and 
Odyssey solution (LI-COR). The description of the homemade western blot buffers is shown in Table 
2.1. Specificity of the following primary antibodies was tested: rabbit anti-US28 (1:1000), rabbit and 
mouse anti-HA (both at 1:500) and rabbit anti-GFP (1:1000) (Abcam). Infra-red fluorescent tagged 
secondary antibodies were used for detection, respectively, IRDye 680RD (Goat Anti-Mouse) and 
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IRDye 800CW (Goat Anti-Rabbit) (both at 1:10000, LI-COR). Membranes were visualized using an 
Odyssey fluorescent scanner (LI-COR) and signal was measured using Image Studio Lite Software 
version 5.0.  
2.2.7. Lentivirus production 
Plasmids pMDLg/pRRE, pMD2.G and pRSV-REV, which express the proteins required for 
packaging, and the defective lentiviral backbone vectors for target gene expression (pLL3.7-EGFP), 
were transfected into HEK293 cells in 6-well plates, using Lipofectamine. Supernatant was collected 
(and replaced with fresh 10% FBS media) at different times post-transfection (12, 24, 48 and 72h), 
and 500µl aliquots were stored at -80°C. Titration was performed in 24-well plates containing HEK 
seeded on cover slips. 24 hours post-infection, cells were fixed with paraformaldehyde, 
counterstained with Hoechst and observed under the fluorescent microscope (Nikon). Titer was 
measured as transducing units (TU), that is, number of cells expressing eGFP, per ml of medium 
containing virus.  
To scale up lentivirus production, transfection reagent was changed to PEI (polyethylenimine) 
solution, first using 6-well trays and then 75 cm2 cell culture flasks. Briefly, plasmid DNA was mixed 
in Opti-MEM (following the proportion of 1x Gag/pol : 0.6x VSV-G : 0.4x REV : 1x reporter), then 
PEI (1µg/ml) was added and tubes were immediately vortexed for 10 sec. After 15 min of incubation 
at r.t., solution was added to cells in fresh medium. Cells were incubated at 37C for 16h before 
medium change. Supernatant was collected 24h and 48h after medium change. To improve lentivirus 
production, different amounts of DNA, µg ratio of PEI:DNA and different ratio between the 4 
plasmids were tested. In order to further improve lentivirus titer, supernatants were clarified (3500 x 
g for 15 min at 4C) and ultracentrifuged (100,000 x g for 2h at 4C). Concentrated stocks were 
Table 2.1. Composition of Western blot buffers 
Buffer Composition 
TBS 5% BSA* 50 mM Tris-Cl, pH 7.6; 150 mM NaCl, 5% (w/v) BSA 
TBS 5% SMP** 50 mM Tris-Cl, pH 7.6; 150 mM NaCl, 5% (w/v) SMP 
TBST 5% BSA* 50 mM Tris-Cl, pH 7.6; 150 mM NaCl, 0.05% Tween 20, 5% (w/v) BSA 
TBST 5% SMP** 50 mM Tris-Cl, pH 7.6; 150 mM NaCl, 0.05% Tween 20, 5% (w/v) BSA 
*BSA= bovine serum albumin 
** SMP = skim milk powder  
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resuspended in Opt-MEM 10% BSA. In addition, the use of Polybrene (final concentration 8 µg/ml) 
during titration was evaluated. 
2.2.8. Nucleofector transfection 
The 4D-Nucleofector system (Lonza) was tried out for HUVEC transfection. Transfections were 
performed in 96-well strips for optimization of conditions. First, transfection was carried out with 
500 ng of pGFP-N1, using P3 Amaxa Primary Cell 4D-Nucleofector X Kit, following manufacturer’s 
instructions. Different pre-set programs for primary endothelial cells transfection were tested. Then, 
a second round of transfection was performed to evaluate the impact of different amounts of DNA in 
transfection efficiency. 
2.2.9. Virus and titrations 
Merlin HCMV strains were used, all based on BAC-derived 1158 rCMV (RL13-UL128-eGFP+ 
HCMV) engineered by Stanton et al. (2010). Besides wild type (wt 1158), a US28 null mutant (STOP-
US28 1158), kindly provided by Dr. Brian McSharry (The University of Sydney) was also tested. 
STOP-US28 has a stop codon and frameshift (TGAT) inserted at nucleotide 21 of US28 ORF. A 
signalling defective mutant, R129Q-US28, was generated during this study.  HCMV stocks were 
grown in HFF until cytopathic effect (CPE) was widespread across the monolayer. Then, cultures 
were frozen and thawed once, aliquoted and stored at -80°C. 
K181 Perth strain was used as wt MCMV. Unless stated otherwise, all MCMV used in this study are 
based on the K181 strain. Three M33 mutants were used in virus recombination: ΔM33/Z MCMV 
(T2), which expresses a lacZ cassette within the M33 ORF (Davis-Poynter et al., 1997); ΔM33/Stop, 
which has an insertion of stop codons and a frame shift (TAAGGGTAGTGAC) within M33 (at 
nucleotide 498) (Farrell et al., 2011); and M33NQY, which has a point mutation in the NRY-motif 
of M33 (R131Q) (Case et al., 2008). Luc-MCMV (referred here as wt-luc), generated in-house 
(MacDonald et al., 2015), encodes luciferase downstream (in-frame) with M78, but expresses it as 
an independent protein via ribosome ‘skipping’, directed by a Porcine Teschovirus-1 derived 2A 
peptide sequence (Kim et al., 2011). Finally, a virus containing a ‘floxed’ expression cassette, with 
conditional rearrangement (colour switch) dependent upon Cre-recombinase was also used: GR 
(m157-EGFP-tdTomato MCMV) expresses a fluorescent protein cassette, which, after replication 
in Cre+ cells, ablates eGFP expression and establishes tdTomato expression (Farrell et al., 2015). 
Additional recombinant viruses, combining luciferase or the GR cassette with mutations of M33, 
were generated via co-infection as detailed below (2.2.12). Virus stocks were routinely grown in 3T3, 
using a low multiplicity of infection (0.01-0.001 pfu/cell). When extensive CPE was present (about 
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90% of cells), cells were submitted to one cycle of freezing and thawing and supernatants were 
clarified of cell debris (2770 x g for 10 min at 4C), prior to storing as aliquots at -80C.  Higher titre 
stocks were prepared immediately after clarification of the supernatant by ultracentrifugation (2h at 
50,000 x g at 4C). Virus pellets were resuspended in Opti-MEM (Gibco) with 2% BSA (Sigma) and 
stored as aliquots -80C.   
To determine viral titer, plaque assays were performed in 24-well trays. Briefly, serial dilutions of 
virus were added to 24h-seeded cells (HFF and MEF were used for HCMV and MCMV titrations, 
respectively). Trays were centrifuged for 30 min at 693 x g and incubated at 37C for either 90 min 
(HCMV) or 30 min (MCMV). Virus was aspirated, monolayers were overlaid with 0.5 ml of 
maintenance medium supplemented with carboxymethyl cellulose (CMC: 5.8 g/l) and incubated at 
37C until CPE was evident. Cells were then fixed (0.4% formaldehyde-PBS), stained (0.1% 
toluidine blue) and the number of viral plaques was counted under an optical microscope (Olympus 
CKX31). Titers are given as plaque forming units per ml (PFU/ml). 
2.2.10. X-gal staining 
To detect lacZ expression in infected cells, monolayers or tissue sections were stained with X-gal. 
For infected monolayers, cells were washed with PBS and fixed (0.5% glutaraldehyde in PBS) for 15 
min. Wells were then overlayed with X-gal substrate (0.2 mM X-gal, 5 mM potassium ferricyanide, 
5 mM potassium ferrocyanide, 2 mM MgCl2, 0.01% sodium deoxycholate and 0.02% NP40 in PBS) 
and incubated at 37C for at least 30 min. After washing wells twice with water, cells were incubated 
with 0.1% neutral red solution for 30 min (for counter staining), then washed with water again and 
air dried before visualization under optical microscope.  
For tissue section staining, BALB-c mice were infected intranasally with 106 PFU. At 6 days post 
infection (p.i.), lungs and salivary glands (SG) were harvested and fixed (1% formaldehyde, 10 mM 
sodium periodate, 75 mM L-lysine) for 24 h at 4°C. Tissues were equilibrated (in 30% sucrose) for 
18h at 4°C before being frozen in OCT. 6 µm sections were taken and kept at -80°C until assay was 
performed. Before staining, slides were thawed at r.t. and then washed with PBS (three times for 5 
min). X-gal substrate was added on top of the sections. After 2h of incubation at 37C in a humid 
atmosphere, substrate was removed. Slides were dipped once in water, then three times in neutral red 
solution and back into water until no red staining was coming off the slides. Slides were allowed to 
dry before mounting the cover slips with permanent mounting medium. 
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2.2.11. Luciferase screening assay 
To screen for virus expressing luciferase, infected wells (from 48-well trays) were washed once with 
PBS. Cells were then scraped and mixed (in the wells) with 100 µl of 2xTMT lysis buffer (100 mM 
Tris, 10 mM MgCl2, 0.2% Tween-20). After 10 min at 37C, 50 µl of cells were transfer into a 96-
well of a black tray. 50 µl of luciferase reagent (1 mM D-luciferin, 2 mM ATP in PBS) were added 
to each well. Luminescence emission was read in a luminescence counter (Perkin Elmer/Wallac 
MicroBeta Jet Liquid Scintillation and Luminescence Counter). 
2.2.12. MCMV recombination via co-infection 
MEF were seeded in 6-well trays and, on the next day, cells were co-infected at 0.1 and 5 MOI with 
one of the following pair of virus: GR and T2, GR and M33Stop, GR and M33NQY or wt-luc and 
T2. After 1h of adsorption, virus was aspirated and cells were incubated for 1 min with acidic solution 
(citric acid in PBS, pH 3) to neutralize any remaining virus. Cells were washed twice with plain 
medium and then incubated with 2% MEM at 37C until CPE was extensive. Trays were 
frozen/thawed and supernatants were aliquoted. As an indicator of recombination rate, supernatant 
from GR-T2 coinfection was titrated: after CPE was evident, green plaques were counted, then cells 
were stained with X-gal for counting of blue plaques. Supernatants from 0.1 MOI co-infection were 
used to infect new wells. After 1h of virus adsorption, MEF were overlayed with CMC and incubated 
at 37C until isolated plaques could be visualized. Plaques were randomly picked and individually 
seeded in 48-wells. When extensive CPE was present, supernatants were stored (-80C) and cells 
were used to screen for recombinants (mutation detection by PCR, lacZ expression by X-gal staining, 
green fluorescence emission by UV microscopy or luciferase activity by luminescence emission). 
Supernatant from wells with only positive recombinants were used to infect MEF (in 6-wells) and 
individual plaques were picked into 24-wells again to ensure purity of master stocks (which were 
again screened for the markers).   
2.2.13. Escherichia coli strains, electroporation and BACs 
Two strains of Escherichia coli were used to produce electrocompetent cells: SW102 and GS1783. 
0.5ml of saturated cultures were inoculated into 25ml of LB broth (with 12.5 µg/ml CAM, if cells 
already had BAC DNA) and incubated at 32C under shaking until growth reached an OD600 of 0.6. 
Bacteria were transferred to a 42C water bath for lambda red recombinase induction for 15 min and 
then placed on ice bath for 30 min (as non-induced control, part of the growth was directly placed on 
ice bath). Cells were centrifuged for 5 min (at 1500 x g at 0C) and resuspended in 5 ml of ice-cold 
molecular biology water. Wash step was repeated twice, then cells were resuspended in 500 µl of 
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water. Always keeping the cells on ice, 50 µl aliquots were transferred to microcentrifuge tubes and 
DNA (BAC DNA, plasmid or PCR product) was added and mixed by flicking the tubes. After 5 min, 
solution was transferred to pre-cooled 1 mm cuvettes and shocked (Bio-Rad electroporater). 
Immediately after, 0.5 ml of cold SOC was added into the cuvette. Cells were grown for 1h at 32C 
under shaking, then half of the growth was seeded on agar with appropriate selection media and grown 
overnight (at 32C). In order to improve BAC electroporation, different parameters (amount of DNA, 
voltage, and antibiotic concentration) were tested. 
Five HCMV BACs were used: pAL111, pAL1120, pAL1158, pAL1160 (Stanton et al., 2010) and 
TB40/E-BAC4 (Sinzger et al., 2008). The first 4 BACs are Merlin strain-derived BACs and were 
carried by SW102 E.coli. They differ in the genotype of a couple of genes: UL128 is mutated in 
pAL1111 and pAL1158; also, pAL1158 and pAL1160 are eGFP positive. All Merlin BACs were 
transformed into the GS1783 strain. 
2.2.14. BAC-derived HCMV stock production  
Commercial kits for BAC DNA extraction were compared: Plasmid Midi Kit (Qiagen), Large 
Construct Kit (Qiagen), NucleoBond BAC 100 (Macherey-Nagel) and NucleoBond Xtra Mid Kit 
(Macherey-Nagel). Extractions were performed using 50 ml of overnight bacterial growth and 
following manufacturers’ protocols. Commercial kits were also compared to standard alkaline lysis 
(mini or midi-prep) protocol using homemade solutions. To evaluate which kit would provide better 
quality DNA to transfections and/or electroporations, restriction enzyme analysis (REA) profile of 
BACs was assessed using either EcoRV or HindIII in an overnight run (20V on a 0.7% gel) with 
DNA extracted by the different methods. 
To produce virus, DNA from different methods of extraction was transfected into HFF seeded in 6-
well trays by calcium phosphate method, using CellPhect Transfection Kit (GE Healthcare). 
Reactions were performed according to manufacturer’s instructions, opting to carry out a glycerol 
shock 6h post-transfection. On the next day, cell medium was replaced with 2% serum medium. A 
week post-transfection, when first signs of CPE were detected, cells were split into new wells to 
stimulate cell division (and, thus, virus replication). At 2 or 3 weeks post-transfection, cells and 
supernatants were collected, sonicated, aliquoted and stored as master stocks at -80C. 
2.2.15. BAC recombineering and growth curve 
Two methods of recombineering were performed: en passant mutagenesis in GS1783 cells (Tischer 
et al., 2010) and galK selection (Warming et al., 2005). Protocols were executed and various media 
were prepared as described by the literature. Using the same principle for recombination from the 
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galK selection system, other selective markers were also tested: galK-Kan, SacB-lacZ-Amp (Stanton 
et al., 2008) and lacZ-Amp. A list of primers tested for recombination is described in the BAC 
recombineering section of Table2.2, while a list with all primers designed for recombineering can be 
found in the Appendix 2.4.  
Integrity of the genome of recombinant viruses was verified by restriction enzyme assay (REA) with 
EcoRV. Viral kinetics in HFF was analysed by growth curve: 0.1 MOI of each virus was used to 
infect individual wells of a 24-well plate (all infections were made in independent duplicates). The 
trays were centrifuged for 30 min at 693 x g and incubated at 37C for 90 min. Virus was aspirated, 
monolayers were washed twice with PBS and twice with medium. Maintenance medium (0.5 ml) was 
added to each well. Media were collected regularly for 15 days and replaced with fresh media.  
Table 2.2. List of primers used in this study 
Primer name*  Sequence (5’ – 3’)** Target  
Cloning 
M13 (R)  AGCGGATAACAATTTCACACAGGA pUC region upstream 
of lacZα gene 
NDP141 (F) CTAGGGATAACAGGGTAATTGCACGT I-SceI site at AatII 
site (Linker) 
NDP142 (R) GCAATTACCCTGTTATCCCTAGACGT I-SceI site at AatII 
Linker (D)*** 
NDP183 (F) cggcaagcttccacgATGGACACCATC UL33 Merlin (at 
HindIII/EcoRI sites) 
NDP184 (F) cgctggatccacgATGGACACCATC UL33 Merlin (HA-tag 
– BamHI/EcoRI sites) 
NDP185 (F) cgctggatccGACACCATCATCCACAACA UL33 Merlin (HA-tag 
no ATG – 
BamHI/EcoRI sites) 
NDP165 (R) gtaggaatTCATACCCCGCTGAGGTT UL33 Merlin (at 
HindIII/EcoRI sites) 
NDP192 (F) cgctggatccATGACACCGACGACGACGAC US28 Merlin (HA-tag 
- BamHI/EcoRI sites) 
(D)*** 
NDP193 (R) cgctgaattcTTACGGTATAATTTGTGAGACGC US28 Merlin (HA-tag 
- BamHI/EcoRI sites) 
NDP209 (F) cgagGAATTCCGCGGAGATCTAGGATGACG
ACGATAAGTAGGG 
Cloning Kan 
(EcoRI/SacII/BglII 
sites) 
NDP210 (R) gcagGGATCCGATATCGGTACCAATTGCAAC
CAATTAACCAATTCTGATTAG 
Cloning Kan 
(MfeI/KpnI/EcoRV/ 
BamHI sites) 
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NDP211 (R) CTTAACCCGGCACCCTGCGG galK (nt 465) 
NDP212 (R) ATGCAACCGGCGCAGGAACA Kan (nt 578) 
NDP213 (F) TCGCTCAGGCGCAATCACGA Kan (nt 628) 
MCMV Mutation detection 
AHT14 (F) GAGCGACTACCTGCACGTG M33 
AHT16 (F) GTGACGATGCTGCCGTTCC M33 
NDP04 (R) CCTGCGGTACGAGGTCAGTT M33  
NDP07 (F) CAATCGGGGTCAGATCAGCA M33 
NDP10 (R) GGCTGTTGATCGACTCGCAC M33 
NDP013 (F) CTGATCTCGGTGAACCA M33 NQY 
NDP15 (F) CTGATCTCGGTGAACAG M33 NRY 
NDP55 (F) GACTCGCGGAAGTTCTCCG M33 (HindIII)  
NDP56 (R) GAAAGAGAAGAGAGAGCGGC M33 (NotI) 
NDP178 (F) CCGTAGCGTTAGGGCAGCCG M155 
NDP180 (R) CGTACAGCGGCGTCCGTCTC M158 
   
BAC Recombinnering 
One step I-SceI recombination 
NDP143 (F) cgctcgccttttgtcactgttgtctcaatccgctgctgtTcgtcttcgt
gggcaccaagtTAGGGATAACAGGGTAATtg 
US28 ITIM mutation 
(BAC) 
NDP 144 (R) ACAGTGCAGTTCTTGCCGAAACTTGGTGC
CCACGAAGACGaACAGCAGCGGATTGAG
ACAAgtcaggtggcacttttcgg 
US28 ITIM mutation 
(BAC) 
NDP 145 (R) ACAGTGCAGTTCTTGCCGAAACTTGGTGC
CCACGAAGACGaACAGCAGCGGATTGAG
ACAAtggtctgacagttaccaatgc 
US28 ITIM mutation 
(BAC) v2 
GalK selection 
NDP186 (F) gtgcgtggaccagacggcgtccatgcaccgagggcagaactggt
gctatcCCTGTTGACAATTAATCAT 
US28-galK 
NDP187 (R) TTATAGCGCTTTTTTAttacggtataatttgtgagacgc
gacacacctctcagcactgtcct 
US28-galK 
NDP188 (F) cggaagcgtcgtcgccccggactgcgcccgcggtctgctattcgtc
cacgCCTGTTGACAATTAATCATCGGCA 
UL33-galK 
NDP189 (R) gggaaatggcgacgggttctggtgctttctgaataaagtaacagga
aagcTCAGCACTGTCCTGCTCCTT 
UL33-galK 
NDP190 (F) actactcgagctgcacagtaggctttgccaccgtagccctgatcgc
cgccCCTGTTGACAATTAATCATCGGCA 
UL33 DQY mutation-
galK 
NDP191 (R) gagcggtacgactgccgcgcgtaggtacgcttatgaagaacgcgg
tatcgTCAGCACTGTCCTGCTCCTT 
UL33 DQY mutation-
galK 
43 
 
Kanamycin selection 
NDP205 (F) ACACCGACGACGACGACCGCGGAACTCA
CGACGGAGTTTGgtccgacgaggtgtgtcgcgAGG
ATGACGACGATAAGTAGGG 
US28-Kan 
NDP206 (R) ttacggtataatttgtgagacgcgacacacctcgtcggaccaaactc
cgtcgtgagttccCAACCAATTAACCAATTCTGA
TTAG 
US28-Kan 
NDP207 (F) ATGGACACCATCATCCACAACACCACGG
TGAGCGCCCCACtcgactctcacaatcgcatcAGGA
TGACGACGATAAGTAGGG 
UL33-Kan 
NDP208 (R) tcataccccgctgaggttatGATGCGATTGTGAGAGT
CGAgtggggcgctcaccgtggtgCAACCAATTAACC
AATTCTGATTAG 
UL33-Kan 
SacB-Amp-lacZ selection 
NDP231 (R) tcataccccgctgaggttatgatgcgattgtgagagtcgatggggg
atttttgtggatgtCTGAGGTTCTTATGGCTCTTG 
UL33 
NDP232 (F) atggacaccatcatccacaacaccacggtgagcgccccacctaga
gggagggggggtagtCCTGTGACGGAAGATCAC
TTCG 
UL33 
   
BAC Recombination Detection 
NDP57 (R) CACGACCGCTATAAGTACCCG US28  
NDP 113 (F) ccgccgggatccATGGATGAAGACGCGACTCC
TTG 
US28 deletion N2-16 
aa (BamHI site) 
NDP 118 (F) CTGCTGTTCGTCTTCGTGGGCA US28 ITIM (YF) 
NDP 119 (R) CACGAAGACGAACAGCAGCGGA US28 ITIM (YF) 
NDP138 (R) ATGCGACCTTTGTGGCGCGA US28 
NDP194 (F) GATCTTGGGGTGTGCCTCG UL33 5’ 
NDP195 (R) GGATCCTACGCCACGCGATTGG UL33 3’ 
NDP196 (F) ATCATCTGCCGCTGGACG galK 
NDP197 (R) TACGCCACCTTTGTCGCC galK 
* (R) = reverse primer; (F) = forward primer 
**italic = restriction sites; bold = mutations;  
***(D) = primers also used for recombination detection 
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2.3 Results 
2.3.1. Cloning and confirmation of expression of US28 mutants in retrovirus packaging plasmids. 
In order to express the vGPCR in hard to transfect cells, we decided to use retrovirus-mediated 
transduction of the viral genes in those cells. Thus, various US28 constructs were cloned into 
retrovirus packaging plasmids (pLL3.7). Because the transcriptional activity of some cell types 
responds better to (human) EF1α than to (HCMV) IE promoter, two sets of plasmids containing wt 
US28 were made using these two promoters. Wild type US28 coding sequence, tagged with HA or 
FLAG, was excised from pcDNA3.1 backbone plasmids (B73 and B72 in the Appendix 2.2, 
respectively) by endonuclease digestion and inserted downstream of the EF1α promoter (B167) or IE 
promoter (B175) of pLL3.7, generating plasmids B171, B172, B176 and B177, respectively. Four 
plasmids encoding US28 mutants (N-terminal deletion, D129Q, Y291F and C-terminal deletion) 
were also generated. HA-US28 mutants (excised from their respective pcDNA3.1-US28 mutant 
plasmid) were cloned into plasmid B176, containing the IE promoter. Example data obtained during 
the cloning process are shown below (Fig. 2.1). If a low efficiency of US28 expression under the IE 
promoter were detected, the mutated US28 sequences would have been subcloned into the plasmid 
expressing EF1α promoter (B171) – that was not necessary. A summary of all lentivirus vector 
constructions and their cloning strategies are shown in Table 2.3.  
We then proceeded to verify the correct expression of the lentivirus plasmids. All HA-IEp constructs 
were transfected into HeLa cells and analysed by immunofluorescence, using anti-HA antibodies. 
There was no visual difference between transfection of pLL3.7 constructions and a control HA-US28 
construct (pcDNA3 derived) (Fig. 2.2). Expression was then evaluated via Western blot assay. First, 
the assay was standardized, establishing the best blocking buffer and primary antibodies efficiency. 
TBS 5% SMP was shown to be the best homemade blocking buffer, but Odyssey solution produced 
blots with lower non-specific binding. Anti-US28 antibody did not show good results, seeming to 
bind non-specifically for both immunofluorescence and Western blot (Fig. 2.3). Rabbit anti-HA 
antibody bound very well to HA, but produced many nonspecific bands on Western blot and, thus, 
the mouse anti-HA was preferably used (Fig. 2.4). Western blot assays corroborated 
immunofluorescence US28 expression results, except for the ΔN clones, which displayed divergent 
running profiles comparing B105 with B182. (Fig. 2.5). Whereas B105 migrated much faster than wt 
US28 (approx. 32kDa and 42kDa, respectively), B182 migration was similar to wt. In the ΔN mutant, 
15 amino acids were deleted from the N-terminal region (MTPTTTTAELTTEFDYDEDA, 
characters in bold represent deleted amino acids). Despite presenting a shorter deletion, the N-
terminal mutant ran faster than the C-terminal deletion mutant, which has a 53 amino acid deletion 
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(apparent molecular weight approx. 35kDa). Although counter-intuitive, this result is consistent with 
published data suggesting that the deleted region of the N- terminus may be a site of post-translational 
modification, possibly O-linked glycosylation (Casarosa  
 et al., 2005; Stropes & Miller, 2008). Data from B105 sequencing confirmed the correct sequence, 
whereas B182 lacked the deletion. A new clone was generated and the correct sequence was 
confirmed by sequencing. The correct sequence of all other pLL3.7 constructions was confirmed by 
sequencing. 
 
 
 
Fig. 2.1. Construction of pLL3.7 vectors encoding various US28. Electrophoresis on 0.8% agarose 
gels stained with Ethidium bromide. On A, digestion of plasmids for cloning: lane 1, B175 digested 
with AfeI (linearized); lane 2 and 3, B175 digested with EcoRI and HpaI; lane 4 and 5, respectively, 
B72 and B73 cleaved with both EcoRI and NruI (red arrows indicate fragments excised). On B and C, 
mapping of clones by REA. On B, B175, B176 and B177 digested by SacI (lanes 6, 7 and 8 
respectively) or by EcoRV (lanes 9, 10 and 11, respectively). Red circles (missing bands) and red arrow 
(unique band) show the expected difference in the patterns. On C, B176 (lane 12) and B186 (lane 13) 
digested by ScaI (arrows highlighting bands diagnostic of R129Q mutation). M: 1kb ladder DNA 
marker (NEB): sizes as indicated on C. 
46 
 
 
   
Table 2.3. US28 Lentiviral plasmids constructed in this project. 
Name* 
Backbone 
plasmid 
US28 (from 
pcDNA) 
Restriction strategy 
US28 Description 
pLL3.7 pcDNA 
B171 
pLL3.7-EF1α-
EGFP 
HA-US28 AfeI PmeI Wild type-eGFP 
B172 
pLL3.7-EF1α-
EGFP 
FLAG-US28 AfeI PmeI Wild type-eGFP 
B176 pLL3.7-IEp HA-US28 
EcoRI 
HpaI 
EcoRI NruI Wild type 
B177 pLL3.7-IEp FLAG-US28 
EcoRI 
HpaI 
EcoRI NruI Wild type 
B180 
pLL3.7-IEp-
EGFP 
FLAG-US28 AfeI PmeI Wild type-eGFP 
B182 
pLL3.7-IEp-
US28 
HA-ΔN-US28 
BstEII 
BamHI 
BstEII 
BamHI 
15 N-terminal 
amino acids 
deletion 
B183 pLL3.7-IEp HA-US28-Y291F 
EcoRI 
HpaI 
EcoRI NruI 
Substitution of 
Tyrosine 291 for 
Phenylalanine 
B186 
pLL3.7-IEp-
US28 
HA-US28-R129Q 
BstEII 
BamHI 
BstEII 
BamHI 
Substitution of 
Arginine 129 for 
Glutamine in the 
DRY motif 
B187 
pLL3.7-IEp-
US28 
HA-US28-CΔ53 
BstEII 
EcoRI1 
BstEII PmeI 
53 C-terminal 
amino acids 
deletion 
*Plasmid maps can be found in Appendix 2.3. 
1 Digested first with EcoRI, blunted then digested with BstEII 
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Fig. 2.2. Detection of expression of various US28 constructs.  HeLa cells were transfected with 
different pLL3.7-US28 plasmids (B-F) or with a control US28-expressing plasmid (pCDNA3-US28-
R129Q) (A). Immunofluorescence was performed using rabbit anti-HA antibody. Transfections are 
as follows: A, B105 (pCDNA3-US28-R129Q); B, B176; C, B182; D, B183; E, B186; F, B187. 
Column 1: secondary antibody fluorescence (AF488); Column 2: nuclear fluorescence (Hoechst). 
Scale bars represent 20m (100x objective). 
 
Fig. 2.3. Anti-US28 antibody (Ab) testing. On A, Western blot using anti-US28 Ab. 1 to 5 represent 
respectively wild type, R129Q, ΔC53, ΔN and Y291F US28; MM, Magic Marker (Life Technologies), 
kDa size as indicated. On B and C, immunofluorescence of the same field of HeLa cells (scale bar 
represents 50m, 40x objective) transfected with B183 using anti-US28 Ab. 
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2.3.2. Lentivirus Production 
In order to produce lentivirus particles, 6-well plate Lipofectamine transfection was used to determine 
the more productive time points for collection of viruses present in the supernatant. First, HEK293 
cells were transfected with pLL3.7 plasmids expressing eGFP under the control of either CMV 
immediate early promoter (IEp) or Eukaryotic translation elongation factor 1 alpha (EF1α) promoter. 
Visually, cells presented similar levels of eGFP expression (data not shown). When the whole system 
was transfected (pLL3.7-eGFP and packing plasmids), about 50% of the cells expressed the green 
 
Fig. 2.5. Expression of US28 constructs by HeLa cells. Western blot of total protein extraction of 
HeLa cells transfected with different US28 expressing plasmids, detected by mouse anti-HA 
antibody.  All samples (1 to 5, respectively, Y291F, ΔN, ΔC53, R129Q and wild type US28) ran as 
expected, around 40 kDa, except for pCDNA-ΔN-US28 (B112). Size indicated on kDa: M, Novex 
Sharp Pre-stained Protein Standard; MM, Magic Marker. 
 
Fig. 2.4. Anti-HA antibody testing. Western blot detecting HA epitope with either mouse anti-HA 
(red) or rabbit anti-HA (green). Lanes 1 & 2, plasmids that don’t express US28; 3, pCDNA-HA-US28 
(B73); 4, pCDNA-HA-US28-ΔC53 (B107); MM, Magic Marker, kDa size as indicated. 
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fluorescent protein; however, lentivirus production was below expectations: lentivirus titers obtained 
from transfection’s supernatant were very low (Fig. 2.6). When comparing supernatant harvested at 
different times, best results were achieved at 48h post-transfection, with approximately 105 
transducing units per ml (TU/ml).  
Because transfection of 75 cm2 flasks using Lipofectamine would be too costly, scaling up of 
lentivirus production was performed using PEI. Both PEI and DNA are quite cytotoxic, so cells suffer 
a lot during the transfection. We tested both how HEK293 and HeLa, a more resilient cell line, reacted 
 
Fig.  2.6. Lentivirus transduction of HEK293 and HTR-8 achieved at low efficiency. Lentivirus 
packaging plasmids and pLL3.7 expressing eGFP were transfected into HEK293 using 
Lipofectamine. Supernatants were harvested at 24, 48 or 72h post-transfection. To measure viral titer, 
cells were infected with serial dilutions of collected supernatant. After 3 days, cells were fixed, 
counterstained with Hoechst and visualized under UV microscope Cells infected with undiluted 
supernatant are shown; green fluorescence indicates transduced cells expressing GFP, blue 
fluorescence indicates cell nuclei (Hoechst).  Panels A and B show a representative field of HEK293 
cells (40x objective).  Panels C and D show a field of HTR-8 cells (10x objective).  For both cell 
types, the ratio of transduced (green) to total (blue) number of cells indicates a transduction efficiency 
of approximately 1-2%. Scale bars represent 100m. 
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to PEI transfection. After media change (12h post-transfection), both cells were approximately 90% 
confluent, although HEK293 had more dead cells floating in the medium. At 24h post-transfection, 
HeLa monolayer was still quite confluent, while HEK293 cells were about 70% confluent. This 
probably reflects the higher cell division rate of HeLa and not a lower rate of cell death due to virus 
production. To improve viral infection, Polybrene was added to media during titration, which doubled 
the amount of green cells detected. To concentrate stocks, supernatants were ultracentrifuged before 
titration. Under the same conditions, HeLa produced almost twice the amount of virus than HEK293: 
while the latter produced 1.5x104 TU/flask, 2.8x104 TU/flask were detected in HeLa’s supernatant. 
Thus, further protocol optimizations were tested only in HeLa cells.  
In HeLa cells, the following parameters were analysed: increasing µg ratios of PEI:DNA, different 
ratios of the plasmids, increasing amounts of total DNA transfected. Three PEI:DNA ratios were 
tested: 6:1, 7:1 and 8:1. While 8:1 was too toxic and yielded little virus, there was little difference 
between 6:1 and 7:1. The following proportions of the 4 plasmids (expressing respectively gag/pol : 
VSV-G : REV : reporter) were tested: 1:0.6:0.4:1 (R1), 1:1:1:2 (R2), 1:0.2:1:1 (R3) or 1:0.5:0.5:2 
(R4). Little variation was found between the different proportions: R1, which was the ratio used so 
far, generated 3x104 TU/flask, while R2 produced 2.7x104, R3 gave rise to 2.1x104 and R4 yielded 
2.3x104 TU/flask. Increasing amounts of total DNA transfected (using the R1 plasmid ratio and 7:1 
PEI ratio) augmented the amount of virus recovered up to the point where it was too toxic for cells: 
while 16 µg (the amount used so far) produced 2x104 TU/flask, 20 µg generated 5x104 TU/flask and 
32 µg produced only 3x102 TU/flask. So, despite all the optimizations, the best titers we obtained 
were around 104 TU/flask. Rather than pursue lentivirus transduction further, it was decided to utilise 
transfection, including an improved method for electroporation described in 2.3.3 below. 
2.3.3. HUVEC transfection 
HUVEC were one of the cell types chosen to investigate the effects of the expression of vGPCR. 
Transfection of HUVEC using Lipofectamine rendered poor results: only 5% of cells transfected with 
reporter plasmid expressed green fluorescent protein. Because lentivirus production was very 
inefficient, an alternative method to transfect HUVEC was sought. The 4D-Nucleofector system was 
designed to electroporate DNA into hard to transfect cells. The system offers two formats, according 
to the amount of cells to be transfected: 96-well strips and cuvettes. For technique optimization, the 
96-well strips were used and the results were then translated to the cuvette format for assay 
performances.  
All pre-set electroporation programs for primary endothelial cells presented great transfection 
efficiency (at least 60% of cells expressing eGFP), however, a few also induced an elevated amount 
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of cell death. Out all of the programs tested, program CA167 was the one with greater amount of 
transfected cells (about 70% expressed eGFP) and least amount of dead cells. The effect of amount 
of DNA transfected was also tested. Cells transfected with 500 ng of DNA had less eGFP positive 
cells then cells transfected with 700 ng or 1000 ng (both of which presented about 80% of transfected 
cells). Because the amount of DNA caused no detrimental effects on cell viability, the use of 1 µg of 
DNA per 105 cells was defined as standard for future assays. 
2.3.4. MCMV recombinants  
Three double recombinant MCMV were generated: a GR-M33Stop, a GR-M33NQY and M33/Z-
luc, via co-infection of each of the single recombinant virus pairs. The single recombinants (K181 
background) were: GR = floxed GFP/tdTom cassette inserted at m157 locus; M33/Z (T2) = lacZ 
disruption of M33; M33Stop = premature stop codon disruption of M33; M33NQY = point mutation 
of M33 to block G protein-coupled signalling; luc = luciferase expressed downstream of M78. In 
order to establish the preferred multiplicity for generation of double recombinants, a trial was 
conducted with the combination of GR and M33/Z. Viruses were mixed at a 1:1 ratio of infectivity 
and used to infect MEF at a multiplicity of infection of either 0.1 or 5 PFU/cell. Supernatant from the 
GR-T2 recombination was titrated on MEF and screened for GFP and lacZ expression.  It was found 
that the 0.1 MOI infection generated 10 times more recombinant virus (approx. 25% double 
recombinants) than 5 MOI infection. Thus, 0.1 MOI infection was used for the various co-infections 
and supernatant plated on MEF to achieve good separation of plaques (<50 PFU/well of 6-well tray). 
Three days post-infection, plaques were picked using a micropipette to aspirate each plaque and 
transfer the aspirate (15ul) to a well of a 24-well plate of MEF. A total of 16 plaques of each co-
infection were collected and screened for the desired recombinants.   
M33/Z-luc virus was screened by first detecting expression of lacZ (detection of blue plaques by X-
gal staining) in infected monolayers. Then, supernatant from positive wells was used to infect new 
monolayers, which were tested for luciferase expression (detection of luminescence by luciferase 
assay). Isolates that were positive in both assays were selected and re-isolated via a second round of 
plaque picking and lacZ / luciferase screening to guarantee stock purity. Also to confirm virus 
phenotype, BALB-c were infected with recombinant virus and at 6 days post infection, lungs and 
salivary glands were collected and tissue sections were prepared. As expected, infected blue cells 
were visualized in the lungs, but no blue cells were detected in the SG (Fig. 2.7). 
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The GR-M33Stop and GR-M33NQY recombinants were screened by a combination of fluorescence 
and PCR. GR virus produced green fluorescent plaques; in addition, the eGFP-tdTomato cassette 
within m157 changed the length of the product amplified with primers that bind within the flanking 
regions m155 and m158 (NDP178 and NDP180) from 1761 bp to 4375 bp (Fig. 2.8). The M33Stop 
mutation replaced a BstEII restriction site for an AflII site in M33 sequence, detected by PCR across 
the region and restriction digest (Fig. 2.9). M33NQY generated a point mutation in M33, which was 
detected with specific primers for wt NRY sequence (NDP4 and NDP15) or mutated NQY sequence 
(NDP4 and NDP13) (Fig. 2.10). Samples that presented both the GR cassette and the designed 
mutation were detected, but the first round isolates all had a mixture of recombinant and parental 
virus detected by PCR. So samples containing the recombinants were re-isolated by additional rounds 
of plaque picking until only recombinant viral DNA was detected via PCR. The NQY (R129Q) 
mutation was also confirmed by sequencing, as even though the NQY PCR worked very well, NRY 
reaction was not as reliable. For all viruses, once recombinants were purified, master stocks were 
made and stored at -80C. Unfortunately, when testing the GR virus in vivo, viral growth in the 
salivary glands was not detected. As our intention was to compare replication in different cell types 
along the pathway to SG colonization between GR virus and GR-M33-mutants, the use of these 
viruses in experiments was interrupted. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.7. ΔM33-luc can be detected in the lungs but not in the SG of mice. Lungs (A) and SG (B) 
of BALB-c mice infected via intranasal with ΔM33-luc. Organs were harvested at day 6 p.i. and 
fixed. Tissue sections were stained with X-gal to confirm expression of LacZ by the presence of blue 
cells. Scale bars represent 100m (10x objective). 
 
A                                                              B 
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Fig. 2.8. Screening for eGFP-td-Tomato cassette in recombinant MCMV. Electrophoresis on 
0.8% agarose gels stained with Ethidium bromide. PCR (using NDP178 and NDP180 primers) 
evaluating the presence (4375 bp) or absence (1761 bp) of eGFP-tdTomato cassete in selected 
plaques. 1-6 represent different isolates from each co-infection (arrows indicate the expected product 
sizes). M: 1kb ladder DNA marker (NEB).  
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Fig. 2.9. Screening for M33STOP mutation in GR-M33Stop recombinants. Electrophoresis on 
0.8% agarose gels stained with Ethidium bromide. On A, PCR (using NDP4 and NDP55) amplifying 
part of M33 (900 bp) were digested with either BstEII or AflII (as indicated) to detect the presence of 
the stop codon: mutation loses BstEII restriction site, but gains an AflII site (arrows indicate the 500 
and 400 bp digested products). Mixtures are present in all recombinants here. Recombinant 4 was 
selected to further isolation. On B, pure recombinant isolates can be detected in our samples. Circled 
numbers mark the double recombinants M: 2 log ladder DNA marker (NEB). 
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Fig. 2.10. Screening for GR-M33NQY recombinants. Electrophoresis on 0.8% agarose gels stained 
with Ethidium bromide. On A, two PCR reactions were performed with isolated virus, one detection 
the mutation (NQY PCR, using NDP4 and NDP13 primers) and one detecting wt sequence (NRY 
PCR, using NDP4 and NDP15 primers). Both reactions amplify a product of 341 bp. Except for 
isolate 1, all presented the mutation, but were also positive for wt sequence (viral mixtures). 
Recombinant 2 was selected to further isolation. On B, a pure double recombinant was detected using 
NQY PCR and M33 PCR (performed with NDP7 and NDP10 primers, as control reaction, amplifying 
a product of 572 bp). Circled numbers mark the recombinants M: 2 log ladder DNA marker (NEB); 
C-, negative control. 
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2.3.6. BAC recombineering  
Recombination via the use of BACs had not previously been established in our laboratory. Several 
alternative methods have been reported, with differences in the selectable markers and bacterial 
strains utilised. Initially, the “En Passant Mutagenesis” method (Tischer et al., 2010) was attempted.  
This method utilises a bacterial strain (E.coli GS1783, kindly provided by Dr. Greg Smith, 
Northwestern University Medical School, Chicago, IL) that has inducible expression of Red 
recombinase (heat shock induction) and the endonuclease I-Sce1 (L-arabinose induction). The 
method relies upon a two-step process: i) Red recombination inserts a selectable marker cassette 
(including an I-SceI site) at the target locus, ii) I-SceI induction drives selection of recombinants via 
a second round of Red recombination, whereby the marker cassette is excised and the mutation 
introduced without any accessory changes to the genome. 
Before attempting mutagenesis, the parental BAC DNA needed to be transferred to the GS1783 strain. 
Bacteria were electroporated with 1.8 kV and 50 ng of each of the Merlin HCMV BAC DNA, but 
poor results were achieved. Since literature did not agree in many points on BAC electroporation, in 
order to improve DNA transfer, a few parameters were tested: DNA extraction kit, amount of DNA 
(10, 50, and 100 ng), voltage (1.3, 1.5, 1.8, 2.1 and 2.4 kV), resistance (100 and 200 Ω) and antibiotic 
concentration (15 and 30 µg/ml Chloramphenicol). Despite all parameters tested, electroporation was 
highly inefficient and no colonies positive for BAC transformation were recovered.   
All the above parameter testing was conducted with DNA extracted up to 3 weeks prior the 
experiments. New electroporations were set using fresh DNA, i.e., BAC DNA extracted by midi-prep 
on the same day of electroporation. Two DNA concentrations (500 ng or 1 µg) were tested and the 
rest of the parameters used were as follows: 1.5 kV, 200 Ω and 15µg/ml Chloramphenicol. On the 
next day, almost a bacterial lawn was observed on the agar plates and these conditions, including 
recently extracted DNA, were established as standard electroporation reaction. Clones that displayed 
the expected REA profile were selected to use in further experiments.  
For the “En passant mutagenesis” method, recombination occurs by electroporating into E.coli 
GS1783 harbouring the BAC a fragment of DNA encoding a selectable marker flanked by an I-SceI 
recognition site and small stretches of homologous sequences (40bp) to the target region which 
include the desired mutation. So, first, we set out to generate a plasmid (B206) containing an I-
SceI/bla cassette. The I-SceI site was inserted in pUC19 upstream of the bla gene, using linkers 
containing the I-SceI recognition site (bold) and ends compatible with AatII ligation (italic) (primers 
NDP141 and NDP142 in Table 2.2). Transformation of pUC19 [AatII] ligated with the I-SceI linker 
produced a decreasing number of colonies mirroring the linker dilution. Colonies from the 10-4 
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dilution were screened for the presence of the site. Presence of the I-SceI site was confirmed by 
colony PCR and I-SceI digestion (Fig.2.11). The positive clone was selected as template for further 
PCRs using the designed recombineering primers. US28-Y291F was the first mutation attempted: 
amplification of I-SceI/bla cassette was performed with primer containing homology to US28 and a 
point mutation (NDP143 and NDP145); products were purified and electroporated into E.coli 
GS1783 containing pAL1158, generating nine colonies. To confirm the presence of the bla gene, 
PCR was performed and only three clones amplified a fragment of DNA with the expected size. These 
were selected to perform the resolution of co-integrates, by growing them at 42°C. All three clones 
produced thousands of colonies after induction. Three isolates of each clone were PCR tested to 
confirm the loss of the resistance gene; however, none presented the mutation, as indicated by the 
restriction profile (Fig. 2.12). Experiments were repeated several times, but we never identified a 
mutated clone. 
 
 
 
 
 
 
 
 
 
 
Fig. 2.11. Detection of I-SceI site in B206. Electrophoresis on 0.8% agarose gels stained with 
Ethidium bromide. On A, I-SceI site was detected in the 5’ orientation by PCR (NDP141 and M13) 
in two clones. On B, clone number 1 was digested with I-SceI enzyme (lane 1) to further confirm 
presence of the site (lane 2, clone 1 undigested; lane 3, control plasmid digested with I-SceI). M: 1kb 
ladder DNA marker (NEB).  
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As en passant mutagenesis failed, galK recombination system was tried out (Warming et al., 2005). 
GalK system uses a similar principle to the en passant method in the first step of recombination: 
primers containing both a sequence of homology (50 bp) to the recombination target region and a 
sequence of homology to galK is used to amplify this gene (plasmid B194 was used as template). The 
products are then electroporated into SW102 bacteria. Selection of recombinants is made by growing 
the bacteria in minimal medium with galactose as the only carbon source. Once the cassette is 
inserted, a second step of recombination is performed, to replace the selective marker with the desired 
mutation: cells are electroporated with DNA containing the same 50 bp of homology used in the first 
step which includes the mutation. Selection of recombinants is made by growing the bacteria in the 
presence of 2-deoxy-galactose (DOG) to negatively select galK recombinants: expression of galK 
allows DOG metabolism, which is toxic to bacteria. If recombination occurred, galK sequence should 
be replaced with the mutation and bacteria should grow normally in the presence of DOG. DOG 
medium was also used as positive control medium after the first step of recombination (bacteria that 
grew in the minimal medium and did not grow in DOG medium would be considerate candidates for 
the second step of recombination). GalK proved to be a poor selection system, with some non-
recombined colonies growing in the minimal medium after electroporation and colonies taking about 
 
 
Fig. 2.12. Screening of recombination by BAC en passant mutagenesis. Electrophoresis on 
agarose gel stained with Ethidium bromide. M: 1 kb ladder (NEB). On A, PCR (using M13 and I-
SceI primers) detecting two positive pUC19 for I-SceI site (lanes1and 2, 569bp product). On B, B206 
(lane 4) and a control (pGP2xNotI) (lane 6) were digested with I-SceI (lanes 3 and 5, respectively), 
linearizing B206 (arrow) and producing two bands in the control (1518 & 981bp) (square). On C, bla 
gene PCR product (about 1kb) of B206 (using US28-Y291F recombineering primers). On D, lanes 9 
to 11 show PCR positive clones (using bla gene and C-tail US28 primers), after first step of 
recombination. On E, digestion of PCR products of clones (lanes 12 to 14) after resolution to confirm 
mutation: Y291F clones lose one RsaI site, producing a different restriction pattern (231bp for 
mutants (lane 15, control) and 141 and 90bp for wild type, as indicated by arrows). 
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3 days to grow in DOG medium (used as positive control). Despite several attempts, insertion of galK 
within US28 or UL33 gene was not accomplished. Because selection seemed to be the problem, a 
plasmid with a second selective marker was constructed (galK/kanR, B246) to be used as 
amplification template, but still no recombinants were retrieved after electroporation of PCR products 
(encoding galK and kanamycin genes flanked by US28 homology sequences) into SW102 bacteria.  
A third method, involving a dual positive/negative selectable marker, utilising SacB for negative 
selection, via sucrose toxicity for SacB positive clones, was tested (Zhang et al., 1998). Dr Brian 
McSharry (University of Sydney) kindly provided us with an adenovirus vector containing a 
lacZ/SacB/AmpR selection cassette and a BAC with this cassette inserted as selective marker within 
US28 (pSD1124-2). To produce a US28-mutated HCMV, linearized or circular B105 (US28-R129Q) 
DNA were electroporated into SW102 containing pSD1124-2 BAC and plated on sucrose selective 
media. This generated hundreds of colonies on the next day, including lacZ negative clones (white 
colonies in presence of X-gal). A few clones were selected to confirm mutation by PCR – also, a 
couple of clones were analysed by REA to ensure the HCMV genome still presented the expected 
digestion pattern. In both recombinations (using either linear or circular plasmid DNA), one out five 
clones selected presented the expected band size in the PCR, i.e., US28 without the selective marker 
cassette (Fig. 2.13). Presence of the R129Q mutation was further confirmed by sequencing in both 
clones. 
Despite successful recombination between our plasmid containing US28 mutated sequence and the 
HCMV BAC encoding the selective markers within US28, insertion of the selective cassette within 
UL33, using PCR to add UL33 homologous arms to the lacZ/SacB/AmpR selection cassette, was 
unsuccessful despite several attempts. In order to discount the possibility that a too short sequence of 
homology (50 bp) between the BAC and the PCR products was the reason for the lack of 
recombination, a plasmid containing lacZ/SacB/AmpR cassette flanked by longer arms of homology 
to UL33 (93 nucleotides at 5’ and 413 nucleotides at 3’) was constructed (B253). Electroporations of 
B253 (linearised) into SW102 containing HCMV BAC produced Amp resistant, blue bacteria, but 
none had the cassette within UL33. To test if the issue was the presence of regions of homology 
within the plasmid (B253 was generated using pUC19 and, thus, encoded a second bla gene and part 
of lacZα sequence outside UL33 coding sequence), a plasmid with the lacZ/SacB/Ampr within UL33 
was constructed using pGFP-N1 backbone (B259) (Fig. 2.14). Using this new vector in 
electroporation of BACs, still, no recombinant BAC encoding the selective cassette within UL33 was 
generated.   
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Fig. 2.13. Screening for R129Q-US28 recombinant. Electrophoresis on 0.8% agarose gels stained 
with Ethidium bromide. On A, REA of 2 recombinant candidates using XbaI (X) or EcoRV (E), both 
of which presented the expected pattern. On B, 5 clones from both linear and circular plasmid DNA 
electroporation were submitted to PCR amplifying part of US28 gene (NDP 138/NDP192). Parental 
BAC produced a fragment of approximately 4.9 kb, because it also amplified the selective marker 
within US28 gene (isolates 2L-5L, 4C and 5C), while recombinants generated a 687 bp amplicon 
(isolates 1L and 3C). On C, PCR amplification of both UL33 (NDP194/NDP195) and US28 
(NDP57/NDP192). The presence of both UL33 (1682 bp) and US28 (712 bp) products demonstrated 
that the HCMV genome and not parental plasmid (B105) was being amplified. M: 1kb ladder DNA 
marker (NEB); C-, negative control; L, clones from linear DNA electroporation; C, clones from 
circular DNA electroporation. 
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2.3.5. BAC-derived HCMV stocks 
To produce infectious virus from HCMV BAC DNA, the DNA must be transfected into mammalian 
cells permissive to HCMV infection. To perform efficient transfections, it is necessary to use a great 
amount of high quality DNA. Thus, four kits were tested for BAC DNA extraction: Large Construct 
Kit (LC), Plasmid Midi Kit (MID), NucleoBond BAC100 (NB), and NucleoBond Xtra Midi Kit 
(NBX). All kits were suitable for BAC DNA extraction, regarding quality of DNA (Fig. 2.15 shows 
REA of BAC DNA extracted with different kits). However, the use of LC Kit – which presented the 
lowest BAC DNA recovery rate – was ruled out, since the other kits presented better results and were 
less time consuming. Most of the transfection tests were performed with DNA extracted by the MID 
and NB kits. Later during the project, the NBX kit was tested and considered the best option to 
perform DNA extractions, as it produced good amounts of DNA was the least time consuming of all 
the kits. Mini or midi-prep with homemade solution also yielded good amounts of DNA, but with 
 
Fig. 2.14. Cloning of LacZ/Amp cassete into UL33 (B259). Electrophoresis on 0.8% agarose gels 
1stained with Ethidium bromide. B258 (pGFP-1N-UL33) was digested with SmaI and SacII, excising 
a 995 bp from UL33 gene (lane 2). Backbone (4358 bp) was gel purified (dashed rectangle on A) and 
ligated with LacZ/Amp cassete, excised from pAL1151 digested with SacII and HpaI (white circle 
on B). REA with HindIII confirmed expected pattern of digestion (4.3, 2.1 and 1.3 kb fragments) for 
all clones (on C). M: 1kb ladder DNA marker (NEB): sizes as indicated; lane 1: B258 undigested; 
lane 2: B258 digestion; lane 3: pAL1151 digestion; lanes 3 to 5: REA of B259 clones. 
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low purity; thus, although BAC DNA extracted by midi-prep could be used for bacterial 
electroporation, it is not recommended for transfection.  
The first transfection of BAC DNA was performed on HFF cells, using a range of LC extracted DNA 
concentrations: 0.3 µg, 0.6 µg, 1.2 µg (pAL1158), 1.05 µg, 2.1 µg and 4.2 µg (TB40/E-BAC4). 
Presence of CPE was only visualized on the wells with the higher DNA amounts, at 1 week post-
transfection for Merlin and 2 weeks for TB40/E. It is important to remark that BAC DNA 
concentration measured by spectrophotometer (NanoDrop, Thermo Scientific) were not always very 
reliable: the BAC DNA was not mixed rigorously to avoid DNA breakage; therefore, freshly prepared 
DNA may tend to present more erroneous spectrophotometer reads as the DNA is not homogeneously 
suspended. So, it is more likely that the long time difference in virus production is more related to 
amount of DNA transfected than virus strain. To confirm virus production, immunofluorescence was 
 
Fig. 2.15. REA of BACs using different method of DNA extraction. Electrophoresis of BAC DNA 
digested with EcoRV on 0.7% agarose gels stained with Ethidium bromide. Comparison of quality 
of DNA extracted using different method. All methods were suitable, although they presented 
different levels of efficiency and practicality. On A, DNA extracted by mini-prep with homemade 
solutions (3 clones of two different BACs). On B, DNA extracted using Plasmid Mid Kit (4.1) or 
Long Construct kit (5.1). On D, comparison of DNA extracted with Long Construct adding NaCl 
during precipitation (7), NB BAC 100 (8-10, respectively, no additives, addition of NaCl or an extra 
DNA precipitation with isopropanol) and Plasmid Mid Kit (11). M: 1kb ladder DNA marker (NEB). 
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performed in cells infected with viruses recovered from the transfections. Antibodies (anti-gB, anti-
pp65 and anti-IE72) were tested, using either 80% acetone or 3% paraformaldehyde (PFA) as fixing 
agent, against both Merlin and TB40/E virus strains. It was possible to detect either strain of viruses 
using both anti-pp65 and anti-IE72 antibodies. Anti-IE72 fixed with PFA bound more specifically to 
infected cells, while acetone demonstrated to be a better fixing agent to anti-pp65 antibody. Anti-gB 
fixed with either solution produced some background, but results were slightly better with PFA for 
Merlin. This antibody did not seem to bind well to TB40/E virus (Figure 2.16). 
A new set of transfections, using only pAL1160 DNA, was performed in duplicates, now testing 
efficiency of DNA extracted with different kits: DNA from LC (approximately 0.2 µg, 0.4 µg and 
0.7 µg of DNA), NB (1.1 µg, 2.3 µg and 4.6 µg of DNA) and MIDI (1 µg, 2.1 µg and 4.2 µg) were 
compared. Two and three weeks post-transfection, virus stocks were collected, aliquoted and titrated. 
LC transfected DNA did not produce CPE in any concentration tested, confirming the need to 
transfect at least 1 µg of BAC DNA to properly retrieve virus in a reasonable amount of time, and, 
 
Fig. 2.16. Antigen detection of BAC-derived HCMV. Three antibodies (anti-gB, anti-pp65 and anti-
IE72) were tested, using 80% acetone (A) or 3% paraformaldehyde (PFA) (B) as fixing solution, 
against both Merlin (1158, left panel) and TB40/E (right panel). Scale bars represent 100m. 
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thus, virus stocks were not collected. For MIDI and NB, interestingly, duplicates did not necessarily 
exhibit same results: while for some duplicates CPE was found in both wells, for others only one well 
presented CPE. Based on the electroporation results, these low (and inconsistent) viral titers of 
transfected BACs were likely due to the use of “non-fresh” DNA and, therefore, all subsequent 
transfections were performed using freshly prepared DNA. Results of titrations are summarised in 
Table 2.4.  
Table 2.4. Titer of recovered virus after BAC transfection on HFF#. 
 MID (PFU/ml**)  NB (PFU/ml**) 
Time\µg DNA* 4.2µg (1) 4.2µg (2)  1.1µg (1) 2.3µg (1) 4.6µg (1) 4.6µg (2) 
2 w.p.t. 102 25  1.25x102 - 25 25 
3 w.p.t. 3x102 50  3.7x102 - 1.75x102 1.2x103 
# Human foreskin fibroblast 
*time: w.p.t., week post-transfection before harvesting virus; DNA: µg of DNA transfected 
**PFU/ml: plaque-forming unit per ml of virus 
Supernatant from transfection trials were kept as master stocks and used to grow working stocks of 
HCMV on HFF. 1158 HCMV was selected to further use as wild type (wt) virus, because both the 
mutant viruses we had (STOP-US28 and R129Q-US28) were made using this BAC background. Both 
mutant viruses productively infected HFF and presented similar growth kinetics to wt at all points, 
except on day 10, when both mutants presented titers of extracellular virus production lower than wt 
virus (Fig 2.17 and 2.18). When testing the permissiveness of the cell lines of interest to HCMV, 
productive infection and CPE was detected in HUVEC (Fig 2.19); however, we could not detect 
productive infection by any of the viruses on HTR-8 (Fig 2. 20).  
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Fig. 2.17. R129Q-US28 STOP-US28 
mutant viruses present similar 
kinetics to parental HCMV at all 
times, but at day 10 p.i. HFF were 
infected at a 0.1 MOI and supernatants 
were collected regularly for 2 weeks. 
Extracellular virus production was 
assessed by titration on HFF of 
supernatant of two independent 
infections for each virus.  
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Fig. 2.18. R129Q produces productive infection in HFF. HFF were infected at 0.1 MOI. At day 5 
p.i., green fluorescent plaques (Column 1) could be observed in all infections (A, negative control 
(no virus); B, wt 1158; C, STOP-US28 1158; D, R129Q-US28). Using anti-gB as primary antibody 
and a secondary antibody conjugated with a red fluorescent protein (AF594), immunofluorescence 
assay was performed, confirming infection (Column 2). Column 3 shows the same field of cells with 
the nuclei counterstained with Hoechst (40x objective). Scale bars represent 50m. 
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Fig. 2.19. Detection of productive infection in HUVEC by wt and R129Q-US28 mutant. HUVEC 
were infected at 0.1 MOI. At day 5 p.i., green fluorescent plaques could be observed in the infected 
monolayer (Column 1). Immunofluorescence assay, using anti-gB and a secondary antibody 
conjugated with red fluorescent protein (AF594), confirmed infection (Columns 2). Column 3 shows 
the same field of cells with the nuclei counterstained with Hoechst. A, negative control (no virus); B, 
wt 1158 infection; C, R129Q-US28 infection (40x objective). Scale bars represent 50m 
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Fig. 2.20. In HTR-8, productive infection by neither wt nor R129Q-US28 HCMV was detected. 
HTR-8 were infected at 0.1 MOI. At day 5 p.i., no green fluorescent plaques were detected in infected 
cells (Column 1). To confirm absence of productive infection, immunofluorescence assay was 
performed using anti-gB as primary antibody and a secondary antibody conjugated with a red 
fluorescent protein (AF594) (Columns 2). Column 3 shows the same field of cells with the nuclei 
counterstained with Hoechst. A, negative control (no virus); B, wt 1158 infection; C, R129Q-US28 
infection (10x objective). Scale bars represent 100m. 
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2.4 Discussion 
Our goal was to generate several tools that would be useful over the course of this study. Some of the 
work achieved good outcomes, some of it failed to produce the expected results. We successfully 
made lentivirus vectors encoding several US28 constructs. Although there were no differences in 
expression patterns of US28 using lentivirus or other expression vectors, their use was not applied in 
this study, because of the poor titers of lentivirus obtained in our transfections. Notwithstanding our 
best efforts, we could not achieve titers higher than the magnitude of 104 TU per 75cm2 flask of HeLa 
cells. However, it seems that the common way of increasing titers is augmenting the number and size 
of transfected flasks (personal communications with Dr. Wenyi Gu). Our titers were still in range of 
lentivirus production obtained with transfection using calcium phosphate, but they were still much 
lower than titers described for new PEI transfection protocols (Benskey & Manfredsson, 2016; 
Tiscornia et al., 2006). Additives, such as sodium butyrate or Polybrene, help improve viral titers 
(Cribbs et al., 2013). Also, pH of solutions, virus concentration and Pellett resuspension play 
important roles in final titers (Ichim & Wells, 2011; Kuroda et al., 2009). However, PEI (or calcium 
phosphate) transfection needs a lot fine tuning to yield high virus production. Because gene 
transduction was a possible method to express the viral genes and not our aim itself, we set lentiviral 
production aside and looked for another assay to introduce the vGPCR DNA in hard to transfect cells, 
such as HUVEC. We then tested the Nucleofector system for transfection of HUVEC. This method 
yielded excellent results, presenting high efficiency of transfection (up to 80% of the cells were 
expressing the reporter gene – for comparison, using Lipofectamine only about 5% of cells were 
transfected). The use of this system was also easy and fast to perform – cells do not even need to be 
seeded 24h prior to transfection, as they are suspended just ahead of electroporation. The selection of 
the right electroporation program is a very an important step, as efficiency and cell viability will 
depend on it. This method does impose a limit of transfected cells – each cuvette supports transfection 
of up to 106 cells – and the cost of the consumables is higher than other transfection methods. Hence, 
although not indicated for all uses, the Nucleofector system is a valid method for transfection. 
The use of antibodies to detect HCMV infection was standardised.  The anti-pp65 and anti-IE72 
antibodies performed well against both strains of HCMV, while anti-gB was suitable for Merlin, but 
not TB40/E infections. Although these antibodies allowed for infection detection, they are not suitable 
to prove the absence of US28 expression by our mutant virus.  Aiming to detect viral infection and 
to confirm the lack of US28 expression by null US28 mutants, we tested a commercial anti-US28 
antibody.  Unfortunately, this antibody failed to bind specifically in both immunofluorescence and 
western blot assays. Further enquiries with the company indicated that the antibody was unreliable 
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and had been withdrawn. Epitope-tagged US28 expressed in transfected cells were detected 
successfully using anti-HA antibodies, with a mouse monoclonal having superior performance.  This 
antibody was not applicable for our HCMV infection studies, since in these constructs US28 was not 
epitope-tagged. Generation of HA-tagged HCMV recombinants was considered.  However, given the 
difficulties encountered with BAC recombineering, generation of additional HA-US28 recombinants 
was not attempted.    
Finally, a big component of this study was the production of recombinant virus. The production of 
recombinant MCMV by coinfection of cells was effective and three double recombinant MCMV were 
produced: GR-M33NRY, GR-M33Stop and M33-luc. The use of M33-luc virus and its 
pathogenesis is discussed in chapter 4. When testing GR and GR-M33Stop pathogenesis, we detected 
that neither the parental virus nor the M33 mutant were able to infect the salivary glands of C57BL/6 
mice, the background strain to be used for the CRE/flox switching experiments. Although this 
phenotype was expected for GR-M33Stop, this was not predicted for the M33 positive GR virus 
(Davis-Poynter et al., 1997). The EGFP-tdTomato cassette encoded by the GR virus was placed 
within m157, which encodes a MHC-I-like molecule, an immunomodulatory protein that binds to 
receptors of NK cells. In mice strains more resistant to MCMV, like C57BL/6 strain used here, it 
binds to an activating receptor in NK cells (Arase et al., 2002). In the absence of m157, therefore, the 
GR virus was expected to have enhanced replication in C57BL/6, presenting either the same or higher 
viral titer in the salivary glands. Subsequent studies in the lab have found that the GR virus does 
replicate in salivary glands of BALB/c mice, albeit with approximately 10-fold reduced titres 
compare with wt. Furthermore, independent Smith strain recombinants with marker cassettes inserted 
at m157 have also failed to replicate in salivary glands of C57BL/6, despite higher titres than wt virus 
in the spleen. This suggests that there may be a previously unreported defect in C57BL/6 for mutants 
with disrupted m157. Consequently, the floxed colour switch approach would require insertion of the 
marker cassette at an alternative locus. 
While MCMV recombination was a straightforward process, the making of HCMV BAC 
recombinants, on the other hand, presented many challenges. It is still not clear why we were unable 
to introduce any of the selective markers within the BAC genome –  at least in desired region, as 
many times bacteria presented the expected phenotype (antibiotic resistance, lacZ expression), but 
were negative when screening the target genes (UL33 or US28) by PCR analysis. HCMV BAC 
recombination is vastly used in the literature (Borst et al., 1999; Hahn et al., 2002; Sinzger et al., 
2008; Stanton et al., 2010; Wang et al., 2004; Zhao et al., 2015). The replacement of the selective 
marker for a mutated sequence was quite simple and uncomplicated in the BAC that already had the 
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cassette. Several strategies were used to try to overcome this problem, but they all failed. Whether it 
was a procedural or a reagent problem, we did not detect the issue preventing the recombinations.  
Virus stocks, however, for the US28 recombinant and wt 1158 HCMV were produced. An interesting 
remark was that the use of recent extracted DNA was a lot more efficient to both transfections and 
transformations. This is probably due to DNA conformations, as relaxed conformations of DNA are 
less active and gain less efficient access to the nuclei than supercoiled DNA (Carbone et al., 2012). 
It is reasonable to assume that a more condensed form of a large molecule is more easily inserted into 
a cell, whether eukaryotic or prokaryotic. When infecting the different cell types, CPE was not 
detected in HTR-8 cells. Immunofluorescence assay confirmed absence of productive infection. 1158 
HCMV has a mutation in UL128, which was described to cause a faster spread of infection in HFF 
and to be essential only to epithelial cells infection (Stanton et al., 2010). The mutation did not prevent 
HUVEC infection, although extracellular viral release was not as effective as in HFF (data not 
shown). UL128 is part of what is considered an accessory mechanism of viral entry, being essential 
only for specific cell types (Zhou et al., 2015). Unfortunately, HTR-8 seems to be one of those cell 
types that requires UL128 for viral entry (Naing, 2015). Because BAC mutants were in the 1158 
HCMV background and we could not insert the selective marker in other BAC backgrounds, we could 
not perform the planned infection experiments in HTR-8. 
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Chapter 3 - HCMV vGPCR effects upon human cell types 
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3.1 Introduction 
G protein-coupled receptors (GPCR) are an abundant family of cell surface molecules able to regulate 
numerous physiological processes, such as cell division, migration, invasion and apoptosis. All beta- 
and gammaherpesviruses encode at least one GPCR homologue (vGPCR); HCMV encodes four, 
designated UL78, UL33, US28 and US27. These receptors are implicated in viral pathogenesis, with 
several examples where constitutive signalling, a distinguishing characteristic of many vGPCR, 
modulates pathogenic phenotypes.  
Of these vGPCRs, US28 has been the most extensively characterised. US28 was shown to increase 
constitutively the activity of transcription factors including nuclear factor–κB (NF-κB) and cAMP-
responsive element binding protein (CREB) in human epithelial cells and in human and primate 
fibroblasts (Casarosa et al., 2001; McLean et al., 2004; Minisini et al., 2003; Waldhoer et al., 2002). 
Signalling via Gαq with activation of phospholipase C (PLC) and accumulation of inositol phosphates 
(IP) was implicated as a major pathway. G protein-coupling was confirmed to play a key role in this 
process as disruption of the GPCR DRY-motif prevented IP accumulation following HCMV infection 
of fibroblasts (Stropes & Miller, 2008).   
In addition to its constitutive signalling, US28 is also rapidly and constitutively endocytosed and 
recycled back to the plasma membrane.  Furthermore, US28 binds both CC and CX3CL1 chemokines, 
although its affinity for the latter is much higher (Kledal et al., 1998). While CC chemokines act as 
neutral antagonists for US28, CX3CL1 was shown to be an effective inverse agonist, causing 
inhibition of constitutive G protein-dependent signalling (Casarosa et al., 2001; Stropes et al., 2009). 
Its broad specificity for chemokines has led to the suggestion that US28 acts as a chemokine “sink” 
by sequestering host inflammatory chemokine responses around the infected cell milieu (Randolph-
Habecker et al., 2002) although this idea has been recently challenged (Boomker et al., 2006). The 
impact of US28 binding to cellular chemokines on motility has been addressed in smooth muscle 
cells (Streblow et al., 1999; Vomaske et al., 2009). Interestingly, both CC and CX3CL chemokines 
induce migration, but via the coupling of different G proteins.  Thus, US28 utilises different 
extracellular chemokines and diverse intracellular G-proteins to produce ligand and cell-type specific 
migration of HCMV-infected cells. 
In contrast to US28, the properties of UL33, have been less well characterised.  Signalling by US28 
has found to differ from UL33 (Waldhoer et al., 2002). Whilst UL33 has been shown to constitutively 
activate the PLC/IP pathway, predominantly via Gαq, signalling through CREB, it has presented no 
induction on NF-κB activation in fibroblasts (Casarosa et al., 2003; Waldhoer et al., 2002). Although 
the effect of UL33 on cellular migration is unknown, studies with the MCMV UL33 counterpart 
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(M33) showed that it was necessary and sufficient to promote SMC migration (Melnychuk et al., 
2005). No studies have been made evaluating the effects on the signalling properties of UL33 when 
the GPCR DRY-motif is disrupted. However, studies with the mouse homolog in HEK cells have 
shown that mutations in the arginine (R131) of the NRY-motif of M33 ablate the G protein 
constitutive signalling of the viral receptor, including CREB activation and IP turnover. On the other 
hand, substitutions of the asparagine (N130) for aspartic acid (D), as found in UL33, increased CREB 
activation by M33 (Case et al., 2008). Similarly, the rat cytomegalovirus homolog, R33, presented 
no constitutive signalling upon mutation of the arginine in the NRY-motif (Gruijthuijsen et al., 2004). 
Trophoblasts are placental cells responsible for invasion of the endometrium (cytotrophoblasts) and 
for regulation of metabolic functions (syncytiotrophoblsts), processes imperative for full term 
gestation. Migration and invasion of trophoblasts through the decidua and maternal uterine spiral 
arteries are crucial events in placentation; failure in these processes results in numerous pregnancy 
complications (Chen et al., 2012; Sharma et al., 2016). The migration/invasion of trophoblasts is 
affected by a number of growth factors via the action of small signalling G proteins and 
phosphorylation of downstream signalling pathways such as MAPK and ERK (Nicola et al., 2008). 
HCMV has been detected in a variety of naturally (Benard et al., 2014; Sinzger et al., 1993) and in 
vitro infected placental cells (Gabrielli et al., 2001; LaMarca et al., 2004; Liu et al., 2011b; Xiao et 
al., 2010).  HCMV infection has been associated with poor placentation and foetal outcome. Placentas 
showing productive HCMV infection have shown altered significant modulation of host cytokines 
(Hamilton et al., 2012; Scott et al., 2012) although the contribution of viral factors have not been 
determined.   
Trophoblasts have been shown to not only enable HCMV entry into the placenta, but also to sustain 
a productive, albeit slow, infection (Gabrielli et al., 2001). Furthermore, HCMV can hinder 
trophoblast differentiation, changing the expression of important adhesion proteins, inflammatory 
molecules and chemotaxis mediators, thus, altering cell functions like invasiveness and placental 
development (Fisher et al., 2000; Maidji et al., 2007; Pereira & Maidji, 2008; Schleiss et al., 2007). 
This scenario correlates with the higher risk of severe disease in foetuses infected during the first 
trimester (Enders et al., 2011; Pass et al., 2006).  
Given that infection of trophoblasts are highly relevant to the pathogenesis of HCMV in utero 
infection, here we evaluated the signalling profile of US28 or UL33 in trophoblast cells and their 
effects on trophoblast migration using an established human trophoblast cell line. We further 
investigated how the ablation of constitutive G protein-coupled signalling could influence trophoblast 
migration using DRY-motif mutants. We then examined whether the vGPCR could be involved in 
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the alterations of the placental environment by assessing changes in the secretion pattern of matrix 
metalloproteins (MMP) and chemokines, molecules with key roles in tissue remodelling, in cells 
expressing the vGPCR (trophoblasts and endothelial cells) and during infection (endothelial cells and 
fibroblasts). 
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3.2 Material & Methods 
3.2.1 Cells and viruses 
A first trimester human extravillous trophoblast cell line HTR-8/SVneo (a kind gift from Professor 
Charles Graham of the Department of Anatomy and Cell Biology at Queen's University, Kingston, 
Canada) was cultivated in RPMI 1640 medium (Gibco). Human Embryonic Kidney (HEK) and 
human foreskin fibroblast (HFF) were cultured in Dulbecco Modified Eagle Medium (DMEM, 
Gibco). The three cell lines were supplemented with 2 mM L-glutamine, 10% fetal bovine serum 
(FBS), 100 U/mL penicillin and 100 µg/mL streptomycin (Gibco, Life Technologies). Human 
umbilical vein endothelial cells (HUVEC) were grown in EBM-2 medium (Lonza), supplemented 
with Bullet kit (hydrocortisone, heparin, ascorbic acid, gentamicin sulphate, amphotericin-B, long R 
insulin-like growth factor, recombinant human fibroblast growth factor, recombinant human 
epidermal growth factor, endothelial growth factor and FBS). All cells were maintained at 37ºC in a 
5% CO2 humidified atmosphere.  
For wild type (wt) HCMV, Stanton et al. (2010) BAC derived 1158 HCMV (rCMV1158 RL13-
UL128-GFP+ Merlin strain) was used. Two recombinants using 1158 HCMV backbone were also 
used: STOP US28 1158 (US28 null mutant, kindly provided by Dr. Brian McSharry) and R129Q 
US28 1158 (US28 G protein signalling mutant). All viruses were grown in HFF and when cytopathic 
effect (CPE) reached about 80% of the monolayer, supernatants were collected, aliquots made and 
stored at -80C. To determine viral titre, plaque assays were performed in 24-well trays. Briefly, serial 
dilution were added to 24 well trays seeded with HFF. After 30 min at 693 x g at room temperature, 
followed by 90 min at 37C, monolayers were overlaid with 0.5 ml of 0.5% carboxymethyl cellulose 
(CMC) 2% FBS DMEM and incubated for 1 week at 37C. Cells were then fixed with 0.4% 
formaldehyde-PBS and stained with 0.1% toluidine blue and the number of viral plaques was counted 
under an optical microscope (Olympus CKX31). 
3.2.2 Transfection 
Cells were transfected with empty pcDNA3.1 vector or containing one of the following constructs: 
wt UL33, D128N UL33, R129Q UL33, wt US28 or R129Q US28. HEK and HTR-8 cells were 
transfected using Lipofectamine 2000 (Life Technologies) as per manufacturer’s instructions. After 
6 hrs, wells were washed and cells were incubated overnight with RPMI medium supplemented with 
0.3% BSA (hereafter referred as minimal medium). HUVEC were transfected using the Nucleofector 
system (Lonza), pre-set program CA167. Transfections were performed with Amaxa P3 Primary Cell 
4D-Nucleofector X Kit L (Lonza), following manufacturer’s instructions, using 3 µg of DNA and 
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3x105 cells per reaction. At 24h post transfection, media were replaced with HUVEC medium, 
containing only 50% of growth factors and FBS concentration (hereafter referred as HUVEC minimal 
medium). 
3.2.3 Migration assay (Boyden Chamber assay) 
HTR-8 cells were transfected with 0.5 µg of DNA as described above. One day post transfection, 
cells were dissociated with TrypLE Express™ (Gibco), washed twice with minimal medium and a 
total of 20,000 cells in minimal medium was applied to the top well of a transwell chamber; the lower 
chamber contained either minimal medium or medium supplemented with either 10% FBS (or 
alternatively, 10% FBS supplemented with 0, 10 or 50 nM CX3CL1, where indicated). After 24h, 
cells that had not migrated were removed from the upper chamber with a cotton swab; migrated cells 
were fixed in methanol, air dried and stained with Giemsa.  Migrated cells from 6-7 fields were 
counted in situ. 
3.2.4 Luciferase reporter assay  
HTR-8 trophoblasts in 96 well trays were transfected with 2.5 ng of DNA together with 100 ng 
reporter constructs (four replicates per plasmid). At 24-h post transfection, serum-starved cells were 
lysed and incubated with luciferase substrate (Perkin-Elmer). After 10 min of incubation in the dark, 
luminescence was measured for 5 sec at room temperature on a microplate luminescence counter. For 
mitogen-activated phosphatase kinases (MAPK) inhibition assays, 5 µg of selective inhibitors (Tocris 
Bioscience) were added per well 1h prior to cell lysis: ERK inhibitor (PD98059), p38 inhibitor (SB 
202190) or JNK inhibitor (SP 600125).  Results are expressed as relative light units (RLU) compared 
to the negative control plasmid, pcDNA3. 
3.2.5 Western blot 
Protein content was extracted from 24h transfected HTR-8 (1µg DNA per 12-well), as described 
before, using pcDNA3 (B66) and/or pEGFP-N1 (B240) as controls. Monolayers were washed twice 
with cold HBSS and incubated on ice for 15 min with 50 µl of protein extraction buffer (1x Pierce 
RIPA buffer, 1x Halt Protease Inhibitor Cocktail and 0.5 mM EDTA (ThermoFisher Scientific)). 
Lysate was transferred to microcentrifuge tubes, sonicated and centrifuged (10 min at 17000 x g at 
4ºC). Supernatants were transferred into new tubes and stored at -20ºC. After addition of sample mix 
(1x LDS and 1x reducing agent, Life Technologies), samples were denatured at 50ºC for 10 min and 
run on a 4-12% Bis-Tris gel (NuPage, Life Technologies), using Bolt Unit and MES SDS running 
buffer (Life Technologies). Gels were blotted onto Nitrocellulose membranes (Life Technologies) 
and incubated with manufacturer’s recommended dilutions of phosphorylated-specific and total 
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antibodies (Cell Signalling) against: Akt (40D4), p-Akt (D9E), ERK p44/48 (L34F12), p-ERK p44/42 
(D13.14.4E), JNK1 (2C6), p-SAPK/JNK (81E11), NF-κB p65 (L8F6), p-NF-κB p65 (93H1), p38α 
(L53F8), p-p38α (D3F9), Src (7G9) and p-Src (D49G4). Anti-HA-tag (ab9110 (Abcam) and anti-
αTubulin (11H10, Cell signalling) were used as controls when necessary. Fluorescent tagged 
secondary antibodies were used for detection: IRDye 680RD (Goat Anti-Mouse) and IRDye 800CW 
(Goat Anti-Rabbit) (LI-COR). Antibody incubations and membrane blocking were performed with 
Odyssey solution (LI-COR). Membranes were visualized using an Odyssey fluorescent scanner (LI-
COR) and signal was measured using Image Studio Lite Software version 5.0. 
3.2.4 MMP and Chemokines detection assays  
Luminex assays were performed using supernatant of both infected and transfected cells. HTR-8 cells 
and HUVEC were transfected, with 1.5 and 3 µg of DNA, respectively, in 12-well trays, as 
aforementioned, except for using pEGFP-N1 vector as control instead of pcDNA3.1. At 48h post-
transfection, supernatants were collected, centrifuged (15 min, at 1000 x g, at 4ºC), aliquoted as 
single-use samples and stored at -80ºC. The three recombinant HCMV were used to infect HUVEC 
and HFF with a 0.1 MOI, allowing 2h of adsorption (30 min at 693 x g, followed by 90 min of 
incubation at 37ºC) before medium change (HUVEC minimal medium and 2% FBS DMEM, 
respectively). Two days post infection, supernatants were collected, centrifuged, aliquots made and 
stored at -80ºC. Bio-Plex Pro Human MMP Panel (9-plex) and Bio-Plex Pro Human Chemokine 
Panel (40-plex) (Bio-Rad) were performed following manufacturer’s instructions, using a magnetic 
wash station (ELx405, Biotek). Minimum media were used as blank and 50 µl of undiluted 
supernatant from either transfect or infected cells were used as sample (assays were set using 3 to 4 
biological replicates in duplicate per sample). Data was acquired and analysed by Luminex 100, using 
xPONENT® 3.1 software (Millipore). 
3.2.7 Statistical analysis 
Statistical analysis was performed using ANOVA with Bonferroni post-test. In all experiments, 
signiﬁcant differences were considered as P values < 0.05. All analyses were made using GraphPad 
Prism version 5.0 software. 
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3.3 Results 
3.3.1 Constitutive signalling of vGPCR correlates with enhanced HTR-8 migration  
In HEK cells, whereas the activity of cAMP-responsive element binding (CREB) protein has been 
described to be up-regulated by both UL33 and US28 constitutive signalling, NF-κB signalling is 
only activated by US28 (Casarosa et al., 2003; McLean et al., 2004; Waldhoer et al., 2002). We first 
established whether a similar profile of constitutive signalling could be detected in HTR-8 cells.  
Thus, signalling mediated by both transcriptional factors was evaluated in HTR-8 by luciferase 
reporter assay. Receptors presented in HTR-8 the same pattern of activation detected in HEK: US28 
significantly activated CREB and NF-κB signalling, but UL33 only enhanced CREB signalling 
pathway (Fig. 3.1). Notably, the level of CREB induction by UL33 in HTR-8 cells was markedly 
higher than observed in HEK. 
In order to invade the endometrium, one of the key functions of trophoblasts is their ability to migrate. 
Since US28 has been described to induce a cell type specific migration, we investigated whether the 
presence of US28 or UL33 could affect trophoblast migration. Using FBS as chemoattractant, 
migration levels were measured in cells expressing either pcDNA (empty vector), US28 or UL33 by 
Boyden chamber assay. In the absence of FBS, neither US28 nor UL33 affected migration compared 
 
 
Fig. 3.1. Like in HEK cells, US28 and UL33 induce CREB signalling, but only US28 induces 
NF-κB activation in HTR-8. Signalling characteristics of wt UL33 and wt US28 in (A) HTR-8 
trophoblasts and (B) HEK cells. Cells were transfected with 2.5 ng of either wt UL33, wt US28 or 
pcDNA3 vector together with 100ng of CREB or NF-κB luciferase reporter. Results of 4 independent 
experiments are expressed as relative light units (RLU) % ± SEM compared to the control plasmid 
(pcDNA3). 
(A)                                                                         (B) 
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with control transfection.  In contrast, when 10% FBS was included in the lower chamber, both US28 
and UL33 induced significantly higher migration than control plasmid (Fig. 3.2).   
CREB signalling by the vGPCR has been associated with their G protein-dependent constitutive 
signalling (Waldhoer et al., 2002). To investigate whether the constitutive activity of the vGPCR was 
responsible for stimulating cell migration, the involvement of G-protein coupling on both migration 
and CREB signalling was compared. HTR-8 cells were transfected with either wt UL33 or two DRY-
motif mutants, D128N or R129Q UL33, which were predicted to present attenuated and null G protein 
signalling phenotype, respectively. CREB-mediated transcription was stimulated by wt UL33 over 
ten-fold compared with control plasmid.  For the UL33 mutants, whereas D128N presented only a 
small reduction of CREB activation compared to wt, R129Q induced CREB activity weakly (Fig. 
3.3A). The effects on the migration phenotype were also modulated by G protein signalling. HTR-8 
expressing wt UL33 showed a significant increase in migration compared to control (pcDNA). Cells 
transfected with signalling mutants presented different effects on migration: while D128N mutant 
stimulated it at similar levels to wt receptor, cells expressing the R129Q mutant exhibited migration 
levels similar to control (Fig. 3.3B). The inability of this mutant receptor to induce HTR-8 cell 
 
Fig. 3.2. In the presence of FBS, US28 and UL33 significantly increase HTR-8 migration. Cells 
were transfected with either wtUS28 (squares), wtUL33 (triangles) or pcDNA vector (circles). After 
6h, cells were serum starved overnight. 20,000 cells were suspended in serum-free medium and 
applied to the upper well of a transwell chamber. The lower chamber contained medium with (+, 
solid symbols) or without (-, open symbols) FBS.  After 24h, cells that had migrated to the lower 
chamber were counted in 8 independent fields and compared by 1-way ANOVA with Bonferroni’s 
post-test (***, P<0.0001). 
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migration coincides with the ablation of CREB signalling of R129Q, suggesting a correlation between 
CREB activation and the migration phenotype and, thus, migration and UL33 constitutive activity. 
US28-induced migration has been so far described as a chemokine-dependent event, with differing 
effects reported for CC or CX3C chemokine ligands (either stimulatory or inhibitory), depending 
upon the cell type (Hjorto et al., 2013; Streblow et al., 1999; Vomaske et al., 2009). Thus, we tested 
whether CX3CL1 binding would affect US28-induced migration of trophoblasts in the presence of 
FBS. In the presence of low concentration of the chemokine (10 nM), a significant reduction was 
detected in US28-dependent migration, and at a higher concentration (50 nM) migration activity 
returned to background levels (Fig. 3.4).  
 
 
  
Fig. 3.3. Disruption of UL33 constitutive G protein signalling causes abolishment of HTR-8 
migration. (A) Quantification of CREB-mediated transcription stimulated by DRY-motif UL33 
mutants.  Trophoblasts were transfected with increasing amounts of either UL33 (▲), R129Q UL33 
(◇) or D128N UL33 (inverted ◮) together with 100ng CREB luciferase reporter. Results are 
expressed as relative light units (RLU) ± SEM of 4 independent experiments compared to the 
negative control (pcDNA3, ●). (B) HTR-8 were transfected with either wt UL33 or UL33 point 
mutants. While R129Q abolishes G protein-mediated migration, D128N preserves it. After 6 h, cells 
were incubated in serum-free medium overnight. A total of 20,000 cells in serum-free medium were 
applied to the top well of a transwell chamber; the lower chamber contained medium + 10% FBS. 
After 24h, cells that had migrated were counted in 6-7 independent fields. Statistical analysis was 
made using 1-way ANOVA, with Bonferroni’s post-test (***, P<0.0001). 
(B) 
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3.3.2 Constitutive CREB activation by vGPCR is mediated by MAPK 
MAP kinases are involved in activation of different signalling cascades, including CREB’s. To 
evaluate the involvement of ERK, JNK and p38 kinases in the constitutive activation of CREB in 
trophoblasts by the vGPCR, cells were transfected with either US28 or UL33 and CREB signalling 
was measured in the presence of specific inhibitors for each kinase. We observed that kinases exert a 
differential contribution to CREB activation according to the vGPCR being expressed in the cells 
(Fig. 3.5). Inhibition of p38 reduced CREB signalling mediated by US28 and UL33 by approximately 
a third. ERK inhibition only reduced CREB activation in HTR-8 transfected with US28. This suggests 
that, in order to promote CREB-mediated transcription, p38 signalling pathway is activated by both 
UL33 and US28, but US28 additionally triggers ERK signalling. On the other hand, JNK inhibition 
affected only HTR-8 cells transfected with UL33: in the presence of JNK inhibitor, CREB activation 
by UL33 presented a three-fold enhancement, indicating that JNK may negatively modulate UL33-
mediated CREB signalling. 
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Fig. 3.4. CX3CL inhibits US28-induced migration in HTR-8 cells. HTR-8 trophoblasts were 
transfected with either US28 (circles) or pcDNA3 vector (triangles). After 6 h, cells were serum-
starved overnight.  20,000 cells in serum-free medium were applied to the upper well of a transwell 
chamber.  The bottom chambers contained medium with 10% FBS alone (-, open symbols), or with 
either 10nM (grey symbols) or 50 nM of CX3CL (black symbols). After 24h, cells in the lower 
chamber were counted in at least 12 independent fields. Statistical analysis was made using 1-way 
ANOVA, with Bonferroni’s post-test (****, P<0.0001; **, P<0.01). 
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To assess differences induced by either US28 or UL33 in the kinase cellular profile, levels of several 
kinases were measured in HTR-8 by western blot 24h post transfection with either wt US28, R129Q 
US28, wt UL33 or R129Q UL33. Results were analysed as a ratio between phosphorylated and total 
proteins and compared against controls. However, whilst the presence of all proteins analysed (Akt, 
ERK, JNK, NF-κB, p38 and Src) was successfully detected, no differences in kinase levels were 
detected. To eliminate the possibility that this was a kinetic matter, the result of a time-dependent 
event, transfected HTR-8 were serum-starved and treated with a stimulant prior to protein extraction. 
Cells were either incubated with plain medium (mock), with FBS (for 5, 30 and 120 min) or with 
CX3CL1 (for 5 min). For these experiments, HEK cells were used as comparison, as ERK and NF-
κB are known to be induced by US28 in this cell line. Still, there were no consistent results. 
Unfortunately, the issue concerning these experiments was not determined and, therefore, no 
conclusions could be drawn.  
3.3.3 MMP expression is induced by vGPCR in a cell type- specific manner 
Matrix metalloproteases (MMP) are involved in the process of tissue remodelling by cleavage of 
extracellular matrix proteins. Expression levels of different MMP by umbilical cord, placenta and 
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Fig. 3.5. MAPK contribute differently to CREB signalling induced by US28 and UL33 in HTR-
8. Trophoblasts were transfected with 2.5 ng of either wt US28 or wt UL33 together with 100ng 
CREB luciferase reporter and incubated with or without selective inhibitors to ERK, JNK and p38. 
Results from 4 independent experiments are presented as % ± SEM relative CREB signalling in the 
absence of inhibitors. Statistical analysis was made using 1-way ANOVA with Bonferroni’s post-test 
(***, P<0.0001; **, P<0,001). 
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decidua have been associated with both normal and abnormal pregnancies (Deng et al., 2015; 
Lockwood et al., 2014; Vegh et al., 1999; Xu et al., 2000). Here, concentration of nine MMP in the 
cell culture supernatant were analysed in two in vitro settings by Luminex assays. First, levels of 
MMP were compared upon expression of wt US28, wt UL33 or their respective R129Q mutants in 
transfected HTR-8 and HUVEC. Then, protein levels were assessed in the supernatant of HUVEC or 
HFF infected with either wt, STOP US28 or R129Q US28 HCMV.  
In transfected HTR-8, the amounts of MMP detected were very low and only MMP-1 and 13 
exhibited values above background levels (no cells, medium alone). Of these, MMP-13 expression 
appeared to be endogenous, since there were no significant differences between US28/UL33-
transfected HTR-8 and transfection with the control plasmid, EGFP.  US28 induced MMP-1 
expression was dependent on G protein signalling, as R129Q US28 presented the same MMP-1 levels 
as control (Fig. 3.6A). UL33 had no significant effect on any of the MMP’s tested. In transfected 
HUVEC, only expression of MMP1 and 10 were detected above background levels with the latter 
exhibiting high endogenous expression which was marginally stimulated by wt US28, but not by the 
US28R129Q.  Similar to HTR-8 cells, UL33 did not have a significant effect on the expression of 
any of the MMPs (Fig. 3.6B).  
In order to study the differences caused by the vGPCR alone and in the context of infection, 
expression of MMP was to be compared between infected and transfected HTR-8 and HUVEC. 
However, HTR-8 are not productively infected by the recombinant 1158 Merlin strain used here (see 
Chapter 2). This virus has a mutation in the UL128 gene, which we found later was essential to HTR-
8 infection, as part of the entry pentamer complex (Naing, 2015). So, here we compared the 
expression profile of infected HUVEC and HFF.  In HUVEC, MMP-10 was marginally induced upon 
HCMV infection, although there was no evidence for the contribution of US28 in this elevation (Fig. 
3.7A). There was no significant effect on HCMV infection on the remaining MMPs tested. In HFF, 
US28 increased production of MMP-2, 10, and (marginally) MMP-3. Expression was dependent on 
US28 G protein signalling, as both null and DRY-motif mutants presented MMP levels similar 
uninfected controls (Fig. 3.7B).  
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Fig. 3.6. MMP expression induced by US28 in transfected cells is cell type-dependent and relies 
on G protein signalling. Cells were transfected with plasmid expressing either GFP (control), wt 
US28, wt UL33 or their respective R129Q mutants. Supernatant collected 2 days post transfection 
were used to determine expression of MMP in a magnetic Human MMP 9-plex Luminex Assay. 
Horizontal lines represent background detection level of each MMP. Statistical analysis was made 
using 2-way ANOVA with Benferroni’s post-test (***, P<0.001) (A) In HTR-8, US28 significantly 
elevated concentration of MMP-1. (B) In HUVEC, levels of MMP-10 were significantly stimulated 
by wt US28. 
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Fig. 3.7. Induced MMP expression in HCMV infected cells. Cells were either mock infected 
(uninfected) or infected with 0.1 MOI of wt, STOP US28 or R129Q US28 Merlin HCMV and, 2 
days post infection, supernatants were collected. For the Human MMP 9-plex Luminex assay, 50 µl 
of sample were used (results represent 3 to 4 biological replicates in duplicates). Background 
readings were always below 22 pg/ml. Statistical analysis was made using 2-way ANOVA with 
Benferroni’s post-test (***, P<0.001; *, P<0.05). (A) Infected HUVEC presented an increase in 
MMP-10 expression, regardless of US28 expression. (B) Infected HFF, demonstrated a significant 
stimulation of MMP-2, 3 and 12 by US28, which was not detected for the R129Q mutant. 
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3.3.4 Infected cells produce similar chemokine profiles 
Chemokines are crucial regulators of placenta angiogenesis and trophoblast invasion. Alterations of 
their expression during pregnancy can cause pathological outcomes (Du et al., 2014). Amniotic fluid 
from congenital HCMV infections has been found to express an elevated amount of cytokines (Scott 
et al., 2012). To ascertain whether the US28 and UL33 are involved in this pro-inflammatory shift, 
using a Luminex Assay, supernatant of transfected or infected cells were screened for the presence 
of 40 chemokines. Table 3.1 summarizes the chemokine profile expressed by HTR-8, HUVEC and 
HFF. 
In transfected HTR-8, 15 out of the 40 chemokines assayed were detected above baseline levels 
(medium alone without cells). Out of the 15, three were stimulated by the vGPCR: CXCL8 and IL-6 
were increased significantly by wt US28, whereas levels of MIF were elevated in cell expressing 
UL33. In both cases, the augmentation of expression was associated with the G protein signalling of 
the vGPCR (Fig. 3.8A). In transfected HUVEC, 17 out of the 40 chemokines were detected above 
baseline levels. Of these, three chemokines were stimulated by the vGPCR. Transfected HUVEC 
exhibited high levels of endogenous CXCL8, which was further elevated by both US28 and UL33 
(Fig. 3.8B). Higher concentrations of CCL20 and IL-6 by wt US28 were also detected.  
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Table 3.1. Chemokines (CK) modulated by HCMV  
 
Transfected 
HTR-8 
HUVEC 
Infected HFF 
Transfected Infected  
vGPCR* induced CK CXCL-8  
IL-6***  
MIF (UL33) 
CXCL-8**  
IL-6*** 
CCL20*** 
 
 
CCL3 
CCL7*** 
CCL8*** 
CCL20*** 
CX3CL1 
 
CXCL5 
 
 
CXCL10 
 
GM-CSF 
 IL-1b 
CCL3 
 
CCL8*** 
CCL20*** 
 
CX3CL1 
CXCL2 
 
CXCL6 
 
CXCL10 
CXCL11 
GM-CSF 
 
HCMV induced CK 
(US28 independent) 
  CCL13*** 
CXCL1 
CXCL2 
CXCL6 
CXCL8 
CXCL11 
CXCL16 
  
IL-6*** 
MIF 
CCL13*** 
CXCL1 
 
 
CXCL8 
 
CXCL16 
IL-1 
IL-6*** 
 
* US28 induced chemokines, except when stated otherwise.  
** Chemokine induce by US28 and UL33. 
** All chemokines in table are pro-inflammatory, except for chemokines marked with (***). which 
do not present a strict pro-inflammatory profile: IL-6 although considered mainly inflammatory, 
it also has anti-inflammatory functions; CCL7, 8 and 13 are considered allergy-related 
chemokines, as they attract and/or activate basophils and mastocytes; CCL20 is considered a 
homeostatic chemokine, inducing homing of T lymphocytes and peripheral dendritic cells to 
lymphoid tissues (Laing & Secombes, 2004; Scheller et al., 2011). 
Grey chemokines = chemokines with different profile of expression between transfected cells or 
between infected cells. 
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Fig. 3.8. Transfected cells presented a different profile of chemokines induced by HCMV 
vGPCR, but up-regulation was dependent on G protein signalling. Cells were transfected 
with plasmid expressing either GFP (control), wt US28, wt UL33 or their respective R129Q 
mutants. Supernatant collected 2 days post transfection were used to determine expression of 
chemokines in a magnetic Human Chemokines 40-plex Luminex Assay. Statistical analysis 
was made using 2-way ANOVA with Benferroni’s post-test (***, P<0.001; **, P<0.01; * 
P<0.05). (A) In HTR-8, US28 significantly elevated concentration of CXCL8 and IL-6, while 
UL33 induced MIF expression. (B) In HUVEC, only levels of CXCL8 were significantly 
induced by both US28 and UL33. Others chemokines, though, presented trends in increased 
expression by US28. Results show statistical analysis using data from all detected chemokines. 
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Whereas in transfected cells only about half of the chemokines were detected above baseline, in 
HCMV-infected HUVEC and HFF all 40 chemokines were detected in the supernatants. In both cell 
types analysed, CCL13, CXCL1, CXCL8, CXCL16 and IL-6 were induced during infection 
independent of the expression of US28 (Fig. 3.9A and B). Interestingly, the elevation of CXCL8 and 
IL-6 that was observed to be dependent on US28 expression in transfected HUVEC, was independent 
of US28 in HCMV- infected counterparts.  MIF expression was increased with HUVEC infection of 
both wt and mutated US28 viruses, consistent with that observed in transfected HUVEC which was 
not dependent on the contribution of US28.  
In infected HUVEC, expression of 12 chemokines was stimulated by US28 with a suggestion that G 
protein-dependent signalling played a role: CCL3, CCL7, CCL8, CCL20, CX3CL1, CXCL5, 
CXCL10, GM-CSF and IL-1b, all of which were dependent on G protein coupling (Fig. 3.10A). 
Notably, the results demonstrate that US28 signalling was a contributory factor, rather than an 
essential requirement for chemokine induction, since chemokine levels in cells infected with 
US28STOP or US28R129Q were still significantly elevated above uninfected HUVEC.  Exceptions 
were CCL3, CCL7 and CXCL5 for which expression levels in the deletion US28 mutant were 
statistically equivalent to uninfected controls. In infected HFF, US28 modulated the expression of 
nine chemokines (CCL3, CCL8, CCL20, CX3CL1, CXCL2, CXCL6, CXCL10, CXCL11 and GM-
CSF), all of which G protein signalling had a contributory role, except for CXCL6, whose levels were 
affected by the null mutant, but remained similar to wt in cells infected with the DRY-motif mutant. 
Similar to infected HUVEC, US28 provided a contributory, rather than an essential influence on 
expression of these chemokines, with the exception of CCL20 and GM-CSF for which both null and 
signalling-deficient mutants exhibited expression equivalent to uninfected control levels (Fig. 3.10).  
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Fig. 3.9. HCMV infection can induce expression of some chemokines, regardless of US28 
influence. HUVEC (A) or HFF (B) were either mock infected (uninfected) or infected with 0.1 MOI 
of wt, STOP US28 or R129Q US28 Merlin HCMV. Two days post infection supernatants were 
collected. For the Human Chemokine 40-plex Luminex assay, 50 µl of sample were used. Results 
show statistical analysis of data from all detected chemokines using 2-way ANOVA with 
Bonferroni’s post-test (P<0.001; **, P<0.01; * P<0.05). 
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Fig. 3.10. US28-mediated G protein signalling plays a contributory role in induction of 
chemokines during HCMV infection. HUVEC (A) or HFF (B) were either mock infected 
(uninfected) or infected with 0.1 MOI of wt, STOP US28 or R129Q US28 Merlin HCMV and, 2 
days post infection, supernatants were collected. For the Human Chemokine 40-plex Luminex assay, 
50 µl of sample were used. Results show statistical analysis of data from all detected chemokines 
using 2-way ANOVA with Bonferroni’s post-test (P<0.001; **, P<0.01; * P<0.05). 
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3.4 Discussion  
US28 and UL33 have been described to subvert several physiological pathways (Casarosa et al., 
2001; Waldhoer et al 2002; Casarosa et al., 2003). Alteration of cellular properties, such as migration, 
represent a tangible outcome as how these changes may contribute to viral pathogenesis. US28 has 
been shown to interfere with migration in a cell type-specific manner, due to its ability to signal 
through different Gα proteins (Hjorto et al., 2013; Melnychuk et al., 2004; Streblow et al., 1999; 
Vomaske et al., 2009).  Whilst CX3CL1 binding to US28 in macrophages has been shown to promote 
migration (Vomaske et al., 2009), CX3CL1-mediated signalling via Gq has been shown to inhibit 
RANTES-mediated SMC migration (Streblow et al., 1999; Vomaske et al., 2009). In these studies, 
we demonstrated that US28 expression stimulated cell motility, which was abrogated in the presence 
of CX3CL1. This inhibitory effect may be due to the effects of CX3CL1 on US28 signalling: 
CX3CL1 has been shown to act as an inverse agonist, as measured by inositol phosphate turnover, 
CREB transcription activation and NF-κB transcription (Waldhoer et al., 2003).  Whilst the effect of 
CX3CL1 on US28 signalling in HTR-8 cells was not examined here, studies with US28-transfected 
choriocarcinoma-primary trophoblasts, (ACIM-88 cell line), showed CX3CL1 to be a partial inverse 
agonist, resulting in a dose-dependent reduction in constitutive CREB signalling (H. Farrell, personal 
communication). Human trophoblasts migrate in response to chemokines and are likely important 
contributors to the successful steps in placentation (Hannan et al., 2006).  In particular, CX3CL1 is 
produced by endometrial cells, particularly epithelial and decidualized stromal cells in the 
endometrium. The receptors for these chemokines are present in adjacent trophoblast cells, supporting 
a role for endometrial chemokines in trophoblast differentiation and directed trophoblast invasion. 
Thus, in the context of a viral infection of trophoblasts, it is possible that CX3CL1-US28 interactions 
dampen their normal migratory response, contributing to poor placentation. 
This is the first time, to our knowledge, that UL33 has been associated with cellular migration.  
Indeed, UL33-mediated migration was greater than that of US28. FBS was used as a chemoattractant 
in the migration assays; whether FBS promotes migration in a non-specific way and UL33 is 
amplifying these intracellular changes or whether FBS is providing a specific chemoattractant is 
unclear. Unlike US28, there are no known ligands for UL33, and it is possible that constitutive 
signalling activity of UL33 may have mediated the effects. The importance of UL33-mediated 
signalling for stimulating migration was demonstrated, with mutation of the invariant arginine of the 
UL33 DRY-motif, conferring a loss in constitutive CREB activation. There is a high degree of 
preservation of the DRY motif in TMIII, especially the Arginine (R) residue, even among the vGPCR, 
which are prone to a greater amino acid diversity than cellular GPCR (Jensen et al., 2012). In studies 
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of viral and cellular GPCR, mutations of the central Arginine residue generally block G protein-
coupling, whereas mutations of the Aspartate (D) may retain or even enhance signalling (Alewijnse 
et al., 2000; Gruijthuijsen et al., 2004; Rovati et al., 2007).  For example, M33 of mouse CMV has a 
variant NRY motif at this position; N-D mutation resulted in enhanced signalling, whereas R-Q 
resulted in ablation of signalling (Case et al., 2008). Similarly, an R-A mutation on US28 resulted in 
a signalling deficient phenotype (Stropes & Miller, 2008). Here, the D128N substitution, which 
retained >70% of CREB activation levels compared with wt UL33, did not affect migration in contrast 
to the signalling deficient R129Q mutation. 
Previous studies have shown Gq-dependent activation of CREB by UL33 (Waldhoer et al., 2002). 
In addition, it has become increasingly clear that several non-classical pathways are capable of 
activating CREB including p38 MAP kinase and ERK1/2 MAP kinase. In an effort to explore how 
the vGPCR stimulate CREB signalling, activation of several kinases were examined by western blot 
(Shaywitz & Greenberg, 1999). The reason why we could not reproducibly detect changes in the 
kinase expression levels is still unclear, but may be due to the assay being inappropriate for the 
detection of constitutively active GPCRs. As these assays are designed to measure the rapid flux of 
downstream effects following ligand binding, it is possible that this assay is unable to detect elevated 
constitutive activity under steady state conditions (H. Farrell, personal communication). In the context 
of ligand-induced signalling, there is a burst of kinase activation following ligand addition, which 
then returns to basal levels.  In contrast, for constitutive signalling, detection of steady state elevation 
of kinase activation is required.  
In addition, it is possible that differences can only be detected with very high expression of the 
vGPCR (in our experiments, about 50% of cells in the control transfections were eGFP positive). 
Indeed, most previous investigations have employed cell types that are readily transfected 
(HEK/COS7) for which the signalling can be easily detected above background levels. However, 
these cell types do not possess any relevance to viral biology and thus the effects observed should be 
regarded with caution.   
To estimate the contribution of alternative pathways to US28 and UL33-mediated CREB activation, 
a panel of pathway inhibitors was applied to transiently transfected HEK-293 cells expressing CREB 
reporter and activator plasmid together with the receptor DNA. Here, in the presence of specific 
MAPK selective inhibitors, US28 and UL33-dependent CREB activation in HTR-8 cells was 
modified. CREB activation in HTR-8 by both vGPCR was shown to be p38 MAPK sensitive, 
supporting previous studies in other cell types (McLean et al., 2004; Vomaske et al., 2009; Waldhoer 
et al., 2002). In contrast, ERK1/2 inhibition affected only US28-mediated CREB activation. US28 
94 
 
has been shown to stimulate ERK1/2 in some studies, (Vomaske et al., 2009; Maussang et al. 2006) 
but not in others (Waldhoer et al., 2002) and thus may be cell-type dependent.  In contrast to p38, 
inhibition of JNK afforded a significant increase in UL33-dependent CREB signalling. Previous 
studies of MAPK activation by HCMV infection have shown that JNK activation is inhibited by 
HCMV-specific mechanisms, presumably to avoid stress-dependent apoptosis (Xuan et al., 2009).  In 
addition, cellular upregulation of CREB has been shown to counteract pro-apoptotic pathways, a 
process that is facilitated by p38 activation (Vaishnav et al., 2003).  Whilst UL33-dependent CREB 
activation appears to be inhibited by JNK, it is possible that UL33 promotes HTR-8 survival by its 
constitutive activation of CREB and p38 in HTR-8 cells and in comparison with other cell types. 
Further studies to determine the interplay of JNK and p38 on UL33-dependent CREB activation are 
required.  It is likely that the profile of MAPK induced by US28 and UL33 depends on the cell type 
and the repertoire of G proteins that mediate particular signalling pathways. That both US28 and 
UL33 can activate CREB through multiple G and G subunits and the vast intracellular crosstalk 
between MAPK (Wagner & Nebreda, 2009) allows for considerable fine-tuning of cellular responses 
to HCMV infection (Casarosa et al., 2003).  It is possible that this is due to G protein signalling, either 
by activation of different Gα subunits or β-arrestin recruitment (Fig. 3.11 summarizes Gα subunit 
signalling pathways that activates the MAPK).  
HCMV infection has been reported to hinder placental differentiation, to affect tissue integrity and to 
elicit a proinflammatory response (Benard et al., 2014; Chou et al., 2006; Schleiss et al., 2007). 
Disruption of normal MMP expression can contribute to those outcomes. Overall, we found very low 
levels of MMP in transfected HTR-8 cells, with a modest increase in MMP-1 induced by US28. 
Gestational disorders have been associated with altered expression of MMP-1. While preeclampsia 
has been linked to a decrease of MMP-1 expression in placenta, umbilical serum and decidua, 
choriocarcinoma has been linked to an increase expression of MMP-1 in extravillous trophoblast 
(Cohen et al., 2012; Deng et al., 2015; Vegh et al., 1999), suggesting that US28 MMP-1 phenotype 
may be more related to cell survival. In transfected HUVECs, detectable levels of MMP-1 and MMP-
10 were recorded, consistent with previous data showing upregulation of these mRNA upon exposure 
to inflammatory stimuli (Montero et al., 2006). However, only MMP-10 was detected in HCMV-
infected HUVECs. Degradation of extracellular matrix by MMP-10 has been described to support 
cell proliferation and migration in HUVEC (Heo et al., 2010; Mauro et al., 2010). Furthermore, US28 
can induce VEGF (vascular endothelial growth factor) expression, which, in turn, can induce MMP-
10 expression, causing an increase in cell migration (Heo et al., 2010; Maussang et al., 2006). This 
suggests that MMP-10 induction favours viral infection.  
 
95 
 
In general, the effect of HCMV infection on placental MMP has been described as inhibitory, rather 
than activating. Schleiss et al. (2007) found repression of MMP-3 in syncitiotrophoblasts and 
suggested that HCMV down-regulated genes associated with extracellular matrix formation and 
stabilization. Yamamoto-Tabata et al. (2004) has also found a down-regulation of MMP-2 in 
HUVECS, uterine microvascular endothelial cells, fibroblasts and cytotrophoblasts and of MMP-9 in 
cytotrophoblasts and HUVEC upon infection with HCMV. Others have also found downregulation 
of MMP-2 and MMP-9 in other trophoblast cells or explant infections (LaMarca et al., 2006; Liu et 
al., 2011a; Liu et al., 2015). Secretion levels of MMP-9 were below the detection threshold in all 
assays performed here, as were the levels of MMP-2 and 3 in HTR-8. In transfected HUVEC, control 
cells expressed detectable levels of MMP-2, however we could not detect MMP-2 secretion in all 
other samples expressing the various vGPCR, a result that could be interpreted as a down-regulation. 
However, upon infection, no differences between infected and uninfected cells were detected.  
In contrast to HUVECs, MMP-2, 3 and 12 were elevated in fibroblasts by US28 during infection, 
indicating that the profile of MMP expression induced by vGPCR may be cell type specific. There 
 
Fig. 3.11. G protein activation of MAPK. There are four main families of Gα subunits, all of which 
can activate MAPK. Gαs stimulates accumulation of cyclic adenosine monophosphate (cAMP). 
Gαi/o inhibits production of cAMP and induces calcium (Ca++) release. Gαq activates phospholipase 
C (PLC). Gα12/13 activates Rho GTPase pathway. Gβγ subunit induces PLC-β and γ pathways. All 
subunits signal through cascades that will eventually activate MAPK and induce gene transcription. 
AC: adenylate cyclase; DAG: diacylglycerol; GEFs: guanine nucleotide exchange factors; GTP: 
guanosine triphosphate; IP3: Inositol trisphosphate; PKA: protein kinase A; PKC: protein kinase C. 
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are a few reasons that could explain this difference with previous studies in the literature. First, we 
used a different strain of HCMV in our experiments; indeed, Yamamoto-Tabata et al. actually found 
differences in the expression levels between the 2 strains they tested (laboratory strain AD169 and 
clinical strain VR1814). A second reason could be the time-course of the infection. We measured 
MMP secretion in supernatant 48 hours post infection, while Yamamoto-Tabata et al. measured it at 
4 days post infection. Thus, expression of viral late genes could have altered the levels of MMP 
detected in their experiments. 
The gestational period is characterized by a unique immunological condition, with distinguishable 
immunologic phases. During implantation and placentation, all the tissue remodelling establishes a 
fine balanced pro-inflammatory environment in the uterus. Still, an infection able to induce high 
amounts of certain chemokines can lead to placental damage and abortion, scenarios found in 
congenital HCMV infections (Chan et al., 2002; Mor & Cardenas, 2010; Yan et al., 2015).  
Our results suggest that HCMV can promote a pro-inflammatory state during infection by stimulating 
the expression of chemokines. The induction of an inflammatory context can impact the cellular 
environment, as different chemokines will affect cellular functions in a cell type-specific manner. 
Moreover, a basic function of chemokines is to attract immune cells, which, in turn, may intensify 
the inflammation. The induction of chemokines during congenital infection has been described. High 
levels of chemokines have been detected in both placentas from stillborn neonates with congenital 
HCMV and in ex vivo explants infected in vitro (Hamilton et al., 2012). Likewise, the establishment 
of an inflammatory environment in the uterus have been reported, where the level of several cytokines 
was elevated in the amniotic fluid of congenital infections (Scott et al., 2012).  
In transfected HTR-8, an increase in MIF (by UL33), CXCL8 and IL-6 (by US28) was detected. 
These results agree with Chou et al. (2006), whose work detected an increase in CXCL8 and IL-6 in 
HCMV-infected HTR-8, and with Halwachs-Baumann et al. (2006), that reported production of IL-
6 in other infected trophoblasts and trophoblast-like cells. All three chemokines have been described 
to induce trophoblast invasion (De Oliveira et al., 2010; Jovanovic Krivokuca et al., 2015; Jovanovic 
& Vicovac, 2009).  
Transfected HUVEC presented elevated levels of CXCL8 stimulated by both US28 and UL33 and at 
least a modest trend in elevated production of IL-6, CCL20, CXC3L1 and IL-1b by US28. When 
expression of chemokines is compared between infected and transfected HUVEC, quite a few more 
chemokines could be detected in infected cells, supporting previous studies of upregulation of growth 
factors/chemokine/cytokines following HCMV infection (Frascaroli et al., 2006; Hamilton et al., 
2012; Li et al., 2014; Murayama et al., 1997; Scott et al., 2012; Smith et al., 2014; Weseslindtner et 
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al., 2014). Indeed, we found 18 chemokines elevated in HCMV-infected HUVEC. Hamilton et al. 
(2012) found higher concentrations of CCL2 and TNF-α in congenital infected placentas. Scott et al. 
(2012) also found those two cytokines and another 11 cytokines/growth factors altered in amniotic 
fluid of congenital infections when screening for 27 molecules. Of the panel of chemokines studied 
by Hamilton and Scott, 13 were shared in the panel examined in this study. Our results show partial 
agreement, with common induction of IL-1b, CXCL10 and GM-CSF and, conversely, no induction 
of INF-, IL-2 and CCL11 during infection.  However, we did not detect induction of TNF- IL-10 
and CCL2 or the down-regulation of IL-4 that Scott et al. did, as they did not detect up-regulation of 
IL-6, CCL3 and CXCL-8 like we did. It is likely that the discrepancies in the results are related to the 
different nature of the samples. While our data was produced by (in vitro) infection of one cell type, 
both authors used ex vivo samples derived from multicellular environments. It is expected that other 
cell types, not tested by us, would have an effect in the overall HCMV-induced cytokines.  
Several factors can be responsible for the difference between the number of chemokines expressed in 
transfected and infected cells. It is possible that some of the molecules expressed only during infection 
are being produced by bystander cells, as a paracrine response to the infection. This difference could 
also be attributed to a more robust expression of the viral gene during infection, as suggested by the 
change in some chemokines from small to significant increase. It can also be a response to the 
infection or a physiological imbalance of the infected cells. In preeclampsia, high levels of CXCL8 
and CXCL10 can be detected. Preterm labour has been associated with high levels of CXCL8 and 
MIF and, in inflammation caused by microorganisms, with high levels of CCL7, CCL8, CCL20 and 
CXCL5 (Du et al., 2014), all of which we were able to detect for infected HUVEC. Furthermore, 
expression of IL-6, CXCL8 and GM-CSF have been previously reported in infected endothelial cells, 
corroborating our results, and were found to induce cell migration and angiogenesis (Botto et al., 
2011; Fiorentini et al., 2011). Most likely, however, more than one viral gene is involved in up-
regulation of certain pathways: in transfected HUVEC, both vGPCR induced CXCL8; in infected 
cells, even though US28 clearly influence induction of various chemokines, in its absence, the level 
of most of these molecules was still higher than in the uninfected cells. Indeed, US28 contributed for 
the induction of 9 chemokines in infected HUVEC, but expression levels of only 3 chemokines 
(CCL3, CCL7 and CXCL5) presented equivalent basal levels between uninfected cells and US28 null 
infected cells, suggesting that US28 was the only viral gene inducing expression of these chemokines 
in HUVEC. Likewise, while US28 contribute for the up-regulation of eight chemokines in HFF, only 
CCL20 and GM-CSF presented equivalent levels between US28 null HCMV infected cells and 
uninfected cells, indicating that no other viral gene was involved in the up-regulation of only these 
chemokines in HFF. The profile of up-regulated chemokines during HFF and HUVEC infection were 
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quite similar. The main difference was that only infected HUVEC induced CCL7, CXCL5 and MIF, 
which, except for MIF, were all dependent on US28 G protein signalling. 
In summary, similar to previous studies, the data here demonstrate that the HCMV vGPCR US28 and 
UL33 have the propensity to alter cellular migration (Hjorto et al., 2013; Vomaske et al., 2009) and 
interfere with transcription (Boomker et al., 2006; Casarosa et al., 2003; Maussang et al., 2009; 
McLean et al., 2004; Waldhoer et al., 2002; Wen et al., 2009) in several cell types. In this study, we 
showed that this may be true in trophoblasts. We demonstrated that HCMV vGPCR US28 and UL33 
can constitutively activate CREB and induce migration of HTR-8 in the absence of chemokines – 
although CX3CL1 was able to inhibit US28-induced migration. G-protein coupling is essential for 
migration induction, as shown by reestablishment of background migration levels by R129Q DRY-
motif UL33 mutant. However, the impact of these receptors in the context of virus infection is still 
unclear and needs further investigation. We also showed that HCMV infection can cause an up-
regulation of several chemokines, inducing a pro-inflammatory context, and that this is partially due 
to US28-dependent G protein signalling.  
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Chapter 4 - Probing cell types relevant to MCMV vGPCR function in vivo 
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4.1 Introduction 
The HCMV is a strictly species-specific pathogen and, thus, animal models have been extensively 
used to study viral pathogenesis. The HCMV and the mouse cytomegalovirus (MCMV) share many 
aspects of their pathogenicity, including the expression of viral GPCR (vGPCR), namely M33 and 
M78 (respectively, UL33 and UL78 homologs) (Hudson, 1979; Rawlinson et al., 1996). Like the 
HCMV vGPCR, M33 has also been shown to alter signalling pathways. M33 can constitutively 
activate the transcriptional factors NFκ-B, CREB and NFAT (Case et al., 2008; Waldhoer et al., 
2002). M33 constitutive activity is dependent on G protein signalling and, thus, on the integrity of 
the NRY-motif.  It has been demonstrated that M33 directly interacts with Gαq/11, signalling in a 
ligand-independent manner. This coupling induces the PLC-β/DAG/IP pathway. Whilst activation of 
CREB has been linked to Gαq/11/DAG signalling through PKC, NFκ-B activation was reported to 
be independent of this pathway (Case et al., 2008; Sherrill & Miller, 2006; Sherrill et al., 2009).  
The biological importance of the vGPCR has been confirmed by in vivo studies, where ablation of 
constitutive signalling of M33 has been correlated with attenuated phenotypes in mice. M33 has been 
shown to be necessary to efficient dissemination into and replication in the salivary glands (Davis-
Poynter et al., 1997). This phenotype has been associated with M33 signalling, as disruption G protein 
signalling (Arg131 mutations) is sufficient to prevent salivary glands infection (Farrell et al., 2011; 
Sherrill et al., 2009). A study using NSG mice – a severe immunocompromised mice strain that lacks 
cellular immunity – demonstrated that in the absence of M33 expression viruses can reach the salivary 
glands, but are unable to replicate in it (Bittencourt et al., 2014). It was also demonstrated that 
infection with M33 deletion mutants is attenuated in the spleen and in the lungs and cannot be 
reactivated. This phenotype was associated with a lower DNA viral load in both organs and with a 
lower number of infected cells in the spleen. It also showed that M33 G protein signalling was 
involved with reactivation in both organs, as signalling mutant viruses (R131Q) present a reduced 
reactivation rate (Cardin et al., 2009; Farrell et al., 2011). Taken together, these data suggest that the 
vGPCR could play a part in colonization and/or replication of specific cell types during viral 
dissemination. Furthermore, an in vitro study showed that MCMV-induced migration of mouse aortic 
smooth muscle cells (maSMC) is dependent on chemokine (CCL5) binding to M33 (Melnychuk et 
al., 2005). The stimulation of migration by M33 further indicates that this vGPCR could be involved 
in viral dissemination.  
MCMV dissemination has been traditionally studied using intraperitoneal or intravenous routes. It 
has been shown that MCMV can infect most visceral organs within 3 to 6 days post-infection. 
Viraemic dissemination from primary to secondary sites of infection occurs by infected leukocytes. 
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Viral clearing occurs at 7 to 10 days post-infection in all sites, except the salivary glands, where 
productive replication can still be detected a month later (Bale & O'Neil, 1989; Collins et al., 1994; 
Hanson et al., 1999; Manning et al., 1992; Stoddart et al., 1994). Intravenous infection, although 
informative, deliver the virus straight into the blood stream, granting direct access to the visceral 
organs. Intraperitoneal infection also circumventing key aspects of the innate immune system. 
Tracking infection using other routes of inoculation could shed light on the obstacles that MCMV has 
to overcome during dissemination, revealing bottlenecks and mechanisms used by the virus to bypass 
the host’s defences. A feasible method to track viral spread is to use viruses expressing luciferase, a 
bioluminescent protein. The emission of luminescence allows a time-course visual identification of 
infection sites (Ostermann et al., 2013). Another method to detect replication sites is the use of the 
Cre-loxP system. Viral replication in specific cell types can be detected by infection of Cre-
recombinase (Cre+) transgenic mice with virus encoding a gene with conditional expression 
controlled by the presence of loxP sites (Sacher et al., 2012). 
Given the importance of M33 expression to salivary gland colonization, here we investigated whether 
M33 plays other relevant roles to virus dissemination. First we examined early progress of infection 
using luciferase tagged wild type and 33 MCMV. We compared different routes of infection – 
intraperitoneal (i.p.), intranasal (i.n) and footpad (f.p.). Unlike intraperitoneal infection, i.n. and f.p. 
inoculation results in the passage of virus through the lymphatics (e.g. involving the superficial 
cervical, mediastinal and popliteal lymph nodes) before the virus is delivered to the bloodstream. We 
further evaluated the impact of M33 in viral dissemination in the presence or absence of type I IFN 
response via footpad infection. Finally, to analyse the contribution of particular myeloid cell lineages 
to M33-dependent salivary gland dissemination, transgenic mice (CD11c-Cre+ and LysM-Cre+) were 
infected with MCMV expressing M33 under the control of the Cre-loxP system. Hence the impact of 
either M33 expression (M33 ‘switched’ on) or M33 ablation (M33 ‘switched’ off) was examined. 
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4.2 Material & Methods 
4.2.1 Cells 
Primary mouse embryo fibroblasts (MEF) were cultivated in Minimum Essential Medium (MEM, 
Gibco). NIH-3T3 and 3T3-Cre+ fibroblasts were grown in Dulbecco's Modified Eagle's medium 
(DMEM, Gibco). All cell lines were supplemented with 10% heat inactivated fetal bovine serum 
(FBS, HyClone), 2 mM glutamine (Gibco) and antibiotics (100 IU/ml penicillin and 100 
µg/mlstreptomycin, Gibco) and maintained at 37ºC in a 5% CO2 humidified atmosphere. 
4.2.2 Mice  
BALB/c, C57BL/6J and transgenic CD11c-Cre+ and LysM-Cre+ mice were maintained at The 
University of Queensland (UQ). Mice were infected with 106 plaque-forming units (PFU) between 6 
and 12 weeks old. Virus was administrated via i.p., i.n. or f.p. routes. Before i.n. and f.p. injections, 
mice were lightly anesthetized using isoflurane inhalation. For imaging, 2 mg D-luciferin (Pure 
Science, NZ) were injected i.p., animals were anesthetized and light emission from whole body were 
measured by charge-coupled device camera scanning (Xenogen IVIS-200). At particular times 
indicated p.i., a selection of animals were euthanized after whole body imaging and organs were 
quickly dissected and blood was collected. Collected organs were first scanned for luminescence, 
then frozen at -80ºC prior to homogenisation in cold 2% FBS MEM and titration on MEF monolayers.  
Blood samples were collected into heparin tubes and either pooled for blood fractionation or 
individually aliquots made for DNA extraction. Anti-IFRN antibody (MAR1-5A3, Bioxcell) was 
administered i.p. (250 µg) one day before viral infection and again at 3 days pi. All animal 
experimentation was done in accordance with National Health and Medical Research Council 
(NHMRC) guidelines and approved by The University of Queensland Animal Ethics Committee 
(Certificate 388-12). 
4.2.3 Virus and infections 
All viruses used in this study derived from wild-type K181 MCMV strain. For the imaging studies, 
BALB/c mice were infected via i.p., i.n. or f.p. with viruses expressing luciferase under the control 
of M78 promoter: M78luc (wt-MCMV-LUC) or M78lucM33 (M33-LUC). For the cell type 
specific studies, MCMV expressing M33 under the control of Cre-recombinase for either expression 
(“switching on”; M33FloxON) or deletion (“switching off”; M33FloxOFF) were used to infect 
CD11c-Cre+ and LysM-Cre+ mice either via i.p. or i.n.. For easier understanding, hereafter virus that 
have been passed in Cre+-cells – and did recombine – will be labelled as M33ON (M33 is being 
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expressed) or M33OFF (M33 expression has ceased), while M33Flox (M33FloxON or M33FloxOFF) 
will refer to virus that still retains the loxP sites and has the capacity to switch in Cre-transgenic mice. 
A schematic representation of the M33 region from both M33Flox viruses before and after 
recombination is illustrated in Figure 4.1.  
4.2.3 Virus stocks and titrations 
Virus stocks were prepared by infection of NIH-3T3 cells (M33ON and M33OFF stocks were grown 
NIH-3T3-Cre+ cells). When cytopathic effect (CPE) was present in 90% of the cells, flasks were 
submitted to one cycle of freeze/thaw, supernatants were clarified (10 min at 2770 x g at 4C) and 
stocks were generated by ultracentrifugation (2h at 50,000 x g at 4C). Virus were resuspended in 
Opt-MEM (Gibco) 2% BSA (Sigma). Titers of virus stocks or organs homogenates were measured 
by plaque assay. Serial dilutions were incubated in 24-well trays of 24h-seeded MEF. After 30 min 
at 693 x g followed by 30 min at 37C, monolayers were overlaid with 0.5 ml of carboxymethyl 
cellulose (CMC) and incubated for 2 days at 37C. Cells were then fixed with 0.1% formaldehyde-
 
Fig. 4.1. Schematic representation of M33 region of recombinant M33FloxON and 
M33FloxOFF viruses. (A) M33FloxON encodes a STOP cassette flanked by loxP sites, blocking 
expression of M33. Once virus replicates in a Cre-recombinase positive cell, M33 expression is 
restored (M33 is ‘switched on’). (B) M33FloxOFF virus encodes loxP flanking M33, however their 
presence do not prevent M33 expression. After replicating in a Cre-recombinase positive cell, the 
virus no longer expresses M33 (M33 is ‘switched off’). 
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PBS and stained with 0.1% toluidine blue and the number of viral plaques was counted under an 
optical microscope (Olympus CKX31). 
4.2.4 Infectious Centre assays 
Bone marrow cells (BMC) were extracted by cutting at the epiphysis of both tibia and femur bones, 
and, using a 26G needle, flushing with PBS to extrude the marrow. BMC were prepared as 2x107 
cells/ml suspensions. Peripheral blood leukocytes (PBL) were isolated from pooled blood samples. 
Samples were diluted 1:2 with RPMI medium and centrifuged (40 min at 300 x g) on a 3 ml of Ficoll 
(GE Healthcare) overlay.  The cells present at the interphase were transferred to a new tube (~ 2 ml) 
and the volume was made up to 12 ml with RPMI medium. Tubes were centrifuged (10 min at 250 x 
g) and PBL were resuspended in PBS at 2.5x106 cells/ml. Assays with both PBL and BMC were 
performed as follows: 300 or 500 µL of cells were seeded in two wells from a 6-well tray and RPMI 
volume taken up to 1ml, then 1 ml of 4x105 MEF cells was added to each well and trays were 
incubated at 37ºC for 1h. Without harvesting medium, 2 ml of CMC were added. After 3 days at 
37ºC, wells were screened for CPE and plaques were counted.  
4.2.5 Quantitative PCR (qPCR) 
Blood DNA extractions were performed using NucleoSpin Tissue DNA Extraction Kit (MN), as per 
manufacturer’s instructions. DNA extractions from tissue samples (either lungs or lymph nodes) were 
performed as indicated by the kit’s protocol, after the suggested overnight pre-lyse step. DNA was 
eluted in 100 µL of pre-warm (70ºC) BE buffer. Reactions (20µl) were prepared as follows: 0.6 mM 
primer forward M78 (5’-CCTAGGGAGCCTCATCCTCT-3’), 0.6 mM primer reverse M78 (5’-
ATCGAGCGTGAGGTACAGGT-3’), 1x Fast Star Universal SYBR Green Mix (ROX) (Roche), 2µl 
of template and q.s.p. molecular biology water. Control reactions were performed amplifying mouse 
Titin gene (primer forward 5’-AAAACGAGCAGTGACGTGAGC-3’; reverse 5’-
TTCAGTCATGCTGCTAGCGC-3’). Standard curves used 10-fold dilutions of pcDNA3-M78-
eGFP plasmid as template. qPCR were performed in a Rotor Gene Q qPCR cycler, using software 
Rotor Gene 2.1.0.9 (Qiagen). 
4.2.6 Statistical analysis 
Statistical analysis was performed using either two-tailed Student t-test or ANOVA, with the 
indicated post-tests. In all experiments, signiﬁcant differences were considered as P values < 0.05. 
All analyses were made using GraphPad Prism version 5.0 software. 
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4.3 Results 
4.3.1 Use of whole body imaging to evaluate MCMV dissemination. 
4.3.1.1 Dissemination following intraperitoneal infection  
In order to analyse the role of M33 during viral dissemination, MCMVs expressing luciferase were 
administrated via different routes and infection patterns were assessed. Expression of luciferase by 
the virus enables the tracking of infection by periodically scanning the animals for luminescence 
emission upon injection of the luciferase substrate, luciferin. For these experiments, we used a 
luciferase-tagged wild type (K181) MCMV, for which luciferase was expressed downstream of the 
M78 ORF via a self-cleaving porcine teschovirus-1 2A peptide linker (designated wt-MCMV-LUC). 
Luciferase expression was driven by the lytic M78 promoter. A luciferase-tagged M33 null 
counterpart (M33-LUC) was generated for these studies. At indicated times post-infection (p.i.) a 
proportion of the mice were sacrificed after luciferin administration and dissected organs subjected 
to imaging and quantification of infectious virus.  
Previous experiments have shown that M33 is essential for MCMV tropism to the salivary gland (SG) 
when inoculated i.p. To evaluate the general applicability and sensitivity of the luciferase marker and 
whole body imaging to detect MCMV dissemination, our first experiment was to confirm tropism 
results from previous published i.p. challenge studies. Results are shown for live imaging during the 
peak of acute infection (day 5 p.i.) and during persistent infection (day 12 p.i.) in BALB/c mice 
infected with wt-MCMV-LUC and M33-LUC. At day 5 p.i. whole body imaging confirmed virus 
spread throughout the abdomen, with high levels of luciferase detected in dissected visceral organs, 
namely the liver, spleen and pancreas (Fig. 4.2A). In addition, mice infected with wt-MCMV-LUC 
showed marked signals at the neck at both time points, which were absent in mice infected with 
M33-LUC. Dissected salivary glands confirmed luciferase expression in the salivary glands of wt-
MCMVL-LUC and their absence in the M33 counterpart (Fig. 4.2B). Low luciferase signals were 
recovered from the bones of both groups of mice (femurs and tibias paired for each hind leg). There 
was variation between mice in the extent of luciferase detected, although paired bones within each 
mouse showed similar levels of luciferase.   
Radiance was quantified from each of the dissected organs (Fig. 4.3A, C) with significant differences 
between virus groups detected in the salivary gland and, to a lesser extent, in the spleen. The radiance 
measurements in other organs were equivalent. With respect to recovery of infectious virus following 
i.p. inoculation, acute infection of wt-MCMV-LUC progressed as previously described (Hamano et 
al., 1998; Stoddart et al., 1994) with the spleen and liver being the principle targets of acute infection 
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Fig. 4.2. Luciferase expression of BALB/c mice infected i.p. with 106 PFU wt-MCMV-LUC 
or M33-LUC.  Live (A) or post-mortem (B) images were taken during either acute (day 5 p.i.) 
or persistent (day 12 p.i.) phases of MCMV infection. The rainbow radiance scale is indicated in 
(A) and was normalised between virus groups. 
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at day 5 p.i. (Fig. 4.3A). For mice infected with M33-LUC, infectious virus in the spleen and liver 
were significantly lower than wt-MCMV-LUC, with 2 out of 3 mice exhibiting low or undetectable 
levels of virus.  These results are consistent with previous studies that showed improved clearance of 
M33 MCMV from these organs beyond day 3 p.i. (Cardin et al., 2009). Whilst wt-MCMV-LUC 
presented low titres at day 5 p.i. and high titres at day 12 p.i. in the SG, M33-LUC was not detected 
in the SG at either time point tested, consistent with the known contribution of M33 to MCMV 
salivary gland tropism (Fig. 4.2). Notably, no infectious virus was detected in the pancreas at day 5 
p.i. from either groups of infected mice despite the detection of high levels of luciferase. Similarly, 
no infectious virus was recovered from the bone marrow of either groups (Fig. 4.3B). 
Both the luciferase and infectious titres recovered from infected mice clearly reflect the role of M33 
in tropism to the salivary glands. However, there were interesting quantitative differences in virus 
tropism detected between the two methods. As noted above, the pancreas showed high levels of 
luciferase at day 5 p.i. despite the absence of detectable infectious virus. Similarly, high luciferase 
levels in wt-MCMV-LUC mice in the salivary glands at day 5 p.i. showed comparatively low levels 
of infectious virus. Furthermore, several bone pairs showed evidence of virus colonisation, in the 
absence of infectious virus. Of interest too, was the demonstration of low, but detectable, levels of 
luciferase, but not infectious virus, in the salivary glands of M33-LUC at day 5 p.i. and is consistent 
with the ability of M33-LUC to colonise the salivary glands, but fail to yield detectable levels of 
infectious virus (Bittencourt et al., 2014). Taken together, the results demonstrate that whilst 
luciferase detection is highly sensitive in the detection of MCMV dissemination, it does not 
necessarily provide a correlative readout of infectious virus. 
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Fig. 4.3.  Comparison of radiance and virus titres in dissected organs from infected mice.  
BALB/c mice were infected i.p. with 106 PFU of either wt-MCMV-LUC (circles) or M33-LUC 
(squares). (A, B) Dissected organs were taken at days 5 and/or 12 p.i., corresponding with acute and 
persistent phases of MCMV infection respectively. Luciferase measurements were taken 
immediately after dissection, then frozen at -80oC until they were homogenised and titred for 
infectious virus on MEF. (C) Luciferase measurements from femur and tibia were taken immediately 
after dissection at day 5 p.i. (D) Bone marrow was flushed from bones and plated out onto MEF to 
quantify infectious centres. Results show the mean +/- SEM radiance or virus titre (n=3, values 
shown on a LOG scale in each case). Statistical comparisons between wild type and M33 groups 
was performed using Students t-test using the Sidak-Bonferroni method, with alpha=5.000% (* = 
P<0.05; **=P<0.01; ****= P<0.0001). The horizontal stippled lines mark the background radiance 
levels or the lower limit of virus detection for titration. 
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 4.3.1.2 Dissemination following intranasal infection.   
In a subsequent experiment, we examined the dissemination of wt-MCMV-LUC and M33-LUC 
following i.n. infection, assessing tropism to primary and secondary sites via the lymphatics and the 
blood.  At 5 days p.i., luminescence in mice infected with M33-LUC was present in the same sites 
as mice infected with wt-MCMV-LUC (nose, neck and thorax; Fig. 4.4A). At 12 days p.i., 
luminescence signal was detected from the neck (SG) of wt-MCMV-LUC, but not from M33-LUC 
infected mice. Radiance coming through the neck region in M33-LUC infection at day 5 p.i. was 
unexpected, as this virus is defective for replication in the SG (Davis-Poynter et al., 1997). Upon 
dissection, however, it was determined that luminescence was being emitted from the superficial 
cervical lymph nodes (SCLN) of M33-LUC infected mice, while, in wt-MCMV-LUC infections, 
the radiance was coming from both SCLN and SG (Fig. 4.4B). Although wt-MCMV-LUC signal was 
generally more intense in live mice, dissected organs presented similar radiance for both viruses, with 
moderate to high levels of luciferase being detected for both viruses (Fig. 4.5A). The exception was 
the SG, for which wt MCMV-LUC recorded significantly higher luciferase levels at both time points.  
Despite high levels of luciferase expression, low or undetectable levels of infectious virus were 
recorded from the noses and SCLN from both groups of infected mice (Fig. 4.5B). Infectious virus 
was registered only in wt-MCMV-LUC infections at both day 5 and 12 p.i. M33-luc infected lungs 
presented 5-fold lower titers than wt (p<0.05); however, no significant difference in lung titres were 
observed in subsequent experiments (data not shown) suggesting that attenuating effects of M33-
LUC on colonisation of the lung were weak. Indeed, comparison of viral load in the lungs of wt-
MCMV-LUC and M33-LUC by qPCR indicated a weak increase in the lung viral load sustained in 
M33-LUC-infected mice at day 3 compared with wt-MCMV-LUC mice, although this difference 
was no longer significant at day 6 p.i. (Fig. 4.6A) Comparison of DNA viral load from lungs and 
mediastinal LN (mLN) showed that, similar to the SCLN, the mLN harboured little lytic virus, with 
DNA copies approximately 1000-fold lower than the lung (Fig. 4.6B). Nevertheless, virus 
colonisation in the mLN by wt and M33 were not significantly different.  
Assessing the role of M33 in viral dissemination into the bone marrow, similar levels of luminescence 
from both tibia and the femur was detected for wt and M33-luc at day 5 p.i. (Fig. 4.7A, B), although 
no lytic virus was recovered from infectious centre assays of recovered BMC (Fig. 4.7C). Attempts 
to image whole blood were unsuccessful. Nevertheless, lytic virus was detected by infectious centre 
assay of purified peripheral blood mononuclear cells (PBMC; Fig 4.7C); there were no significant 
differences between wt-MCMV-LUC and M33-LUC in the levels of lytic virus.  
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Fig. 4.4. Luciferase expression of BALB/c mice infected i.n. with 106 PFU wt-MCMV-LUC 
or M33-LUC. Live (A) or post-mortem (B) images were taken during either acute (day 5 p.i.) 
or persistent (day 12 p.i.) phases of MCMV infection. The rainbow radiance scales are indicated 
in (A) and were normalised between virus groups. Lu: lungs; h: heart; SG, salivary gland; scln: 
superficial cervical lymph nodes. 
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Fig. 4.5. Quantification of radiance (A) and virus titres (B) of dissected organs from BALB/c 
mice infected intranasally with either wt-MCMV-LUC or M33-LUC (from Figure 4.3). 
Results show the mean +/- SEM radiance or virus titre (n=3, values shown on a LOG scale in each 
case). Statistical comparisons between wild type (circles) and M33 (squares) groups was performed 
using Students t-test using the Sidak-Bonferroni method, with alpha=5.000% (* = P<0.05; 
**=P<0.01; ****= P<0.0001). The horizontal stippled lines mark the background radiance levels or 
the lower limit of virus detection for titration. 
 
Fig. 4.6. Viral DNA load in the lungs and mLN from intranasally infected mice.  BALB/c mice 
were infected i.n. with 106 PFU wt-MCMV-LUC (circles) or M33-LUC (squares). DNA was 
extracted from lungs (A) or mLN (B) collected at days 3 and 6 p.i. (n=3/group). Viral load was 
quantified by qPCR. Results are presented as LOG copies/reaction, showing means +/- SEM.  
Statistical analysis was made using Student’s t-test with Sidak-Bonferroni method with alpha = 
5.0000% (*P<0.05). The horizontal stippled line denotes the limit of detection. 
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Fig. 4.7. Luciferase expression of bones and viremia detection of BALB/c mice infected via i.n. 
with 106 PFU wt-MCMV-LUC or M33-LUC. (A, B) Post-mortem images were taken during 
acute phase (day 5 p.i.) of MCMV infection. The rainbow radiance scale was normalised between 
virus groups. (C) Infectious centre assays were performed in duplicate with bone marrow cells 
(BMC) or peripheral blood mononuclear cells (PBMC) pooled samples collected at day 5 p.i. from 
wt-MCMV-LUC (circles) or M33-LUC (squares) infected mice (n=3). Titres are presented as 
PFU/107blood cells. Statistical analysis was performed using 2-way ANOVA with Bonferroni’s post-
test. Statistical analysis was made using Student’s t-test. 
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4.3.1.3 Dissemination following footpad infection.  
In order to study viral dissemination from a more peripheral location, footpad inoculations of wt-
MCMV-LUC and M33-LUC were performed in BALB/c mice and live progress of infection was 
measured during the following 6 days. A footpad infection with MCMV resulted in rapid 
amplification of wild type and M33 null viruses at the inoculation site, (day 3 and 6 p.i. images shown 
as example [Fig. 4.8A]) with levels that persisted for the duration of the experiment.  On some days, 
radiance levels between mouse groups were shown to be significantly different; however, there was 
no consistent trend, suggesting that both viruses were equivalent in their ability to colonise the 
footpad (Fig. 4.8B).  Differences in dissemination of the virus to the neck were highly significant by 
day 5 p.i; unlike wt-MCMV-LUC, radiance levels from the necks of M33-LUC-infected mice did 
not exceed background levels.  In dissected organs, both viruses seeded to the popliteal lymph node 
(pLN) by day 3 p.i. (Fig. 4.9A), with equivalent radiance levels (Fig. 4.9B).  Whilst wt-MCMV-LUC 
dissemination to the spleen and salivary gland was evident by day 6 p.i. there was no evidence of 
dissemination by M33-LUC.  Taken together, the imaging results suggest that M33-LUC has the 
capacity to amplify at the inoculation site, and seed to the pLN where infection was efficiently held 
in check for the first 3 days p.i. However, unlike wt-MCMV-LUC, the M33 null counterpart failed to 
colonise the spleen or the salivary gland.  Virus titres performed on organs taken at day 6 p.i. showed 
equivalent virus titres in the footpads between virus groups, with diminished levels by day 6 p.i. (Fig. 
4.10).  In the pLN, titres were also equivalent, although it was noted that lack of significance at day 
3 p.i. may be accounted for the unusually large variance between virus groups.  Notably, despite the 
detection of high levels of luciferase in wt-MCMV-LUC-infected mice in the spleen and salivary 
glands by day 6 p.i., infectious virus was low or undetectable in the spleen and salivary glands. 
Recent studies have shown that containment of MCMV infection in the pLN is mediated by 
subcapsular sinus macrophages (Farrell et al., 2015), whose mechanism of action is highly dependent 
on IFN-α/β (Farrell et al, unpublished). Accordingly, we determined if the block in M33-LUC 
dissemination to the spleen and salivary glands could be lifted by removing IFN α/β signalling.  A 
day before virus inoculation, to block IFN-α/β response, mice were injected with antibodies against 
IFNR. Organs from control mice and in mice lacking an intact IFN-α/β response were dissected for 
imaging and harvested for titration at 3 and/or 6 days p.i. 
In the absence of IFN-α/β signalling, radiance from the footpad and pLN by day 6 p.i. was 
significantly higher for both wt-MCMV-LUC and M33-LUC infected mice (100-fold increase in 
radiance for both groups; Fig. 4.11A,C). Whilst elevated radiance was also observed in visceral 
organs and the salivary glands of all IFNR-treated mice compared with untreated controls, for wt-
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MCMV-LUC mice the increase was more marked, with a 1000-10,000 fold increase in luciferase 
signal compared with 10-100-fold increase for M33-LUC (Fig. 4.11B,D).  
 
 
Fig. 4.8. Kinetics of luciferase expression in BALB/c mice infected with either wt-MCMV-LUC 
or M33-LUC via the footpad.  Live imaging of infected mice was performed in live mice daily 
for 6 days. Examples of live imaging at days 3 and 6 are shown in (A). Quantification of radiance in 
the footpads and necks of infected mice over the 6 day period is shown in (B). Statistical analysis 
was made using 2-way ANOVA with Bonferroni’s post-test (***, P<0.001; ****; P<0.0001). The 
horizontal stippled line denotes the background radiance levels. 
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Fig. 4.9. Luciferase expression in dissected organs from BALB/c mice infected with either wt-
MCMV-LUC or M33-LUC via the footpad.  Live imaging of mice infected with either wt-
MCMV-LUC (circles) or M33-LUC (squares) was performed in live mice daily for 6 days.  
Examples of live imaging at days 3 and 6 are shown in (A): 1, footpads; 2, popliteal limph nodes 
(pLN); 3, spleens; 4, livers; 5, salivary glands (SG). Quantification of radiance in the footpads and 
necks of infected mice over the 6 day period is shown in (B) Statistical analysis was made using 2-
way ANOVA with Bonferroni’s post-test (***, P<0.001; ****, P<0.0001). The horizontal stippled 
line denotes the background radiance levels. 
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Fig. 4.10. Virus titres of dissected organs from BALB/c mice infected via footpad with either 
wt-MCMV-LUC or M33-LUC. Results show the mean +/- SEM virus titre (n=3, values shown 
on a LOG scale in each case). Statistical comparisons between wild type and M33 groups was 
performed using Students t-test using the Sidak-Bonferroni method, with alpha=5.000% (* = P<0.05; 
**=P<0.01; ****= P<0.0001). The horizontal stippled lines mark in each case the lower limit of 
detection. 
 
117 
 
In mice pre-treated with the IFNR antibody and infected with wt-MCMV-LUC, enhanced levels of 
infectious virus were recovered from all sites (Fig. 4.12A-E). In contrast, for M33-LUC, infectious 
virus was recovered only from the site of primary infection (footpad) and the draining pLN (Fig. 
4.12A, B). Despite greater increase in luminescence emission, titration of spleens, livers and salivary 
glands from M33-LUC-IFNR- infections did not yield infectious virus.  
Taken together, the results from the footpad challenges demonstrate that M33 was not required for 
primary colonisation of the footpad or dissemination to the local draining LN. However, M33 was 
 
Fig. 4.11. Blocking INFR signalling increases virus flux at local and distal sites following 
footpad MCMV inoculation.  BALB/c mice were injected (clear symbols) or not (black symbols) 
with an anti-IFNR antibody i.p. days -1 and +3.  Mice were challenged with 106 PFU of either wt-
MCMV-LUC (A and B) or M33-LUC (C and D) via the footpad at day 0. On days 3 and 6 p.i. mice 
were administered luciferin i.p. and organs immediately dissected and imaged.  Luminescence is 
expressed as average radiance +/- SEM. The horizontal stippled line denotes the background radiance 
level.  Statistical analysis was made using 2-way ANOVA with Bonferroni’s post-test (****, 
P<0.0001; ***, P< 0.001). 
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necessary for dissemination beyond the pLN.   In the absence of host containment of virus in the pLN 
by IFNR antibody blocking, M33 was required to establish a productive infection at distal sites. 
 
Fig. 4.12. Titres of dissected organs from BALB/c mice infected via footpad with either wt-
MCMV-LUC or M33-LUC in the presence or absence of IFN- α/β response. Results show the 
mean ± SEM virus titre (values shown on a LOG scale in each case). BALB/c mice were injected 
(clear symbols) or not (black symbols) with an anti-IFNR antibody (-IFNR) i.p. days -1 and +3. 
Mice were challenged with 106 PFU of either M33-LUC (square) or wt-MCMV-LUC (circles) via 
the footpad at day 0. Statistical comparisons between wt and M33 groups was performed using 
Students t-test using the Sidak-Bonferroni method, with alpha=5.000% (* = P<0.05; **=P<0.01; 
****= P<0.0001). The horizontal stippled lines mark in each case the lower limit of detection. 
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4.3.2 Identification of the contribution of particular cell types in M33-dependent dissemination 
4.3.2.1 Evaluation of MCMV virulence upon insertion of loxP sites at M33. 
To investigate whether M33 plays an essential part in viral dissemination through infection of specific 
cell types, transgenic CD11c-Cre+ and LysM-Cre+ mice were infected with MCMV containing loxP 
sites, which allow for either expression (M33FloxON: virus has a STOP cassette, flanked by loxP 
sites, upstream of M33) or deletion (M33FloxOFF: virus has loxP sites upstream and downstream of 
the M33 ORF) of M33. Given the M33-dependent salivary gland tropism phenotype, a series of 
experiments were undertaken to evaluate the contribution of M33 in mice expressing Cre-
recombinase in two cell types: CD11c+, (a marker of dendritic cells), and LysM, (a marker of 
monocytes and macrophages). Viral dissemination to the salivary glands via these cell types was 
evaluated by i.p. and i.n. inoculation. 
Prior to studies in transgenic mice, we first evaluated the effect of the loxP insertion on MCMV 
virulence.  For these studies, BALB/c mice were infected with each of the engineered viruses, either 
before, or after, loxP excision (the latter using a virus inoculum that had been passaged in Cre+ cells 
in vitro). Both the i.p. and i.n. routes of challenge were examined. Previous studies had already 
determined the virulence of M33ON and M33FloxOn and demonstrated that, as desired, M33FloxON 
was fully attenuated for SG tropism through the insertion of STOP cassette. Removal of STOP 
cassette by loxP excision in M33ON restored SG tropism, with only a mild attenuation (1-1.5 log 
reduction in titre) compared with wild type MCMV (Fig 4.13A; Bruce, 2014). Both M33FloxOFF 
and M33OFF viruses exhibited the same level of replication in the pancreas (Fig. 4.13A). Whilst the 
M33ON and M33FloxOn viruses were not evaluated in the pancreas in this study, subsequent 
experiments confirmed that they replicated in the pancreas at wild type levels (H. Farrell, Personal 
Communication). Taken together, the insertion of loxP sites conferred a modest attenuation for the 
M33FloxOFF virus following i.p. infection, with levels of replication recovered in the SG anticipated 
to be sufficient to determine effects of cell-specific switching in vivo.  
We then analysed if loxP insertions would affect MCMV virulence via i.n. infection. BALB/c mice 
were infected with either of the recombinant viruses and their respective in vitro switched version 
(inoculum prepared in Cre+ cells in vitro). Lungs were collected at day 6 p.i. and there were no 
differences in titers between wt virus and any of the ON or OFF viruses. At day 12 p.i., while 
M33FloxON and M33OFF were fully attenuated in the SG, M33ON and M33FloxOFF presented the 
same level of infection as wt virus (Fig. 4.13B). Thus, via i.n. route, only recombinant viruses that 
were not expressing M33 (M33FloxON and M33OFF) presented the desired attenuated profile that 
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was detected in the SG, but not in the lungs. Therefore, as viral switching was functioning in vitro 
and the viruses presented the desired phenotype, we proceeded to test in vivo cell-specific switching.  
4.3.2.2 Phenotypic effects of switching M33 on in CD11c+ and LysM+ cells in vivo.  
To examine whether CD11c+ and LysM+ cells were replication sites relevant to SG colonization, mice 
were infected with viruses that would only be detected in the SG after replicating in those cells. First, 
CD11c-Cre+ and non-transgenic C57BL/6 mice were infected via i.p. with M33FloxON and M33ON 
 
Fig. 4.13. Effects of insertion of loxP sites on MCMV replication in vivo. BALB/c mice were 
infected either i.p (A) or i.n. (B) with wild type K181 or the designated loxP mutants. At indicated 
times p.i. organs were harvested and quantified for infectious virus. Titres are expressed as LOG 
PFU/ml +/-SEM (n=4 per group). Statistical analysis was performed using 1-way ANOVA with 
Bonferroni’s post-test (*** = P<0.001; ns = not significant; nd = not done). The horizontal stippled 
line shows the lower detection limit. 
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virus. Infection of non-transgenic mice with M33FloxON showed full attenuation in the SG at day 
15 p.i. in contrast with mice infected with M33ON. In CD11c-Cre+ transgenic mice, virus could be 
detected in the SG in only half of the cohort (n=4/group), although these were at similar titres to 
M33ON. Infection of LysM-Cre+ mice produced similar stochastic results, with phenotypic evidence 
in switching in a proportion of transgenic mice (three out of 4 mice) (Fig. 4.14A, B).  
Looking at i.n. infections, when M33FloxON virus was inoculated in CD11c-Cre+ mice, at day 19 
p.i., not only all mice (n=5/group) exhibited virus in the SG, but titres were similar to those detected 
in mice infected with M33ON virus. In LysM-Cre+ mice, switching effects were not as marked 
compared with CD11c-Cre+ mice, with no significative differences M33FloxOn titres between wild 
type and transgenic mice, with only half of the cohort showing evidence of virus replication in the 
SG (n=4/group) (Fig. 4.14C, D).  
4.3.2.3 Phenotypic effects of switching M33 off in CD11c+ and LysM+ cells in vivo. 
We then analysed the impact of viral replication in CD11c+ and LysM+ cells to SG colonization by 
infecting mice with viruses that once replicated in those cell would not be able to infect the SG (thus, 
virus recovered from the SG would have been originated from other sources). When CD11c-Cre+ 
mice were infected via i.p. route with M33FloxOFF, switching was not detected, as virus was detected 
in the SG of all mice and at titres equivalent to M33OFF (n=3/group). Comparing M33FloxOFF i.p. 
infections in LysM-Cre+ and non-transgenic mice, all mice presented virus in the SG (n=5/group), 
however, titers were moderately (but significantly) reduced in LysM-Cre+ mice, suggesting a 
potential phenotypic effect of switching in LysM-Cre+ cells, when compared to CD11c-Cre+ (Fig. 
4.15A, B). 
Analysing M33FloxOFF i.n. infections, switching had a phenotypic effect in 3 out of 4 CD11c+ mice: 
two showed complete attenuation in the SG and one mouse exhibited a ten-fold reduction compared 
with mice infected with M33FloxOFF (day 18 p.i., n=4/group). In LysM+ mice, the M33FloxOFF 
cohort sustained a modest (although significant) reduction in virus titre compared with the M33OFF 
cohort (n=5/group), with one mouse in the M33FloxOFF group exhibiting full attenuation (Fig. 
4.15C, D).  
These findings indicate that, in intraperitoneal infections, both LysM-Cre+ and CD11c-Cre+ cells are 
sites of MCMV replication and, although these cells provide virus that can reach the SG (as seen by 
the M33FloxON results), they are not essential for SG colonization, since there was no phenotypic 
effect of switching off M33 (demonstrated by M33FloxOFF data). The situation is slightly different 
following intranasal infection.  In this setting, both switching on and off showed phenotypic effects.  
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These data suggest that LysM+/CD11c+ cells may be important for the dissemination of virus to the 
SG following intranasal infection. 
 
 
 
 
Fig. 4.14. Replication of M33FloxON MCMV in CD11c-Cre+ and LysM-Cre+ cells in vivo. wt 
C57BL/6 mice or transgenic Cre+ mice, either CD11c-Cre+ (A and C) or LysM-Cre+ (B and D), were 
infected via i.p. (A and B) or i.n. (C and D) with 106 PFU of M33FLoxON, M33ON or wt MCMV 
(K181). Salivary glands (SG) were collected at the indicated days post-infection (dpi). Titres are 
expressed as LOG PFU/ml ± SEM. Horizontal stippled line represents detection limit (20 PFU/ml). 
Statistical analysis was made using Students t-test (****, P<0.0001). M33ON: M33 is being 
expressed; M33FloxON: M33 will be expressed after virus replicates in Cre+ cells. In the legend, 
content of the parenthesis indicates the strain of mice infected.    
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Fig. 4.15. Replication of M33FloxOFF MCMV in CD11c-Cre+ and LysM-Cre+ cells in vivo. wt 
C57BL/6 mice or transgenic Cre+ mice, either CD11c-Cre+ (A and C) or LysM-Cre+ (B and D), were 
infected via i.p. (A and B) or i.n. (C and D) with 106 PFU of M33FLoxOFF, M33OFF, T2 (MCMV 
M33 null mutant) or wt MCMV (K181). Salivary glands (SG) were collected at the indicated days 
post-infection (dpi). Titres are expressed as LOG PFU/ml ± SEM. Horizontal stippled line represents 
detection limit (20 PFU/ml). Statistical analysis was made using Students t-test (*, P<0.05). 
M33OFF: M33 expression is ablated; M33FloxOFF: M33 will stop being expressed after virus 
replicates in Cre+ cells. In the legend, content of the parenthesis indicates the strain of mice infected.    
124 
 
4.4 Discussion 
M33 is essential to SG tropism via i.p. infection (Davis-Poynter et al., 1997). Here, we investigated 
whether M33 would also be required for MCMV dissemination to the SG using i.n. and f.p. infections 
and whether these routes would present other intermediate steps that require M33 expression. It was 
also investigated whether replication in specific myeloid cell types are required for SG colonization, 
comparing i.p. and i.n. inoculations.   
MCMV pathogenesis has been studied mainly using i.p. and intravenous (i.v.) routes of infection. 
After i.p. challenge, it has been suggested that virus circulates in the blood as cell-free virions before 
reaching the liver and the spleen within the first hours following infection. Intraperitoneal inoculation 
mirrors i.v. infection pattern of dissemination, which delivers free virus directly into the bloodstream. 
Still, from the peritoneal cavity, the free virus needs to pass through the lymphatic system and the 
thoracic duct before accessing the circulation (Hsu et al., 2009). Thus, despite being informative and 
passing through some immunological barriers, i.p. inoculation might not pose the same physiological 
challenges faced by the virus during peripheral infection. Intranasal and footpad infections represent 
viral dissemination to distal sites, involving the negotiation of local draining lymphatics and cell-cell 
transmission to distal organs by a cell-associated viremia.  One could argue that these inoculation 
routes represent more biologically relevant transmission routes: footpad inoculation delivers virus 
subcutaneously, which would be equivalent to transmission by biting; intranasal infection, as 
performed here, delivers virus to both lungs and nose, simulating a proposed natural entry route of 
herpesvirus (Saederup et al., 2001; Tan et al., 2014).  
Here we evaluated viral dissemination using viruses expressing luciferase. Our results demonstrated 
that M33 is essential to SG tropism and/or colonization, regardless of the route of infection. There 
were no differences between levels of viremia or primary sites of infection between wt and M33 
viruses, suggesting that M33 defect is not present at the early stages of infection, during primary 
organ colonization either directly by free virus, but at a later stage, after establishment of a cell-
associated viremia. Bittencourt et al. (2014) also found similar numbers of blood leukocytes infected 
by both wt and M33 virus, suggesting that M33 is not necessary for blood dissemination. The 
authors also demonstrated that M33 virus could replicate at low levels in severe 
immunocompromised mice upon intra-glandular injection, suggesting that M33 is not 
immunomodulatory in its action.   
Following f.p. inoculation, wild type MCMV is not detected in the spleen until day 2-3 p.i., 
demonstrating a marked dissemination “bottleneck” in the draining LN (Farrell et al., 2015) which is 
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alleviated by the administration of antibodies to IFNR.  In comparison to wt MCMV, M33 MCMV 
infection was enhanced upon blocking of IFN-α/β, suggesting that M33 acts independently of the 
host innate response to disseminate the virus. Infection via f.p. is controlled at the pLN by local 
macrophages (subcapsular sinus macrophages) and in their absence, both wtMCMV and M33 
replicate more freely in the pLN, with an increased virus flux reaching the spleen (Farrell et al., 2015). 
However, in the absence of M33, colonisation of visceral organs was unable to be established even 
in the absence of host innate IFNsignalling. Whilst the data suggest that M33 is required for an 
essential role in cell-cell transmission, it is possible that infected cells in the pLN expressing M33 
altered the local inflammatory context, affecting how macrophages responded during infection 
(Slinger et al., 2010; Vomaske et al., 2009). Given that macrophages are permissive for MCMV, M33 
signalling could directly alter macrophage behaviour, favouring colonisation of distal organs.  
Following intranasal infection, M33 infection was comparable with wt MCMV in the nose and lung.  
Whilst infection of the mLN is non-productive (H. Farrell, personal communication), qPCR 
demonstrated equivalent levels of colonisation between wt and M33 MCMV.  Although not tested 
here, previous reports (Cardin et al., 2009) showed that M33 was attenuated in spread to the spleen 
following i.n. infection, demonstrating a M33-dependent defect in virus colonisation beyond the 
viraemic phase of infection. 
The role of M33 was also evaluated in dissemination to the bone marrow. Previous studies have 
shown MCMV colonisation of the bone marrow within the first week following i.p infection (Gibbons 
et al., 1997) although the levels of lytic virus were reportedly low. Whilst M33 has been shown to 
have a role in the establishment and/or reactivation of latency (Cardin et al., 2009), the impact of 
M33 on colonisation of the bone marrow is unknown. Here we showed colonisation of the bone 
marrow by both wild type and M33-null viruses following i.p. or i.n. infection, providing further 
evidence that M33 is not required for dissemination to this site. Despite the confirmation of the 
presence of the virus in the bone marrow, we could not detect replicating virus in our titration assays. 
Pollock et al. (1997) were able to detect viral genome in the bone marrow cells of infected mice, 
however they could not detect infectious virus. It is well established that HCMV can infect and induce 
latency in pluripotent mononuclear cells in the bone marrow, particularly CD34+. Even though 
monocytes carry the viral genome, replicating virus can only be detected upon cell differentiation 
(Goodrum et al., 2002; Hahn et al., 1998; Reeves & Sinclair, 2013). The inability of MCMV to 
produce progeny in the undifferentiated cells of the bone marrow does not exclude the possibility of 
initial stages of replication occurring, during the acute phase of infection, before latency be 
established. Pollock et al. (1997) determined that cells within the bone marrow could carry from one 
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to ten copies of viral genome. That amount of replication could be responsible for the luciferase signal 
detected. In the future, it would be interesting to verify if, in the presence of a colony growth factor 
to stimulate cell differentiation, infectious virus would be detected from the bone marrow cells. 
To evaluate the contribution of specific myeloid cell types to SG dissemination, a Cre-loxP-system 
was used (Sacher et al., 2012). Transgenic mice expressing Cre-recombinase in either dendritic cells 
(CD11c+) or macrophage/monocytes (LysM+) were infected with MCMV expressing M33 flanked 
by loxP sites. Excision of the loxP sites by Cre-recombinase led to either expression or ablation of 
M33 expression (M33FloxON and M33FloxOFF respectively). While the M33FloxON infection 
informed directly whether virus has replicated in the Cre+ cells en route to the SG, M33FloxOFF 
infections informed about the contribution of these cell types to SG tropism. In evaluating the 
switching off of M33, it was noted that there was a large variance in the phenotype observed, with 
some members of the cohort exhibiting total attenuation in SG virus titres whilst others showed titres 
comparable with non-transgenic mice.  Reasons for this include (1) the timing of virus harvest – the 
longer the time post-infection, the effects of passage through the cell type of interest is diluted (a 
solution would be to harvest organs at earlier time points to achieve a more stringent test); (2) the 
expression of marker of interest may be variable in vivo, which has quite varied expression between 
and within mice – this has been shown in particular for LysM; (3), for CD11c, assignment of 
transgenic from wild type mice relies on genotyping (mice for experiments are generated from a 
heterozygous Cre+ mouse crossed with C57BL/6 so 50% of the progeny are transgenic)  there is a 
possibility of genotyping error here (LysM are generated by homozygous Cre+ crossed with BL/6, so 
all mice are transgenic heterozygous). This system may have some problems, as in some infections, 
there were some titre variations, which can be related to variability in expression of Cre-recombinase, 
depending on the transgene used. Still, these experiments are useful to determine contribution of 
particular cell lineages to SG infection. Firstly, our results demonstrated that following i.p. infection, 
CD11c+ and LysM+ cells are not essential mediators of the M33 SG tropism phenotype, although 
these two cell types were a source of virus that ultimately infected the SG. It is well documented that 
MCMV can infect different cell types; however, it exhibits selectivity for specific cells at early points 
of infection (Hsu et al., 2009). Viral dissemination is mainly associated with cells from the myeloid 
lineage (Bale & O'Neil, 1989; Hanson et al., 1999; Noda et al., 2006; Stoddart et al., 1994), and 
mononuclear phagocytes (monocytes, macrophages and dendritic cells), the very first cellular defence 
against infection at entry sites, are recognized reservoirs of MCMV (Alexandre et al., 2014; Hamano 
et al., 1998; Reeves & Sinclair, 2013; Stoddart et al., 1994).  
Following intranasal infection, our data suggest that CD11c+ and LysM+ may be important for virus 
dissemination to the SG. As these are preliminary experiments in small numbers of mice, further 
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experiments are required to confirm this – to do a time course of infection for example, focussing on 
early events of SG colonisation. In addition, comparison of the number and phenotype of cells that 
colonise the mediastinal lymph node (that is en route to the SG) and the SG itself (stain with anti-IE 
MCMV antibody and myeloid cell markers such as CD11c) will provide insight into the cells that are 
critical for MCMV dissemination. We hypothesise that myeloid cells, especially CD11c+ cells are 
the critical conduits of virus dissemination to the salivary glands following intranasal infection. 
In conclusion, the use of modified virus, such as luciferase tagging or with genes under the control of 
Cre-loxP system, are quantitative and sensitive approaches to study viral dissemination. Our results 
confirm that M33 is not essential for haematogenous dissemination, but it is indispensable for SG 
tropism and cell-cell transmission of MCMV at sites distal to infection.  Additional studies are 
required to determine whether the effect is due to M33-dependent alteration of infected leukocytes 
that are pivotal to post-viraemic colonisation, or M33-dependent attenuation of lytic infection in key 
cell types.     
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Chapter 5 - General Discussion 
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During infection, the cytomegaloviruses (CMVs) can alter cell physiology to favour viral replication 
(McCormick & Mocarski Jr, 2007; Spector, 2015). They can also induce changes in the extracellular 
environment to improve virus dissemination. In order to achieve these outcomes, the CMVs have 
developed several mechanisms that not only evade the immune system, but also modulate its response 
with presumed beneficial effects for the virus (Engel & Angulo, 2012; Jackson et al., 2011; Noriega 
et al., 2012). The vGPCR are a remarkable example of one these mechanisms. By hijacking G protein 
cellular signalling, the CMV can potentially subvert a myriad of gene transcription pathways, which, 
in turn, can disrupt several cellular functions, such as cell division, differentiation, apoptosis, 
migration and activation. Little is known of the contribution of the vGPCR to these processes and the 
outcome on virus pathogenesis.  However, it is likely that the effects of the vGPCR will depend on 
the cell type infected and thus, on the nature of the cellular pathways that are modulated. 
5.1 Effects of vGPCR in human cell types and potential roles during infection 
The placenta supports the development of the foetus and is responsible for the metabolic exchanges 
between mother and baby during the pregnancy (Gude et al., 2004). The pathogenesis of HCMV 
congenital infection is not restricted to the direct effects of virus infection of the foetus, but it also 
includes the effects of virus infection of placenta: HCMV causes oedema, inflammation, enlargment, 
and other developmental and structural abnormalities in this organ (La Torre et al., 2006; Mühlemann 
et al., 1992; Pereira et al., 2014; Zhong & Ma, 1993). These changes in the placenta contribute to the 
poor pregnancy outcomes with HCMV infection associated with foetal intrauterine growth restriction 
(IUGR) and stillbirths (Iwasenko et al., 2011; Pereira et al., 2014). Here we investigated the roles of 
the vGPCR during infection of cell types relevant to congenital infection pathogenesis.   
Upon the expression of US28 or UL33 in a first trimester trophoblast cell line (HTR-8), both receptors 
induced activity of CREB; US28 additionally induced NF-B activation. UL33 and US28 signalling 
through CREB was found to be mediated by MAP kinases. Both CREB and NF-B have been 
associated with a range of cellular functions, including cell survival and immune regulation (Basak 
& Hoffmann, 2008; Mayr & Montminy, 2001). NF-B has been shown to prevent apoptosis and 
induce cell proliferation during foetal development (Torchinsky & Toder, 2004). Also, NF-B has 
been shown to regulate the activity of both HCMV immediate early enhancer and promoter and thus 
facilitates an optimal intracellular environment for virus infection (Sun et al., 2001). In trophoblasts, 
CREB induces the transcription of genes related to syncytium formation (Toufaily et al., 2015; Zhou 
et al., 2014). This process is mediated by ERK1/2 and p38 MAPK and it has been suggested that 
sustained activation of these kinases can influence trophoblast cell cycle, including cycle arrest and 
differentiation (Delidaki et al., 2011). CREB activation also regulates the expression of placental 
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growth factor, which is found to be abnormal in pregnancy disorders, such as IUGR (Depoix et al., 
2011). It has been shown that HCMV infection interferes with trophoblast cycle progression and cell 
differentiation. Such changes can be detected both before and after viral DNA replication, 
demonstrating that late viral gene expression is only partially responsible for these events (Tabata et 
al., 2015). Taken together, it is possible that the vGPCR play a part in the initial changes of the cell 
machinery, usurping the cellular transcriptional machinery to favour viral replication. It would be 
interesting to verify if indeed the vGPCR signalling can contribute to cell survival and arrest of 
differentiation in trophoblasts, since US28 in particular has been tentatively associated with 
tumorigenesis (Maussang et al., 2009; Maussang et al., 2006).  
Control of cellular migration is an important function of chemokine receptors and has been 
investigated for CMV vGPCRs in a variety of cell types, although effects of the vGPCRs upon 
trophoblast migration have not been reported previously.  Stimulation of trophoblast migration was 
detected upon US28 expression.  These findings are consistent with previous reports of US28-induced 
migration of other cell types: vascular smooth muscle cells (SMC), macrophages and HEK cells 
(Hjorto et al., 2013; Melnychuk et al., 2004; Streblow et al., 1999; Streblow et al., 2003; Vomaske 
et al., 2009). In the case of macrophages and HEKs, CX3CL1 was reported to stimulate migration, 
whereas in SMCs CX3CL1 was found to inhibit migration (which was dependent instead upon CCL5 
induction). In HTR-8 cells, CX3CL1 resulted in inhibition of US28-induced migration, suggesting a 
mechanism similar to that of SMCs. It would be interesting to analyse if US28 activation of NF-B 
can modulate the migration properties of trophoblasts, since NF-B has been described to induce 
migration in an ERK-dependent manner in trophoblasts and migration (and adhesion) of HCMV 
infected monocytes to the endothelia has been described to be mediated by NF-B signalling (Smith 
et al., 2007; Wang et al., 2013). Our findings of UL33-induced migration of HTR-8, correlated with 
CREB activation, are quite novel.  M33, the mouse vGPCR homolog, was reported to induce 
migration of SMC in a CCL5-dependent manner (Melnychuk et al., 2005), but there are no prior 
reports of UL33-induced migration to our knowledge.   
The potential influence of US28 and UL33 upon trophoblast migration during infection remains to 
be determined and care must be taken in extrapolating from transfected cells to the context of virus 
infection. Previous studies have described reduced migration and invasion of HCMV infected 
cytotrophoblasts (Liu et al., 2011; Yamamoto-Tabata et al., 2004). HCMV infection is described to 
alter the expression of several chemokines (Scott et al., 2012; Streblow et al., 1999) and chemokines 
can interfere with cell taxis (e.g., HCMV infection of cytotrophoblasts inhibits CXCL12 expression, 
which mediates migration of this cell type) (Warner et al., 2012). HCMV infection has also been 
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associated with modulation of canonical and non-canonical Wnt signalling, thereby inhibiting 
trophoblast migration in response to Wnt ligands (Angelova et al., 2012; van Zuylen et al., 2015). It 
is possible that several alternative pathways, including those involving the vGPCR, may contribute 
to modulation of trophoblast migration and that the prevailing effects will depend upon the context 
of infection, for example differentiation state of the cell.  The HTR-8 cell line of this study, derived 
by SV40 large T transformation of an extravillous trophoblast, exhibits progenitor cell characteristics 
(Graham et al., 1993; Weber et al., 2013). An additional function for US28 has been proposed 
following observation of transcription during latency (Beisser et al., 2001). Potentially it may 
contribute to repression of the lytic cycle since, in its absence (but not in the absence of the other 
three HCMV vGPCR), transcription from the major IE promoter occurs in hematopoietic CD34+ 
progenitor cells, culminating in viral progeny production (Humby & O'Connor, 2015). It may be 
speculated that latently infected cells and US28-related triggers for reactivation may modulate CMV-
induced placental dysfunction.  
Matrix metalloproteinases are important factors for modification of the extracellular environment, 
including effects associated with tissue remodelling, cell migration and modulation of various cell 
signalling pathways. Inhibition of migration following HCMV infection has been associated with 
down-regulation of MMP-2 (in HUVECS, fibroblasts and extravillous cytotrophoblasts) and MMP-
9 (in cytotrophoblasts) (LaMarca et al., 2006; Liu et al., 2011; Liu et al., 2015; Yamamoto-Tabata et 
al., 2004). We could not detect expression levels of either MMP-2 or MMP-9 in HTR-8 trophoblasts. 
On the other hand, we were able to detect a small induction by US28 of MMP-1 levels in HTR-8 cells 
and in MMP-10 levels in HUVEC. Neither of these MMP were measured in the aforementioned 
studies of HCMV infection of trophoblasts. Furthermore, up-regulation of MMP levels by HCMV 
has been previously detected in SMC. Infected SMC, which have been used in migration studies, 
were reported to present an increase in MMP-1 and MMP-3 expression (Prochnau et al., 2011; 
Streblow et al., 1999). These results suggest that HCMV infection may alter the MMP expression 
profile in a cell type-dependent manner; however, the significance of these changes needs to be further 
addressed. It should be investigated if the induction of MMP-1 and 10 influences the migration 
phenotype of HTR-8 and HUVEC.  Also, if not migration, what other trophoblast functions could be 
modified by alteration of MMP expression? MMP are highly regulated during pregnancy and changes 
in their levels by viral infection could explain implantation failures, miscarriages and IUGR setting 
in HCMV congenital infection. MMP-1, 3 and 9 are induced in the foetal membranes close to labour, 
while MMP-2 is particularly important in regulating trophoblast invasion during the first trimester 
(Cockle et al., 2007). This indicates that up-regulation of these proteases could induce important 
tissue remodelling and, thus, migration. In addition, MMP secretion can be influenced by chemokine 
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expression, but they can also regulate the inflammatory process, activating or inactivating several 
chemokines (Nissinen & Kahari, 2014).  
Besides altering cellular signalling pathways, US28 has been proposed as a ‘chemokine sink’, due to 
its ability to bind to a range of chemokines and be constantly endocytosed (Fraile-Ramos et al., 2001; 
Kledal et al., 1998; Kuhn et al., 1995). Even though US28 has been associated with chemokine 
sequestration (Randolph-Habecker et al., 2002), which would diminish leukocyte attraction, US28 
has been shown to induce a more pro-inflammatory than anti-inflammatory profile, inducing IL-6, 
VEGF, COX-2 and CCL5 expression (Slinger et al., 2010; Soroceanu et al., 2011; Streblow et al., 
1999). So, here we evaluated the expression of an extensive panel of chemokines by HTR-8 and 
HUVEC and the ability of UL33 or US28 to influence their secretion. In HTR-8, UL33 induced the 
expression of MIF. In both cells types, US28 expression induced CXCL8 and IL-6 and it also induced 
CCL20 in HUVEC. In the context of virus-infected cells (HUVEC and HFF), induction of CXCL8 
and IL-6 was observed independent of US28 expression, whereas US28 did contribute to induction 
of CCL20. The induction of CCL20 is intriguing, since this is a potent chemoattractant for immature 
dendritic cells (DC) and such cells are susceptible to HCMV infection, both lytic and latent (Sinclair 
& Reeves, 2014). US28 was also implicated for induction of CCL3, CCL8, CX3CL1, CXCL10 and 
GM-CSF in both cell types, with cell-type specific induction of CCL7, CXCL5, IL-1b (HUVEC) and 
CXCL2, CXCL6, CXCL11 (HFF).  These results corroborate the role of the vGPCR as pro-
inflammatory molecules. The basic function of chemokines is to attract or activate leukocytes: 
peripheral dendritic cells (CCL20), monocytes, T lymphocytes (CCL3, CCL20, CXCL10, CXCL11, 
CX3CL1), neutrophils (CXCL2, CXCL5, CXCL6, CXCL8), basophils and mastocytes (CCL7, 
CCL8) (Laing & Secombes, 2004). IL-1b, IL-6 and CXCL8 can induce migration and/or invasion of 
trophoblasts (Sharma et al., 2016). Furthermore, IL-8 expressed by trophoblasts has been reported to 
stimulate migration of monocytes (Shirasuna et al., 2016). MIF is a pro-inflammatory regulator 
(Renner et al., 2005). Its expression has been associated with increased migration in trophoblasts, 
which also presented an increase in MMP-2 and 9 (Jovanovic Krivokuca et al., 2015). In HUVEC, 
MIF promotes changes in adhesion molecules and chemokine expression and induces leukocyte 
recruitment (Cheng et al., 2010). In HUVEC cultures, GM-CSF was also shown to induce 
transendothelial migration of monocytes (Shang & Issekutz, 1999). IL-6 and GM-CSF have been 
described to promote cell survival and proliferation, respectively, in HUVEC (Botto et al., 2011; 
Stasko et al., 2002). Taken together, it seems that the vGPCR have potential to promote, rather than 
diminish, a pro-inflammatory state within the infected cell. The establishment of an inflammatory 
context may recruit cells susceptible to virus infection.  In the context of the placenta, it may be 
speculated that vGPCR induced chemokines may recruit myelomonocytic cells and, upon infection, 
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help them to cross into the foetal circulation and, ultimately, reach the foetus. Furthermore, many of 
these chemokines can induce migration of the trophoblasts as well, which may also benefit viral 
dissemination.  
On the other hand, promotion of inflammation should also help to contain the infection, although this 
correlates with poor pregnancy outcome (Challis et al., 2009). For example, HCMV infection 
activates decidual NK cells into cytotoxic cells, which migrate into the sites of infection, where they 
can alter the levels of IL-6 (further increase) and CXCL-8 (reduction), among other changes in the 
chemokines induced by HCMV (Siewiera et al., 2013). Although our results are limited to 
transfection and infection of a limited number of cell types, they do suggest that the vGPCR play a 
role in modulating the chemokine environment, which may affect the pathogenesis of infection, 
including in the placenta. 
Infection using an ex-vivo model can be more informative than cell culture infections, as they offer a 
broader context to infection. Thus, in the future, it would be beneficial to analyse the effects of the 
vGPCR by infecting placental explants with wild type virus and null or signalling deficient US28 and 
UL33 HCMV. This way we can try to comprehend the effects induced by the vGPCR expression 
during infection and compare these findings with results obtained in defined cell-types in tissue 
culture. Finally, since UL33 and US28 present functional complementation with M33, the use of the 
intrauterine infection mouse model may provide a means to study in vivo effects of the vGPCR on 
congenital infections (Juanjuan et al., 2011; Li & Tsutsui, 2000): histological studies of infected 
placentas and detection of chemokine levels in the amniotic fluid and in the sera can be evaluated 
during infection in the presence or absence of M33, revealing if in vitro findings can also be detected 
in vivo. 
5.2 M33 role in MCMV dissemination  
Viral dissemination plays an important part in the pathogenesis of an infection. Current understanding 
of the initial phase of infection by HCMV is very limited and there is no consensus regarding natural 
route of infection due to abundance or sources of infection (Britt, 2008; Forbes, 1989). Understanding 
the critical steps in this process may help to develop effective strategies to control viral infection. The 
use of the mouse model of infection may provide insightful information into viral contraction and 
mechanisms of dissemination.  In the present study we compared viral dissemination via different 
routes of infection using a wild type luciferase-tagged mouse CMV (MCMV-LUC) and a M33 null 
luciferase-tagged MCMV (M33-LUC). This approach proved to be useful to track both productive 
and non-productive lytic infection, allowing visual detection of viral distribution during acute and 
persistent phases. A possible explanation of the lack of association between intensity of radiance and 
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recovery of infectious virus is the expression characteristics of the luciferase gene in the MCMV 
genome. The luciferase coding sequence was placed under the control of the M78 promoter, a gene 
with early kinetics (Oliveira & Shenk, 2001). Potentially, therefore, expression may be detected in 
cells that are either not fully permissive or have not yet entered the stage of infectious virion 
production. If the gene was under the promoter of a late protein, like a component of the viral capsid, 
it is probable that radiance signal would be better associated proportionally associated with viral 
production (Zhang et al., 2016a). Nonetheless, as our main objective was to study viral dissemination, 
regulation of luciferase expression by a promoter of an early gene serves as a more sensitive method 
to detect sites of viral spread.  
Our results corroborated previous findings of wild type MCMV distribution following intraperitoneal 
infection, with detection of wt-MCMV-LUC in the liver, spleen and salivary glands by day 5 post-
infection (Mercer & Spector, 1986; Stoddart et al., 1994). Luminescence signal was detected in the 
neck and widespread in the peritoneal cavity. Upon dissection, radiance emission was also detected 
at sites where we could not retrieve infectious MCMV, such as the pancreas and the long leg bones 
(the femur and the tibia). Detection of infectious virus has been described for both sites (Bale et al., 
1987; Shanley et al., 1993). A couple of scenarios could explain our failure to detect viral replication 
in these sites. The signals emitted from bones were quite low, thus, even if there were replicating 
virus, titres could have been below detection levels. Furthermore, it has been established that infected 
bone marrow cells can be a reservoir of MCMV, carrying the virus genome, but only producing 
virions upon cell differentiation (Koffron et al., 1998a; Pollock et al., 1997; Yuhasz et al., 1994). The 
pancreas, on the other hand, presented quite elevated luminescence signals. Price et al. (1998) 
detected high levels of inflammation already at day 3 post-infection in the pancreas, but infected cells 
were very rarely found. Thus, it is possible that the inflammatory influx at the pancreas consists of 
infected leucocytes, which are poorly productive. Histological analysis would shed light on the nature 
and phenotype of the cells at this site.  Similar to wt-MCMV-LUC, intraperitoneal infection with 
M33-LUC also supported literature findings, with lower levels of virus in visceral organs, when 
compared to wild type, and no colonization of the salivary glands at any analysed day (Cardin et al., 
2009; Davis-Poynter et al., 1997; Farrell et al., 2011). At day 5 post-infection, M33-LUC 
luminescent emission was significantly lower in the spleen than wt-MCMV LUC. Interestingly, 
M33-LUC presented marginal detection levels of radiance in the salivary glands at day 5, which 
had disappeared by day 12 p.i. It tempting to suggest that this luminescence may be due to 
dissemination at this site as reported by Bittencourt et al., 2014.  Again, histological examination 
would shed light on the nature of cells that are important for virus carriage to distal sites. Bones of 
135 
 
mice infected with M33-LUC presented luminesce signal equivalent to wt-MCMV-LUC, 
suggesting that M33 does not play an important role of early colonization of the bone marrow. 
Because intraperitoneal infection gives almost direct access to major organs, in our study, viral 
dissemination and M33-dependent tropism was also analysed upon intranasal infection. Intranasal 
infection allows for identification of primary and secondary sites of infection using a more 
biologically relevant route of infection – when compared to intraperitoneal infection. Intranasal 
infection delivers virus to primary sites (lungs and nasal mucosa), where the virus can replicate before 
spread through the lymphatic system or the bloodstream (Jordan, 1978; Tan et al., 2014). wt-MCMV-
LUC infected mice presented high luminescence signal in the nose, lungs, superficial cervical lymph 
nodes (SCLN), salivary glands and long leg bones at day 5 post-infection. High titres of infectious 
virus, on the other hand, were only detected in the lungs and salivary glands. Nose and SCLN 
presented little or no productive infection, respectively. While no infection was detected in the bone 
marrow, when analysing peripheral blood mononuclear cells, a low level of infected cells was 
detected in wt-MCMV-LUC mice. When infection was performed with sM33-LUC, the same levels 
of both luminescence and viral titres were found between wild type and deletion virus, except for 
salivary glands, which still did not present virus replication at both day 5 and 12 post-infection, but 
low levels of luminescence could be detected at day 5. Our results agree with Cardin et al. (2009), 
who also compared intranasal infection between wt and M33 MCMV and detected no differences 
in the lungs, lower levels of infection in the spleens (not analysed here) and no colonization of the 
salivary glands by M33 MCMV during acute infection. Viral dissemination via the intranasal route 
has been less explored, but recently is becoming a focus of interest. Using a Smith-derived strain of 
MCMV, Oduro et al. (2015) also found high titres of virus in the lungs (at day 5) and in the salivary 
glands (at day 14) in intranasally infected mice. They reported a very limited splenic infection, 
characterized by very low titres of MCMV being detected only between 5 to 7 days post-infection. 
Likewise, comparing a low passage (HaNa1) with a high passage (Smith) strain of virus, Zhang et al. 
(2016b) found that, upon oronasal inoculation, both strain of viruses could be detected in the nose, 
lungs and salivary glands; however, virus was detected in the spleen, liver and kidneys only in mice 
infected with the Smith strain. Another study from this group, comparing neonate and adult mice 
infection with the HaNa1 strain, confirmed the same sites of infection in adult mice and demonstrated 
persistent infection of the nasal mucosa for both neonates and adult mice. Furthermore, they showed 
that only neonate inoculation produced a systemic MCMV infection, with virus replication in the 
spleen, kidneys and brain (Xiang et al., 2016). 
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An additional peripheral route of viral dissemination is inoculation via the footpad; thus, we also 
analysed M33 roles in viral dissemination following footpad infection. Infection with wt-MCMV-
LUC produced high levels of radiance in the footpads during the 6 day of the experiment. By day 3, 
radiance was detected in the popliteal lymph nodes (pLN) and, by day 6, in the spleens. Basal signal 
emission from the neck (salivary glands) was detected on day 3 and 4 post-infection, and, by day 5, 
high levels of luminescence were present in this organ. Viral replication, on the other hand, was 
detected in the footpad and at low levels in the pLN. Viral replication in the salivary glands emerged 
by day 6 p.i. M33-LUC was found to be equivalent to wt-MCMV-LUC at the challenge site, and to 
the draining pLN.  However, no colonisation – either by luminescence or infectious titres were 
recovered from organs beyond the pLN.  Footpad infections performed by Saederup et al. (2001) also 
induced high levels of viral replication in the footpad following infection with wt MCMV, with 
dissemination noted to the spleen, lungs, liver and salivary gland following the viraemic phase. 
Previous works of our group have showed that, following footpad infection, the pLN is a key site to 
limit viral dissemination, where infection of the local macrophages and antiviral innate responses, 
such as type I interferon response, are responsible for restriction of viral replication (Farrell et al., 
2015a) (H. Farrell, Personal Communications). Thus, we analysed viral dissemination in the absence 
of interferon- response. Blocking of the interferon receptor induced higher radiance levels of both 
wt-MCMV-LUC and M33-LUC in all sites of infection (footpad, pLN, spleen, liver and salivary 
gland). Viral replication of wt-MCMV-LUC was, on average, approximately 100-fold higher in the 
absence of type I interferon response. On the other hand, only a modest increase was detected in 
infectious M33-LUC in the footpad and the pLN, which remain the only sites of viral replication. 
These results suggest that M33 plays an essential role in viral dissemination to secondary sites of 
infection via footpad infection, i.e. via lymphatics, but it is not involved in circumventing the immune 
system effectors in the in the lymph nodes.  
Upon intraperitoneal infection, MCMV has been shown to arrive at the local lymph nodes, mainly at 
the mediastinal lymph node, as cell-free virus. Most of the viruses gain direct access to the thoracic 
duct, and, thus, the bloodstream, allowing haematogenous spread of the infection into the liver and 
spleen. Following footpad infection, much of the draining free virus is captured by the subcapsular 
sinus macrophages within the lymph nodes (Hsu et al., 2009). During footpad infection, virus must 
go through the local lymph node to gain access to other sites. At the pLN, it infects subcapsular sinus 
macrophages. These macrophages and other immune effectors at the pLN can effectively contain the 
infection, but for only a short period: although a substantially lower amount of virus is detected in the 
lymph nodes than in the footpad, a couple of days later, virus can be detected colonizing the spleen 
(Farrell et al., 2015a). Even though we did not perform a histological study of the mediastinal lymph 
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node after intranasal infection, it is likely that the same scenario would be identified, as we detected 
a great reduction between the viral load of the lungs and the mediastinal lymph nodes and others have 
found low levels of infection of the spleen following intranasal infection (Oduro et al., 2015; Zhang 
et al., 2016b).  
As haematogenous dissemination is a critical step in MCMV pathogenesis, we used conditional M33 
expression to examine the role of two myeloid cell types, LysM+ cells (maker present mainly in 
monocytes and macrophages) and CDllc+ cells (found mainly in dendritic cells), in the colonization 
of the salivary glands. Albeit not essential to viral dissemination into the salivary glands, both cell 
lineages can be considered contributors to the carriage of MCMV to the salivary glands. These cell 
types play several roles during MCMV infection: they serve as both sites of replication/reservoir and 
immune cell effectors, inducing cytokines, presenting antigen and activating NK cells (Hamano et 
al., 1998; Hanson et al., 1999; Mathys et al., 2003); they are also sites of latency or influence latency 
establishment (Holzki et al., 2015; Koffron et al., 1998b; Pollock et al., 1997; Sinclair, 2008); and, 
given their nature, they are critical agents of viral dissemination (Daley-Bauer et al., 2014; Farrell et 
al., 2015b). Comparing inoculation routes, we detected a particular prominent switching on both 
LysM+ and CDllc+ cells upon intranasal infection. This is supported by Xiang et al. (2016) finding 
that, following intranasal inoculation, infected cells in the nasopharynx-associated lymphoid tissues 
were macrophages and dendritic cells. Recently, Farrell et al., (2016) identified olfactory neurons 
(OMP+) as the first cells infected following intranasal MCMV infection. Local, nasal replication by 
wild-type MCMV was not extensive, but from here, systemic spread was rapid and associated with 
macrophage infection.  Following lung infection, alveolar macrophages are also found to be a source 
of MCMV dissemination (Farrell et al., 2015b).  It would be of interest to investigate, through 
histological studies, if the virus colonizing the salivary glands only replicated in these cell types at 
one point or if it was carried by these specific cells into the gland. Nonetheless, our results indicate 
that other myeloid cell types are also involved in the colonization of the salivary gland. In order to 
determine the other sources of infectious virus to dissemination into the salivary glands, more 
experiments, using different transgenic mice will need to be performed.  
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2.1 Bacterial media 
 
2xTY  
Tryptone 16 g/L 
Yeast extract  10 g/L 
NaCl  5 g/L 
 (if preparing agar, add 15g/L of bacteriological agar) 
 
LB 
Tryptone 10 g/L 
Yeast extract   5 g/L 
NaCl  10 g/L 
 (if preparing agar, add 15g/L of bacteriological agar) 
 
GalK selection media 
M9 Medium  
NaHPO4 6 g/L 
KH2PO4 3 g/L 
NH4Cl 1 g/L 
NaCl 0.5 g/L 
  
 5x M63 Medium    M63 Minimal Agar  
(NH4)4SO4 10 g/L  800 ml of 1.9%  Agar (autoclaved) 
KH2PO4 68 g/L  200 ml 5X M63 medium (pH 7) 
FeSO4.7H20 2.5 mg/L  1M MgSO4.7H20 1 ml 
Autoclave   Biotin* 1 mg 
  Leucine* 45 mg 
  Chloramphenicol* 12.5 ug/ml 
  Carbon source*: (0.2%) 
  either 20% glycerol  10 ml (positive selection) 
  or 2-deoxy-galactose 10 ml (negative selection) 
  *To be added after autoclaving (at ~50C) 
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Amp/LacZ/SacB Selection Media 
Low Salt LB (positive selection agar)  Negative Selection Medium 
Tryptone 10 g/L  Tryptone 10 g/L 
Yeast extract   5 g/L  Yeast Extract   5 g/L 
NaCl  5 g/L  Agar 15 g/L 
Agar 15 g  Sucrose** 50 g/L 
Ampicillin* 50 ug/ml  IPTG (100mM)* 1 ml 
Chloramphenicol* 12.5 ug/ml  X-gal* 40 mg 
IPTG (100mM)* 1 ml  Chloramphenicol* 12.5 ug/ml 
X-gal* 40 mg    
*To be added after autoclaving (at ~50C) 
** Warm up the media before autoclaving to avoid caramelization 
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2.2 List of plasmids 
 
List of plasmids mentioned in Chapter 2. 
Plasmid 
number 
Alternative 
name 
Backbone 
Sequences cloned 
into plasmid 
Observation 
B66 pcDNA3.1 pcDNA3.1 - Vector for gene 
expression 
B72  pcDNA3.1 FLAG-wt* US28  
B73  pcDNA3.1 HA-wt US28  
B86 pUC19 pUC19 - Vector for cloning 
B105 DQY or R129Q pcDNA3.1 HA-US28-DQY DRY motif mutated 
US28 
B107 C53 or C pcDNA3.1 HA-US28-C53 Deletion of 53 C-tail 
amino acids of US28 
B112 N15 or N pcDNA3.1 HA-US28-N15 Deletion of 15 N-
terminal amino acids of 
US28 
B150 Y291F or ITIM pcDNA3.1 HA-US28-Y291F Y291F mutation of 
US28 
B167 pLL3.7- EF1α pLL3.7- EF1α 
 
- Lentiviral vector 
(expresses GFP) 
B171+ - pLL3.7-EF1α HA-US28  
B175 pLL3.7-IEp  pLL3.7-IEp - Lentiviral vector 
(expresses GFP) 
B182+ N15 or N pLL3.7-IEp HA-US28-N15 Deletion of 15 N-
terminal amino acids of 
US28 
B183+ Y291F or ITIM pLL3.7-IEp HA-US28-Y291F Y291F mutation of 
US28 
B186+ DQY or R129Q pLL3.7-IEp HA-US28-R129Q 
 
DRY motif mutated 
US28 
B187+ C53 or C  HA-US28-C53 Deletion of 53 C-tail 
amino acids of US28 
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B194  pGalK pGalK - Expresses galK gene 
B206+  pUC19 I-SceI restriction site  
B240 pGFP-N1 pGFP-N1 - Expresses GFP 
B246+ pGalK-kanS pGalK kanS Expresses kanamycin 
resistence gene  
B247 pEP-KanS pEP-KanS -  
B252 pAL1151 adeno 
vector 
  Expresses SacB, Ampr 
and LacZ genes 
B253+  pUC19 94ntMerlinUL33-
LacZ-Amp-SacB-
200ntUL33 
Selective markers 
replace most of UL33 
sequence  
B258+  pGFP-N1 wt UL33  
B259+  pGFP-N1 94ntMerlinUL33-
LacZ-Amp-
200ntUL33 
Selective markers 
replace most of UL33 
sequence 
+: plasmid generated in this study 
*wt: wild type 
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2.3 Maps of parental plasmids 
B66 (pcDNA3.1-HA) 
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B72 (pcDNA3.1-FLAG-US28) 
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B73 (pcDNA3.1-HA-US28) 
 
 
  
178 
 
 
B86 (pUC19) 
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B105 (pcDNA3.1-US28-DQY) 
 
  
180 
 
B107 (pcDNA3.1-US28-C53) 
 
 
  
181 
 
B112 (pcDNA3.1-US28-N15) 
 
  
182 
 
B150 (pcDNA3.1-US28-Y291F) (ITIM) 
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B167 (pLL3.7-EF1α) 
 
  
184 
 
B175 (pLL3.7-IEp) 
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B194 (pGalK)  
 
  
186 
 
B240 (pGFP-N1) 
 
  
187 
 
B247 (pEP-KanS) 
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B252 (pAL1151 adeno vector) 
 
 
Restriction Enzyme Sites of B252 
Name Cut Positions 
MfeI 8 cut positions: 5867, 9958, 11573, 27987, 32092, 35439, 36921, 40760 
NcoI 22 cut positions: 566, 5612, 7397, 8637, 10307, 11164, 12484, 14676, 16060, 20446, 
22160, 22646, 23426, 23510, 23674, 24094, 25897, 27295, 31394, 32998, 37311, 
42960 
NdeI 5 cut positions: 5016, 21492, 30356, 40778, 43409 
SacII 31 cut positions: 358, 4382, 5770, 7424, 7747, 8123, 8374, 8743, 10326, 10464, 
10502, 11433, 13111, 13149, 13275, 14726, 15638, 16229, 17076, 18255, 18312, 
19236, 19806, 21096, 22812, 23583, 24491, 25293, 25763, 27820, 28119 
SalI 7 cut positions: 938, 972, 11405, 11784, 18690, 35257, 37051 
SmaI 16 cut positions: 2274, 5885, 6065, 8528, 15008, 16407, 20862, 22317, 25857, 29237, 
29467, 32360, 34623, 37045, 39266, 43666 
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2.4 Maps of generated plasmids 
B171 (pLL3.7-EF1α-HA-US28) 
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B182 (pLL3.7-HA-US28N15) 
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B183 (pLL3.7-HA-US28Y291F)  
 
  
192 
 
B186 (pLL3.7-US28R129Q) 
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B187 (pLL3.7-US28-C53) 
 
  
194 
 
B206 (pUC19-I-SceI) 
 
 
  
195 
 
B246 (pGalK-kanS) 
 
 
  
196 
 
B253 (pUC-94ntMerlinUL33-LacZ-Amp-SacB-200ntUL33) 
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B258 (pGFP-N1-UL33) 
 
 
  
198 
 
B259 (pGFP-N1-UL33-LacZ-Amp) 
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2.5 List of designed recombineering primers  
 
Primer sequence 5'-->3' 
Amp F TGGTCTGACAGTTACCAATGC
I-SceI R CAATTACCCTGTTATCCCTAG
HA insertion 
US28  (N-term)
F cagacggcgtccatgcaccgagggcagaactggtgctatcTACCCATACGATGTTCCAGATTACG
CTatgacaccgacgacgacgacTGGTCTGACAGTTACCAATGC
HA insertion 
US28  (N-term)
R actccgtcgtgagttccgcggtcgtcgtcgtcggtgtcatAGCGTAATCTGGAACATCGTATGGGTA
gatagcaccagttctgccctCAATTACCCTGTTATCCCTAG
HA insertion 
US28  (N-term)
F acggcgtccatgcaccgagggcagaactggtgctatcatgTACCCATACGATGTTCCAGATTAC
GCTacaccgacgacgacgaccgcTGGTCTGACAGTTACCAATGC
HA insertion 
US28  (N-term)
R caaactccgtcgtgagttccgcggtcgtcgtcgtcggtgtAGCGTAATCTGGAACATCGTATGGG
TAcatgatagcaccagttctgcCAATTACCCTGTTATCCCTAG
ΔUS28v1 F aactggtgctatcTACCCATACGATGTTCCAGATTACGCT atgacaccgacgacgacgacTGG
TCTGACAGTTACCAATGC
ΔUS28v1 R gggtttGTATGAAAAGGCCGAGGTAGCGCTTTTTTATTACgtcgtcgtcgtcggtgtcat
CAATTACCCTGTTATCCCTAG
ΔUS28v2 F ACACCGACGACGACGACCGC GGAACTCACGACGGAGTTTGATCCGACGAG
GTGTGTCGCG TGGTCTGACAGTTACCAATGC
ΔUS28v2 R ttacggtataatttgtgagacgcgacacacctcgtcggac AAACTCCGTCGTGAGTTCCCAAT
TACCCTGTTATCCCTAG
ΔUS28 (pEPkan-
S)
F ACACCGACGACGACGACCGCGGAACTCACGACGGAGTTTG GTCCGACGAG
GTGTGTCGCGCAACAAAGCCACGTTGTGTC
ΔUS28 (pEPkan-
S)
F ACACCGACGACGACGACCGCGGAACTCACGACGGAGTTTG GTCCGACGAG
GTGTGTCGCGAGGATGACGACGATAAGTAGGG
ΔUS28 (pEPkan-
S)
R ttacggtataatttgtgagacgcgacacacctcgtcggac CAAACTCCGTCGTGAGTTCCCAA
CCAATTAACCAATTCTGATTAG
ITIM mutation F cgctcgccttttgtcactgttgtctcaatccgctgctgtTcgtcttcgtgggcaccaagtTAGGGATAACAGG
GTAATtg 
ITIM mutation R ACAGTGCAGTTCTTGCCGAAACTTGGTGCCCACGAAGACGaACAGCAGCG
GATTGAGACAAGTCAGGTGGCACTTTTCGG
ITIM mutation F ACAGTGCAGTTCTTGCCGAAACTTGGTGCCCACGAAGACGaACAGCAG
CGGATTGAGACAATGGTCTGACAGTTACCAATGC 
R129Q mutation F tgccagtttgtgttttatcacggagattgcactcgatcAGtactacgctattgtttacatTGGTCTGACAGTT
ACCAATGC
R129Q mutation R GTTTTACAGGCCGATATCTCATGTAAACAATAGCGTAGTActGATCGAGTG
CAATCTCCGTGCAATTACCCTGTTATCCCTAG
ΔN_US28 F aactggtgctatcTACCCATACGATGTTCCAGATTACGCT atgGATGAAGACGCGAC
TCCTTGTGGTCTGACAGTTACCAATGC
ΔN_US28 R TAAGCACGTCGGTGAAAACACAAGGAGTCGCGTCTTCATCcatAGCGTAAT
CTGGAACATCAATTACCCTGTTATCCCTAG
US28_ΔC53 F TGTCACTGTTGTCTCAATCCGCTGCTGTACGTCTTCGTGGGCACCAAGTTT
CGGCAAtaataaaaaagcgctacctcggcTGGTCTGACAGTTACCAATGC
US28_ΔC53 R cacggggttt gtatgaaaaggccgaggtagcgcttttttaTTATTGCCGAAACTTGGTGCCAATT
ACCCTGTTATCCCTAG
US28_ΔC53 
(stop codon) v2
F TCCGCTGCTGTACGTCTTCGTGGGCACCAAGTTTCGGCAAtAAtCTGCACT
GTCTGCTTGCCGATGGTCTGACAGTTACCAATGC
US28_ΔC53 
(stop codon) v2
R AAAAGAGTCGCTGGCGAAACTCGGCAAGCAGACAGTGCAGaTTaTTGCCG
AAACTTGGTGCCCACAATTACCCTGTTATCCCTAG
Red Recombination
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Primer sequence 5'-->3' 
Amp F TGGTCTGACAGTTACCAATGC
I-SceI R CAATTACCCTGTTATCCCTAG
HA insertion 
UL33 (C-tail)
F tcgactctcacaatcgcatcataacctcagcggggtatgaTACCCATACGATGTTCCAGATTAC
GCTgctttcctgttactttattcagaaTGGTCTGACAGTTACCAATGC
HA insertion 
UL33 (C-tail)
R gacgggttctggtgctttctgaataaagtaacaggaaagcAGCGTAATCTGGAACATCGTATG
GGTA tcataccccgctgaggttatCAATTACCCTGTTATCCCTAG
ΔUL33 F gactgcgcccgcggtctgctattcgtccacgatggacaccTCATAACCTCAGCGGGGTATAG
CGTAATCTGGAACATCGTATGGGTA TGGTCTGACAGTTACCAATGC
ΔUL33 R CTGGAACATCGTATGGGTA TCATACCCCGCTGAGGTTATGAggtgtccatcgt
ggacgaat CAATTACCCTGTTATCCCTAG
ITIM F tggtgccccacctacactgcctcattaatcccatcctgtTcgcgctgctgggtcatgattTGGTCTGACA
GTTACCAATGC
ITIM R ctgccgcatgcgttgcagaaaatcatgacccagcagcgcgAacaggatgggattaatgaggCAATTAC
CCTGTTATCCCTAG
UL33_R<>Y 
(DYY)
F gtttgccagtttgtgttttatcacggagattgcactcGATtaCTACtacgctattgtttacaTGGTCTGA
CAGTTACCAATGC
UL33_R<>Y 
(DYY)
R ttttacaggccgatatctcatgtaaacaatagcgtaGTAGtaATCgagtgcaatctccgtgaCAATTA
CCCTGTTATCCCTAG
Red Recombination
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Primer sequence 5'-->3' 
US27galKUS28 F gtgcgtggaccagacggcgtccatgcaccgagggcagaactggtgctatcCCTGTTGACAATTAAT
CATCCGCA
US27galKUS28 R TCGTAGTCAAACTCCGTCGTGAGTTCCGCGGTCGTCGTCGTCGGTGTCATT
CAGCACTGTCCTGCTCCTT
US27galKUS28 
revised
R ttatagcgcttttttaTTACGGTATAATTTGTGAGACGCGACACACCTCTCAGCACT
GTCCTGCTCCTT
US27-HA-US28 F gtgcgtggaccagacggcgtccatgcaccgagggcagaactggtgctatcTACCCATACGATGTTCCA
GATTACGCTggatcc atgacaccgacgacgacgaccgcggaactcacgacggagtttgactacga
US27-HA-US28 R tcgtagtcaaactccgtcgtgagttccgcggtcgtcgtcgtcggtgtcatggatccAGCGTAATCTGGAACA
TCGTATGGGTA gatagcaccagttctgccctcggtgcatggacgccgtctggtccacgcac
HA18bpUS28_ga
lK_6bpUS28lox
F ACCCATACGATGTTCCAGATTACGCTggatcc ATGACACCGACGACGACGCCT
GTTGACAATTAATCATCCGCA
HA18bpUS28_ga
lK_6bpUS28lox
R TTACGGTATAATTTGTGAGACGCGACACACCTCGTCGGACAGCGTGTCGG
TCAGCACTGTCCTGCTCCTT
ΔUS28 F gaactggtgctatcTACCCATACGATGTTCCAGATTACGCTggatcc atgccgtaataaaaaagc
gctaAACTTCGTATAGCATACATTATACGAAGTT
ΔUS28 R AACTTCGTATAATGTATGCTATACGAAGTTtagcgcttttttattacggcatggatccAGC
GTAATCTGGAACATCGTATGGGTA gatagcaccagttc
US28 ITIM recomb between plasmid and parental BAC2
US28 R129Q recomb between plasmid and parental BAC2
ΔN_US28 recomb with plasmid (smaller upstream homology - only 39nt)
US28_ΔC53 F GTTGTCTCAATCCGCTGCTGTACGTCTTCGTGGGCACCAAGTTTCGGCAAT
AAtaaaaaagcgctatAACTTCGTATAGCATACATTATACGAAGTTATAGCG
US28_ΔC53 R CGCTATAACTTCGTATAATGTATGCTATACGAAGTTatagcgcttttttaTTATTGC
CGAAACTTGGTGCCCACGAAGACGTACAGCAGCGGATTGAGACAAC
galK recombineering
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Primer sequence 5'-->3' 
UL33galKUL34 F AAATCCCCCATCGACTCTCACAATCGCATCATAACCTCAGCGGGGTATG
ACCTGTTGACAATTAATCATCCGCA
UL33GalKUL34 
revised
F CGGAAGCGTCGTCGCCCCGGACTGCGCCCGCGGTCTGCTATTCGTCCACG
CCTGTTGACAATTAATCATCCGCA
UL33galKUL34 R gggaaatggcgacgggttctggtgctttctgaataaagtaacaggaaagcTCAGCACTGTCCTGCTC
CTT
UL33-DRY-
GalK
F ACTACTCGAGCTGCACAGTAGGCTTTGCCACCGTAGCCCTGATCGCCGCC
CCTGTTGACAATTAATCATCCGCA
UL33-DRY-
GalK
R gagcggtacgactgccgcgcgtaggtacgcttatgaagaacgcggtatcgTCAGCACTGTCCTGCT
CCTT
UL33_HA F aaatcccccatcgactctcacaatcgcatcataacctcagcggggtatgaTACCCATACGATGTTCCAG
ATTACGCTgctttcctgttactttattcagaaagcaccagaacccgtcgccatttccc
UL33_HA R gggaaatggcgacgggttctggtgctttctgaataaagtaacaggaaagcAGCGTAATCTGGAACATCG
TATGGGTA tcataccccgctgaggttatgatgcgattgtgagagtcgatgggggattt
50bp_galK_23bp
_HA 
F ATGGACACCATCATCCACAACACCACGGTGAGCGCCCCACCTAGAGGGA
GCCTGTTGACAATTAATCATCCGCA
50bp_galK_23bp
_HA 
R TCATACCCCGCTGAGGTTATGATGAGCGTAATCTGGAACATCGTATGGGTA
TCAGCACTGTCCTGCTCCTT
ΔUL33_HA F ATGGACACCATCATCCACAACACCACGGTGAGCGCCCCACCTAGAGGGA
GGGGCATCATAACCTCAGCGGGGTATGATACCCATACGATGTTCCAGATT
ACGCT
ΔUL33_HA R AGCGTAATCTGGAACATCGTATGGGTA TCATACCCCGCTGAGGTTATGAT
GCCCCTCCCTCTAGGTGGGGCGCTCACCGTGGTGTTGTGGATGATGGTGTC
CAT
UL33 ITIM recomb between plasmid and parental BAC2
galK recombineering
